Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - GAMG [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - hTERT-RPE1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - JURKAT [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - OE19 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - SuSa [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" "Single Cell Type RNA - Alveolar cells type 1 [NX]" "Single Cell Type RNA - Alveolar cells type 2 [NX]" "Single Cell Type RNA - B-cells [NX]" "Single Cell Type RNA - Basal glandular cells [NX]" "Single Cell Type RNA - Basal keratinocytes [NX]" "Single Cell Type RNA - Bipolar cells [NX]" "Single Cell Type RNA - Cardiomyocytes [NX]" "Single Cell Type RNA - Cholangiocytes [NX]" "Single Cell Type RNA - Ciliated cells [NX]" "Single Cell Type RNA - Club cells [NX]" "Single Cell Type RNA - Collecting duct cells [NX]" "Single Cell Type RNA - Cone photoreceptor cells [NX]" "Single Cell Type RNA - Cytotrophoblasts [NX]" "Single Cell Type RNA - Distal tubular cells [NX]" "Single Cell Type RNA - Ductal cells [NX]" "Single Cell Type RNA - Early spermatids [NX]" "Single Cell Type RNA - Endothelial cells [NX]" "Single Cell Type RNA - Enterocytes [NX]" "Single Cell Type RNA - Erythroid cells [NX]" "Single Cell Type RNA - Exocrine glandular cells [NX]" "Single Cell Type RNA - Extravillous trophoblasts [NX]" "Single Cell Type RNA - Fibroblasts [NX]" "Single Cell Type RNA - Glandular cells [NX]" "Single Cell Type RNA - granulocytes [NX]" "Single Cell Type RNA - Hepatocytes [NX]" "Single Cell Type RNA - Hofbauer cells [NX]" "Single Cell Type RNA - Horizontal cells [NX]" "Single Cell Type RNA - Intestinal endocrine cells [NX]" "Single Cell Type RNA - Ito cells [NX]" "Single Cell Type RNA - Kupffer cells [NX]" "Single Cell Type RNA - Late spermatids [NX]" "Single Cell Type RNA - Leydig cells [NX]" "Single Cell Type RNA - Macrophages [NX]" "Single Cell Type RNA - Melanocytes [NX]" "Single Cell Type RNA - monocytes [NX]" "Single Cell Type RNA - Mucus-secreting cells [NX]" "Single Cell Type RNA - Muller glia cells [NX]" "Single Cell Type RNA - Pancreatic endocrine cells [NX]" "Single Cell Type RNA - Paneth cells [NX]" "Single Cell Type RNA - Peritubular cells [NX]" "Single Cell Type RNA - Proximal tubular cells [NX]" "Single Cell Type RNA - Rod photoreceptor cells [NX]" "Single Cell Type RNA - Sertoli cells [NX]" "Single Cell Type RNA - Smooth muscle cells [NX]" "Single Cell Type RNA - Spermatocytes [NX]" "Single Cell Type RNA - Spermatogonia [NX]" "Single Cell Type RNA - Suprabasal keratinocytes [NX]" "Single Cell Type RNA - Syncytiotrophoblasts [NX]" "Single Cell Type RNA - T-cells [NX]" "Single Cell Type RNA - Undifferentiated cells [NX]" "Single Cell Type RNA - Urothelial cells [NX]" ABCA4 "ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1" ENSG00000198691 "ATP binding cassette subfamily A member 4" P78363 1 93992835-94121132 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" Translocase "Age-related macular degeneration, Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 142.7" "Group enriched" "Detected in some" 14 "Cone photoreceptor cells: 424.1;Rod photoreceptor cells: 455.0" "Cancer enhanced" "Detected in many" "lung cancer: 3.1" "Region enriched" "Detected in some" 13 "pons and medulla: 25.5" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 5.0;EFO-21: 11.2;HeLa: 3.5;SK-BR-3: 4.2;SuSa: 5.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA064420, HPA078826" Enhanced Approved Cytosol NA NA Cytosol "HPA064420: , HPA078826: " "unprognostic (1.25e-1)" "unprognostic (3.93e-1)" "unprognostic (3.29e-2)" "unprognostic (7.17e-4)" "unprognostic (1.28e-1)" "unprognostic (3.00e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.45e-4)" "unprognostic (3.77e-2)" "unprognostic (5.25e-1)" "unprognostic (3.70e-1)" "unprognostic (5.18e-2)" "unprognostic (1.17e-9)" "unprognostic (1.61e-2)" "unprognostic (1.55e-1)" "unprognostic (2.47e-1)" "prognostic unfavorable (2.72e-4)" 0.7 0.0 0.3 0.2 0.4 0.0 1.1 0.2 0.9 0.7 0.2 3.2 0.2 3.7 0.2 12.9 0.2 0.6 0.2 0.2 2.0 0.2 6.7 1.2 0.4 0.3 0.3 0.2 0.3 0.2 0.0 0.2 0.8 25.5 0.3 0.0 142.7 0.2 2.1 0.2 3.5 4.2 0.2 0.2 0.2 0.1 2.1 0.2 0.2 0.7 0.2 0.2 0.3 0.2 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.5 0.0 0.2 0.0 0.0 0.0 5.0 0.2 0.3 0.0 0.2 0.1 0.0 0.0 11.2 0.5 0.2 1.1 0.0 0.0 0.1 0.0 0.0 0.7 3.5 1.2 0.6 0.0 0.0 0.5 0.0 0.5 0.0 0.2 1.0 0.0 0.0 0.2 0.0 1.4 0.5 0.0 2.0 0.0 0.0 0.2 0.3 0.3 0.5 0.5 0.0 0.0 1.0 4.2 0.2 5.1 0.4 0.0 0.2 0.3 2.2 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.3 0.4 0.2 0.9 2.0 0.2 0.3 0.2 25.5 0.2 0.0 0.6 0.0 0.2 0.1 14.3 0.8 0.0 2.7 0.0 7.0 424.1 0.1 0.0 0.0 8.5 0.8 0.0 0.0 0.0 1.1 0.2 1.5 0.0 0.0 0.1 9.5 0.0 0.6 0.0 15.5 0.0 0.0 0.0 0.0 0.0 31.8 0.0 0.0 0.4 0.0 455.0 0.0 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.5 ABCG4 WHITE2 ENSG00000172350 "ATP binding cassette subfamily G member 4" Q9H172 11 119149012-119162653 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 20.7;parathyroid gland: 7.4;retina: 7.5;testis: 7.2" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 55.0;Rod photoreceptor cells: 47.1" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 5.5;HAP1: 2.9;U-2 OS: 2.8" "Low region specificity" "Detected in all" HPA057635 Enhanced NA NA "HPA057635: " "unprognostic (3.26e-2)" "unprognostic (4.75e-4)" "unprognostic (6.31e-2)" "unprognostic (1.83e-3)" "unprognostic (3.76e-2)" "unprognostic (3.66e-2)" "unprognostic (1.13e-1)" "unprognostic (9.35e-2)" "unprognostic (1.67e-1)" "unprognostic (9.07e-2)" "unprognostic (3.29e-2)" "unprognostic (8.78e-2)" "unprognostic (2.25e-1)" "unprognostic (4.15e-4)" "unprognostic (2.26e-1)" "unprognostic (6.48e-3)" "unprognostic (2.65e-3)" 0.7 1.6 3.9 0.7 5.7 0.3 0.4 20.7 12.8 0.8 0.8 0.8 0.0 0.9 1.1 1.3 1.9 0.6 1.2 2.2 4.9 6.6 0.8 0.5 0.5 0.5 4.7 5.2 0.5 1.2 7.4 0.3 0.7 12.7 0.9 0.7 7.5 0.4 2.0 0.4 1.2 0.7 1.4 1.5 0.5 0.5 7.2 0.5 0.6 1.5 0.0 1.5 0.7 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.4 1.2 5.5 0.8 0.0 0.1 0.2 0.1 0.7 1.5 0.0 0.1 0.0 0.6 0.2 2.4 0.5 2.9 0.3 0.7 0.3 1.0 1.0 0.1 0.0 1.9 0.0 1.6 0.5 0.0 1.0 0.0 0.7 1.2 2.8 0.1 0.1 0.9 0.2 0.4 0.0 2.4 0.0 0.6 0.1 0.0 0.1 0.0 0.0 0.5 1.1 1.7 0.2 0.1 0.3 0.4 0.0 0.2 0.4 2.8 0.4 0.2 0.3 0.3 0.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 5.7 20.7 12.8 4.9 6.6 4.7 5.2 12.7 0.5 0.0 0.0 0.0 0.0 0.0 11.4 0.8 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.4 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 47.1 0.0 0.1 3.1 0.6 0.0 0.1 0.0 0.0 0.0 AC010319.2 ENSG00000269035 19 17436611-17460804 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 32 "retina: 41.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC diff: 1.3;HHSteC: 1.0;THP-1: 1.2" HPA041580 Approved Uncertain "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700" 0.9 0.2 0.4 0.1 0.5 0.1 0.3 0.1 0.5 0.1 0.4 0.1 0.0 0.1 0.1 0.1 0.1 0.5 0.1 0.3 0.5 0.4 0.1 0.1 0.3 0.1 0.2 0.0 0.7 0.1 0.1 0.3 0.1 1.2 0.1 0.1 41.6 0.1 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.5 0.1 0.5 0.5 0.4 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 AIPL1 LCA4 ENSG00000129221 "Aryl hydrocarbon receptor interacting protein like 1" Q9NZN9 17 6393693-6435199 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 37 "retina: 123.7" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 388.8;Rod photoreceptor cells: 1307.2" "Cancer enriched" "Detected in single" 12 "testis cancer: 0.5" "Low region specificity" "Detected in single" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "HaCaT: 4.1;OE19: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA026578 Enhanced Uncertain Nucleoplasm,Cytosol NA NA "Nucleoplasm, Cytosol" "HPA026578: AB_2671905" "unprognostic (2.42e-2)" "unprognostic (1.17e-1)" "unprognostic (2.02e-2)" "unprognostic (1.68e-3)" "unprognostic (3.24e-1)" "unprognostic (1.13e-3)" "unprognostic (3.76e-1)" "unprognostic (5.35e-2)" 0.1 0.1 1.4 0.4 0.3 2.9 0.1 0.5 0.8 0.2 0.1 0.1 0.1 0.0 0.1 0.3 1.1 0.0 0.3 0.1 0.6 0.5 0.1 0.1 0.2 0.1 0.5 0.1 0.2 0.1 0.0 0.8 0.1 0.1 0.1 0.0 123.7 2.3 0.1 0.1 2.4 0.1 0.1 0.1 1.0 0.2 3.3 0.1 0.2 0.4 0.1 0.2 0.1 0.1 1.0 1.1 2.2 0.7 1.1 0.6 0.0 0.1 1.5 0.5 0.1 0.1 0.0 0.4 0.0 0.3 0.1 0.5 0.1 0.1 0.3 0.1 0.0 0.1 4.1 0.1 0.2 0.2 0.2 0.3 0.4 1.7 0.4 0.0 0.2 0.3 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.8 0.0 0.4 0.2 0.1 0.8 7.6 1.3 0.1 0.0 0.0 0.1 1.0 0.2 0.2 0.9 0.3 0.0 0.3 0.2 0.0 0.0 0.3 0.2 0.4 0.3 0.3 0.1 0.1 0.6 0.5 0.2 0.9 0.7 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.3 1.0 0.3 0.4 2.2 1.1 0.5 1.1 0.4 0.0 1.4 0.3 0.5 0.5 0.6 0.5 0.5 0.1 0.1 0.1 3.0 0.6 0.0 1.0 0.7 109.4 0.6 0.0 0.0 2.3 0.0 388.8 0.1 0.0 0.0 7.5 0.3 0.0 0.0 0.0 0.0 0.3 0.5 0.0 0.0 0.1 62.0 0.0 2.5 0.0 1.0 0.0 0.3 1.7 0.0 0.0 135.1 0.1 0.0 0.4 0.0 1307.2 0.0 0.1 0.2 0.0 0.4 0.2 0.0 0.0 2.0 ANKRD33 "C12orf7, DKFZp686O1689, PANKY" ENSG00000167612 "Ankyrin repeat domain 33" Q7Z3H0 12 51887960-51891664 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in some" 14 "placenta: 21.9;retina: 19.5" "Group enriched" "Detected in some" 23 "Cone photoreceptor cells: 157.1;Rod photoreceptor cells: 154.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "BEWO: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" HPA058753 Enhanced NA NA "HPA058753: AB_2683808" "unprognostic (4.42e-2)" "unprognostic (2.13e-5)" "unprognostic (8.25e-4)" "unprognostic (2.37e-1)" "unprognostic (3.25e-5)" "unprognostic (2.42e-1)" "unprognostic (4.07e-1)" "unprognostic (6.21e-2)" "unprognostic (5.51e-10)" "unprognostic (4.41e-3)" "unprognostic (5.56e-2)" "unprognostic (2.18e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 1.5 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.8 21.9 0.0 0.0 0.0 19.5 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.3 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.2 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.7 0.3 0.0 0.0 0.0 154.5 0.0 0.0 0.0 0.2 0.0 4.2 0.0 0.0 0.0 ANO2 "C12orf3, TMEM16B" ENSG00000047617 "Anoctamin 2" Q9NQ90 12 5531869-5946232 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "placenta: 46.9;retina: 30.6;testis: 13.4" "Group enriched" "Detected in many" 12 "Cone photoreceptor cells: 76.6;Early spermatids: 58.6;Late spermatids: 219.4;Rod photoreceptor cells: 168.7" "Cancer enhanced" "Detected in some" "testis cancer: 2.4" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 4 "basophil: 5.1" "Lineage enriched" "Detected in single" 51 "granulocytes: 5.1" "Cell line enhanced" "Detected in some" "BJ hTERT+: 8.6;HUVEC TERT2: 8.5;U-2 OS: 22.5" "Region enriched" "Detected in some" 4 "basal ganglia: 20.0" "HPA036276, HPA057499" Enhanced Supported "Nucleoplasm,Plasma membrane" NA NA "Plasma membrane" Nucleoplasm "HPA036276: AB_10670713, HPA057499: AB_2732613" "unprognostic (6.32e-2)" "unprognostic (1.01e-1)" "unprognostic (3.77e-1)" "unprognostic (1.25e-2)" "unprognostic (1.55e-1)" "unprognostic (4.05e-3)" "unprognostic (2.86e-1)" "unprognostic (2.62e-1)" "unprognostic (1.11e-2)" "unprognostic (1.90e-1)" "unprognostic (1.84e-3)" "unprognostic (3.78e-3)" "unprognostic (1.04e-2)" "unprognostic (1.10e-2)" "unprognostic (9.93e-2)" "unprognostic (2.27e-1)" "unprognostic (2.17e-1)" 5.8 0.1 1.0 1.3 2.3 0.0 4.3 1.2 1.3 3.3 1.0 1.6 0.9 0.8 1.8 2.1 0.9 1.9 1.5 3.9 1.9 0.9 1.2 0.9 4.7 0.9 1.6 2.0 0.9 0.9 1.4 0.9 46.9 1.2 1.4 0.7 30.6 0.9 1.6 2.3 0.6 0.9 2.1 1.1 1.9 1.0 13.4 0.9 0.9 1.6 1.3 0.9 1.3 2.3 0.0 0.0 5.1 0.0 0.0 0.0 0.2 2.2 0.0 4.0 0.0 0.0 0.2 1.9 0.0 8.6 0.4 0.9 0.0 0.1 0.1 0.2 0.0 0.1 0.3 0.0 0.1 0.6 0.2 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 8.5 0.0 0.0 1.7 0.0 0.8 0.0 0.0 4.1 2.0 0.0 1.7 0.0 0.9 0.1 0.1 0.0 0.0 2.1 1.4 0.0 3.7 1.2 0.0 0.2 0.0 22.5 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.2 1.0 2.3 1.2 1.3 1.9 0.9 1.6 2.0 1.2 0.9 0.0 0.0 0.0 0.0 0.0 7.4 1.1 0.0 0.0 0.0 0.0 76.6 1.1 0.0 0.0 58.6 3.6 0.0 0.0 0.0 1.8 0.3 0.0 0.0 0.0 0.2 9.5 0.0 1.8 0.0 219.4 0.3 0.0 0.0 0.0 0.0 10.6 0.0 0.0 1.4 0.0 168.7 0.0 0.4 1.5 1.3 0.1 2.1 0.0 0.0 0.0 ARMS2 "ARMD8, LOC387715" ENSG00000254636 "Age-related maculopathy susceptibility 2" P0C7Q2 10 122454653-122457352 "Disease related genes, Predicted intracellular proteins" "Age-related macular degeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "placenta: 21.2;testis: 6.6" "Group enriched" "Detected in some" 4 "Early spermatids: 16.7;Late spermatids: 45.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.1;HeLa: 1.3;HSkMC: 1.5;SiHa: 1.1;SuSa: 2.1;TIME: 1.3;WM-115: 2.0" HPA067225 Enhanced NA NA "HPA067225: AB_2685806" "unprognostic (3.05e-1)" "unprognostic (1.50e-1)" "unprognostic (5.69e-3)" "unprognostic (2.29e-1)" "unprognostic (2.61e-2)" "unprognostic (2.84e-2)" "unprognostic (3.49e-2)" "unprognostic (1.98e-2)" "unprognostic (3.47e-3)" "unprognostic (3.60e-2)" "unprognostic (5.29e-5)" "unprognostic (2.53e-2)" "unprognostic (9.46e-3)" "unprognostic (2.68e-2)" "unprognostic (5.25e-2)" 0.5 0.0 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.4 0.2 0.2 0.0 0.7 0.2 0.2 0.2 0.4 1.7 0.3 0.2 0.2 0.4 0.2 0.2 0.2 0.2 2.3 0.2 0.0 1.0 21.2 0.2 0.2 0.0 0.2 2.7 0.2 0.2 1.9 0.2 0.2 0.2 0.2 0.2 6.6 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.5 0.0 0.7 0.0 1.1 0.0 0.0 0.0 0.0 0.9 0.3 0.0 0.1 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.2 0.6 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 1.1 0.0 0.0 2.1 0.0 0.0 1.3 0.3 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 16.7 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 45.2 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.5 0.0 7.2 0.0 0.0 0.0 ARR3 ARRX ENSG00000120500 "Arrestin 3" P36575 X 70268305-70281840 "Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 62.9" "Cell type enriched" "Detected in some" 14 "Cone photoreceptor cells: 1449.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 3.7;Karpas-707: 5.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA063129 Enhanced NA NA "HPA063129: AB_2732696" "unprognostic (1.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.70e-2)" "unprognostic (5.37e-2)" "unprognostic (2.82e-1)" "unprognostic (1.37e-2)" "unprognostic (2.06e-2)" "unprognostic (1.22e-1)" "unprognostic (1.35e-2)" "unprognostic (8.09e-2)" "unprognostic (1.33e-1)" "unprognostic (4.02e-3)" "unprognostic (2.77e-7)" "unprognostic (8.64e-2)" "unprognostic (6.53e-2)" "unprognostic (6.06e-2)" "unprognostic (1.43e-1)" 0.3 0.5 0.3 1.0 0.3 0.7 0.3 0.3 0.3 0.3 1.2 0.3 0.3 1.4 0.7 0.3 0.3 0.4 0.7 0.7 0.3 0.2 0.4 0.3 0.3 1.9 0.3 0.3 0.6 0.7 0.0 0.4 0.4 0.3 0.4 0.2 62.9 0.4 0.3 0.5 5.6 3.6 0.3 0.3 0.9 0.8 0.4 0.3 0.3 0.9 0.3 0.3 0.8 0.3 1.3 0.7 0.5 0.4 0.0 1.6 0.3 0.4 0.7 3.2 2.1 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.6 1.1 1.2 0.3 0.0 0.3 0.7 0.0 0.0 0.0 1.4 3.2 0.4 1.1 0.0 0.0 0.7 1.6 0.1 0.0 0.0 0.0 3.7 0.0 1.0 0.4 5.8 0.0 0.5 1.2 0.6 0.9 0.5 0.6 1.1 0.6 0.1 0.0 1.5 0.4 0.9 0.6 0.2 0.1 2.1 0.1 0.4 2.4 1.5 2.0 1.4 0.1 1.4 0.8 0.8 1.3 2.0 1.4 0.0 0.4 0.5 0.9 0.2 0.0 1.3 0.4 0.0 0.5 0.4 1.6 0.1 0.1 0.0 0.0 0.7 0.2 0.3 0.3 0.3 0.3 0.3 0.3 0.2 0.3 0.3 0.3 0.3 0.0 0.0 0.0 0.0 0.0 45.6 0.2 0.0 0.0 0.0 0.0 1449.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.1 0.0 0.0 0.0 0.0 102.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ATP1B2 AMOG ENSG00000129244 "ATPase Na+/K+ transporting subunit beta 2" P14415 17 7646627-7657768 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 148.8" "Group enriched" "Detected in many" 6 "Bipolar cells: 345.9;Cone photoreceptor cells: 235.6;Muller glia cells: 268.9;Rod photoreceptor cells: 188.4" "Cancer enriched" "Detected in many" 17 "glioma: 200.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 13.5;HAP1: 4.1;K-562: 6.1;SuSa: 8.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010698 Supported NA NA 17000 "HPA010698: AB_1845174" "unprognostic (9.39e-2)" "unprognostic (1.86e-2)" "unprognostic (3.89e-3)" "unprognostic (4.96e-3)" "unprognostic (3.90e-3)" "unprognostic (9.33e-2)" "unprognostic (4.86e-1)" "unprognostic (5.93e-2)" "unprognostic (5.43e-2)" "unprognostic (1.29e-2)" "prognostic favorable (1.05e-4)" "unprognostic (1.10e-1)" "prognostic unfavorable (4.17e-4)" "unprognostic (4.60e-3)" "unprognostic (1.43e-1)" "unprognostic (2.24e-1)" "unprognostic (3.79e-2)" 4.1 6.5 54.7 2.5 61.6 8.1 2.5 62.9 148.8 9.4 3.4 25.1 0.0 2.7 8.0 15.1 3.4 10.9 4.4 5.0 46.1 33.4 6.9 3.4 3.9 2.9 42.4 41.9 23.3 3.3 3.8 10.8 5.0 68.9 4.6 3.8 28.4 3.3 7.6 4.6 2.7 3.0 5.8 58.7 4.8 2.4 4.3 25.7 0.0 4.4 0.0 2.6 3.3 2.0 1.3 0.7 1.5 1.0 1.3 2.0 0.5 0.0 0.0 13.5 0.6 0.4 0.3 0.1 0.2 0.0 0.5 0.3 0.5 0.0 0.4 0.3 0.1 0.2 0.4 4.1 0.2 0.2 0.1 1.7 0.3 0.1 0.1 0.2 0.1 1.3 0.8 0.0 0.5 0.0 0.1 0.0 0.3 6.1 0.8 0.0 0.4 0.3 0.4 2.8 0.1 0.3 0.2 0.0 0.2 0.1 0.1 0.2 2.6 0.0 0.1 0.1 8.2 0.2 0.3 0.0 0.2 1.0 0.1 0.2 0.5 0.2 0.1 1.2 0.3 0.3 0.9 1.0 0.5 2.0 0.3 1.8 1.3 0.7 1.4 0.3 0.8 1.1 1.0 1.5 1.3 0.2 0.7 0.2 0.5 54.7 61.6 62.9 50.8 46.1 33.4 42.4 41.9 68.9 25.7 0.0 0.0 0.0 0.2 1.6 345.9 2.8 5.1 0.0 0.0 0.0 235.6 0.0 0.0 0.0 0.2 1.8 0.5 23.3 0.0 0.1 2.4 0.4 0.0 0.0 0.3 17.5 0.0 5.5 1.5 0.2 17.3 0.6 0.0 0.0 0.0 268.9 0.0 0.0 43.5 0.1 188.4 25.8 22.8 0.4 6.3 1.0 0.2 0.0 0.0 0.1 BCO2 "B-DIOX-II, BCDO2, FLJ34464" ENSG00000197580 "Beta-carotene oxygenase 2" Q9BYV7 11 112175467-112224699 "Enzymes, Predicted intracellular proteins" "Dioxygenase, Oxidoreductase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 28.9;liver: 44.0" "Cell type enhanced" "Detected in many" 17 "Cone photoreceptor cells: 386.8;Horizontal cells: 127.1;Rod photoreceptor cells: 238.0" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 5 "NK-cell: 2.8" "Lineage enriched" "Detected in single" 5 "NK-cells: 2.8" "Cell line enhanced" "Detected in some" "CAPAN-2: 7.6;HHSteC: 16.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA061542 Supported NA NA "HPA061542: " "unprognostic (2.92e-1)" "unprognostic (1.89e-1)" "unprognostic (3.76e-2)" "unprognostic (1.40e-1)" "unprognostic (1.91e-1)" "unprognostic (1.50e-2)" "unprognostic (7.60e-3)" "unprognostic (1.88e-1)" "unprognostic (3.18e-2)" "unprognostic (6.40e-2)" "unprognostic (2.39e-2)" "unprognostic (6.91e-2)" "unprognostic (1.36e-4)" "unprognostic (2.31e-2)" "unprognostic (9.86e-2)" "unprognostic (1.07e-2)" "unprognostic (1.34e-1)" 2.3 14.7 4.0 0.9 6.8 0.8 1.3 1.9 4.6 1.2 1.5 5.9 0.3 1.1 2.0 2.8 2.1 9.5 6.0 28.9 3.5 3.9 1.6 44.0 1.8 0.9 10.5 2.6 1.5 1.3 0.8 16.3 3.9 9.5 1.3 1.1 12.4 1.1 1.5 17.3 1.5 1.6 4.4 11.0 1.0 1.1 2.4 9.8 0.0 1.9 1.0 1.3 1.3 2.7 0.3 0.5 0.3 0.6 2.8 0.2 0.0 0.1 1.3 0.6 0.8 0.5 0.6 0.0 0.4 0.3 0.1 0.7 0.0 7.6 0.5 0.6 0.9 0.7 1.6 0.0 0.3 0.5 0.1 0.2 1.0 0.7 0.5 16.4 0.5 0.3 0.1 3.1 0.2 0.5 1.5 0.1 0.1 0.2 0.4 0.1 0.1 0.6 1.6 0.1 0.8 0.2 0.4 0.2 0.2 0.3 0.3 0.6 0.3 0.6 0.3 0.0 0.2 0.4 0.3 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.3 0.0 3.4 0.4 0.1 0.6 0.0 0.1 0.0 0.0 0.3 0.2 0.1 0.5 0.2 0.0 0.0 0.3 2.8 0.2 0.2 0.0 0.0 4.0 6.8 1.9 4.6 3.5 3.9 10.5 2.6 9.5 9.8 3.0 1.9 3.7 15.0 3.0 12.6 42.5 38.2 53.5 9.1 5.2 386.8 0.2 0.0 2.8 2.2 4.0 7.0 0.0 1.8 0.3 5.6 7.3 5.7 78.4 0.9 127.1 7.9 15.4 3.0 1.7 3.7 2.6 1.7 4.6 0.7 13.3 1.2 3.5 3.5 1.0 238.0 0.0 4.6 5.4 2.4 2.8 0.6 3.9 2.9 8.9 BEST1 "BEST, BMD, RP50, VMD2" ENSG00000167995 "Bestrophin 1" O76090 11 61949821-61965515 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Sensory transduction, Transport, Vision" "Chloride channel, Ion channel" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 218.0" "Cell type enhanced" "Detected in many" 5 "granulocytes: 70.9;Macrophages: 85.3" "Group enriched" "Detected in some" 6 "glioma: 2.0;melanoma: 6.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 8 "neutrophil: 23.3" "Lineage enriched" "Detected in many" 8 "granulocytes: 23.3" "Cell line enhanced" "Detected in some" "ASC diff: 9.4;SK-MEL-30: 33.5;U-266/70: 9.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA057464 Enhanced NA NA "HPA057464: AB_2683444" "unprognostic (2.41e-3)" "unprognostic (3.67e-2)" "unprognostic (5.91e-3)" "unprognostic (1.21e-1)" "unprognostic (1.25e-1)" "unprognostic (2.73e-1)" "unprognostic (1.53e-2)" "unprognostic (1.04e-1)" "unprognostic (1.23e-1)" "unprognostic (3.26e-1)" "unprognostic (1.07e-3)" "unprognostic (2.06e-1)" "unprognostic (4.27e-10)" "unprognostic (1.38e-1)" "unprognostic (4.93e-2)" "unprognostic (3.59e-3)" "unprognostic (2.72e-3)" 5.2 2.9 7.4 9.5 11.8 26.4 2.3 1.6 12.6 2.0 1.4 16.0 0.7 2.1 2.6 9.6 3.0 2.6 6.2 2.5 9.2 5.3 1.4 1.1 4.7 2.5 14.8 6.0 3.7 2.2 0.5 1.4 2.8 9.4 1.6 1.3 218.0 1.2 1.9 0.7 3.0 2.0 2.1 16.9 5.4 1.3 3.9 13.3 0.3 2.3 0.4 0.6 3.9 2.3 0.3 1.6 23.3 2.8 0.1 0.1 0.9 0.5 0.5 0.2 0.4 9.4 2.0 0.9 0.7 1.2 0.2 0.8 0.3 0.3 0.1 1.3 0.6 1.3 0.7 0.0 0.0 0.1 0.1 0.1 0.0 3.6 0.6 2.9 0.1 0.3 2.7 1.1 1.2 2.6 1.2 0.0 0.5 0.5 5.3 1.2 0.3 0.1 0.4 0.0 0.5 1.3 0.0 0.1 0.2 0.0 1.3 0.7 0.5 1.0 0.1 33.5 0.5 0.5 1.3 0.1 0.6 0.4 0.5 0.2 9.0 0.5 0.5 3.4 0.4 1.0 1.5 2.3 2.1 0.1 2.7 0.1 0.3 0.1 0.1 1.6 0.1 0.1 0.0 23.3 0.1 2.8 0.3 0.1 0.9 7.4 11.8 1.6 5.9 9.2 5.3 14.8 6.0 9.4 13.3 23.8 66.0 6.0 5.8 32.3 1.8 3.2 12.7 37.5 62.6 1.8 0.0 12.7 0.0 2.4 6.6 8.3 19.1 0.0 2.9 18.2 15.0 9.1 70.9 4.7 33.7 0.0 9.9 22.7 60.1 1.8 14.1 85.3 52.3 4.6 10.3 6.0 3.0 14.4 6.3 4.8 9.0 6.5 8.3 1.6 2.8 28.5 17.0 10.2 10.9 5.4 CABP5 CaBP3 ENSG00000105507 "Calcium binding protein 5" Q9NP86 19 48029953-48044053 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "retina: 53.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 87.0;Rod photoreceptor cells: 222.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "basophil: 2.2" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.2" "Cell line enhanced" "Detected in single" "HBF TERT88: 1.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA043698 Enhanced NA NA "HPA043698: AB_10797147" 0.0 0.1 0.1 0.0 0.2 2.2 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.1 0.0 0.2 0.2 0.2 0.0 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 53.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 1.7 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.2 0.0 0.4 9.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.4 9.9 0.1 0.2 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 87.0 0.3 0.0 0.0 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.0 0.0 0.0 222.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CACNA1F "AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2" ENSG00000102001 "Calcium voltage-gated channel subunit alpha1 F" O60840 X 49205063-49233371 "Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Calcium transport, Ion transport, Sensory transduction, Transport, Vision" "Calcium channel, Ion channel, Voltage-gated channel" "Cone-rod dystrophy, Congenital stationary night blindness, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 10 "retina: 55.8" "Group enriched" "Detected in some" 15 "Bipolar cells: 66.5;Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 91.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "plasmacytoid DC: 4.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "MCF7: 2.8;U-266/70: 4.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA068379 Enhanced NA NA "HPA068379: AB_2732782" "unprognostic (1.20e-3)" "unprognostic (8.62e-2)" "unprognostic (4.25e-3)" "unprognostic (1.56e-2)" "unprognostic (8.46e-2)" "unprognostic (1.84e-1)" "unprognostic (1.23e-2)" "unprognostic (1.76e-1)" "unprognostic (1.23e-1)" "unprognostic (9.04e-2)" "unprognostic (7.36e-2)" "unprognostic (1.59e-1)" "unprognostic (6.08e-7)" "unprognostic (8.03e-2)" "unprognostic (1.09e-1)" "unprognostic (4.65e-2)" "unprognostic (3.77e-3)" 0.7 0.8 1.8 0.7 1.5 4.0 1.8 5.3 2.0 0.7 1.0 0.7 0.7 1.9 0.7 2.7 0.7 1.0 0.7 0.7 0.8 0.6 0.7 0.7 1.4 2.7 0.7 0.7 0.7 1.4 0.0 0.7 0.7 0.7 0.7 1.5 55.8 1.2 0.9 0.7 2.4 3.7 0.7 0.7 1.8 1.0 0.7 0.7 0.7 1.2 0.7 0.9 0.7 0.7 1.4 4.6 2.0 0.9 0.5 1.0 0.2 0.2 2.5 0.2 0.0 0.6 0.0 2.5 0.4 0.2 0.0 0.0 0.1 0.9 1.4 0.5 0.5 0.0 0.1 0.4 0.0 0.0 0.1 0.0 0.7 0.0 0.5 0.6 0.1 0.8 0.6 0.0 0.4 0.0 0.2 0.8 0.8 1.0 0.3 0.0 2.8 1.3 1.5 1.1 1.9 0.0 0.1 0.0 0.5 0.4 1.5 0.6 0.0 0.0 0.1 0.0 0.9 0.9 1.5 1.0 0.2 0.3 0.3 0.1 4.6 1.6 0.1 0.8 0.4 0.0 0.9 0.7 0.6 0.6 0.5 0.5 0.7 0.8 0.4 0.8 1.4 0.5 1.0 2.0 0.5 0.9 4.6 0.7 0.2 1.8 1.5 5.3 2.0 0.8 0.6 0.7 0.7 0.7 0.7 0.0 0.3 0.0 0.1 0.0 66.5 1.2 0.0 0.0 0.0 1.8 125.7 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.2 6.4 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.3 5.5 0.0 0.0 0.4 0.0 91.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.3 0.1 CDHR1 "CORD15, KIAA1775, PCDH21, RP65" ENSG00000148600 "Cadherin related family member 1" Q96JP9 10 84194635-84219621 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" Receptor "Cone-rod dystrophy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 31.2;intestine: 22.6;retina: 42.5;skin 1: 86.8" "Group enriched" "Detected in many" 5 "Cone photoreceptor cells: 357.4;Rod photoreceptor cells: 231.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 13.8" "Region enhanced" "Detected in many" "basal ganglia: 31.2" "Cell type enriched" "Detected in single" 11 "NK-cell: 10.5" "Lineage enriched" "Detected in single" 11 "NK-cells: 10.5" "Cell line enhanced" "Detected in some" "HAP1: 10.5;HEK 293: 5.4;HEL: 6.3;K-562: 4.5;NTERA-2: 4.6;RPTEC TERT1: 17.2" "Region enriched" "Detected in some" 21 "olfactory region: 408.8" "Low region specificity" "Detected in all" HPA036819 Enhanced "Intracellular and membrane" NA NA "HPA036819: AB_10671750" "unprognostic (8.91e-4)" "unprognostic (5.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.71e-2)" "unprognostic (2.63e-2)" "unprognostic (3.03e-2)" "unprognostic (6.40e-2)" "unprognostic (7.77e-2)" "unprognostic (1.41e-1)" "unprognostic (2.67e-1)" "unprognostic (6.69e-4)" "unprognostic (1.90e-1)" "unprognostic (5.51e-3)" "unprognostic (1.26e-1)" "unprognostic (2.27e-1)" "unprognostic (4.56e-3)" "unprognostic (5.07e-2)" 0.3 1.2 1.9 0.7 31.2 0.5 2.3 0.9 7.7 2.8 12.3 2.2 0.0 0.3 0.6 2.2 4.8 0.6 0.5 0.9 3.4 2.1 0.5 0.5 0.4 0.7 1.5 3.1 0.8 0.4 0.3 1.5 0.4 9.3 0.9 22.6 42.5 1.0 2.2 0.7 86.8 5.3 0.9 1.2 3.0 0.4 0.4 3.0 2.4 0.4 3.3 0.9 0.4 1.5 0.0 0.0 0.0 0.0 10.5 0.9 0.1 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 10.5 2.0 0.0 0.0 5.4 6.3 0.0 0.0 0.2 0.0 0.2 0.0 2.3 0.0 0.8 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 1.5 4.6 0.0 0.0 0.0 0.0 1.4 17.2 0.0 3.6 0.8 0.0 0.0 0.0 2.7 0.0 0.2 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.7 0.0 0.9 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 10.5 0.0 0.0 0.0 0.1 1.9 31.2 0.9 7.7 3.4 2.1 1.5 3.1 9.3 3.0 0.0 0.3 0.0 0.3 45.4 19.5 1.0 0.0 0.0 1.2 0.0 357.4 0.0 0.0 0.0 0.0 0.0 26.2 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 4.8 12.2 0.0 0.3 0.0 0.0 0.0 3.3 0.0 35.5 25.1 0.0 24.6 0.0 0.1 231.3 0.0 0.2 0.0 0.0 59.0 0.0 2.9 47.2 0.1 CFAP161 "C15orf26, FLJ38615" ENSG00000156206 "Cilia and flagella associated protein 161" Q6P656 15 81007033-81149175 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 18.0;fallopian tube: 22.4;retina: 14.9;testis: 18.2" "Cell type enhanced" "Detected in some" 27 "Ciliated cells: 42.8;Club cells: 6.8;Early spermatids: 13.4;Spermatocytes: 11.9" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Region enhanced" "Detected in many" "pons and medulla: 18.0" "Cell type enhanced" "Detected in single" "neutrophil: 2.3" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "HEL: 42.4;K-562: 14.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA076975 Supported NA NA "HPA076975: " "unprognostic (1.19e-1)" "unprognostic (1.47e-1)" "unprognostic (6.07e-2)" "prognostic favorable (3.05e-4)" "unprognostic (1.57e-3)" "unprognostic (2.81e-1)" "unprognostic (1.22e-1)" "unprognostic (1.38e-1)" "unprognostic (2.18e-1)" "unprognostic (1.73e-1)" "unprognostic (3.33e-2)" "unprognostic (3.13e-1)" "unprognostic (1.29e-3)" "unprognostic (8.93e-2)" "unprognostic (1.47e-1)" "unprognostic (9.24e-2)" "unprognostic (6.22e-2)" 0.8 0.4 2.3 0.4 5.2 0.9 0.6 0.4 1.1 1.5 0.4 6.8 0.2 0.2 1.1 5.4 0.4 22.4 0.5 1.1 3.3 3.3 0.5 0.5 4.0 0.3 0.6 1.1 4.2 2.7 0.2 9.9 2.1 18.0 0.4 0.3 14.9 0.5 0.5 0.5 0.9 0.4 0.6 0.8 0.9 0.5 18.2 1.5 0.0 1.0 0.0 0.6 0.5 0.2 0.0 0.3 2.3 0.4 0.0 0.7 7.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 42.4 0.0 0.1 0.0 0.0 5.7 0.0 0.0 0.1 0.5 0.0 0.9 0.0 14.2 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.6 0.1 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.7 0.0 0.0 0.5 0.4 0.0 0.2 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.0 0.1 2.3 0.0 0.1 0.1 0.0 7.3 2.3 5.2 0.4 1.1 3.3 3.3 0.6 1.1 18.0 1.5 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 42.8 6.8 0.0 0.0 0.0 0.0 0.0 13.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 11.9 2.5 0.0 0.0 0.0 0.0 0.1 CHRNA3 ENSG00000080644 "Cholinergic receptor nicotinic alpha 3 subunit" P32297 15 78593052-78621295 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "adrenal gland: 33.6;lymphoid tissue: 57.2;retina: 74.1" "Cell type enriched" "Detected in some" 18 "Cone photoreceptor cells: 155.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 6.0" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 5 "SH-SY5Y: 86.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA029430 Enhanced NA NA "HPA029430: AB_10603785" "unprognostic (2.28e-1)" "unprognostic (3.45e-1)" "unprognostic (2.58e-2)" "unprognostic (2.36e-1)" "unprognostic (1.32e-1)" "unprognostic (1.12e-1)" "unprognostic (9.16e-3)" "unprognostic (1.97e-1)" "unprognostic (4.28e-2)" "unprognostic (7.20e-2)" "unprognostic (3.12e-1)" "unprognostic (1.01e-1)" "unprognostic (1.86e-4)" "unprognostic (2.65e-3)" "unprognostic (2.76e-1)" "unprognostic (1.53e-1)" "unprognostic (4.48e-1)" 0.4 33.6 0.8 4.0 2.4 0.1 0.3 6.0 0.4 0.5 8.2 0.7 0.2 1.2 0.5 0.1 0.5 0.1 0.8 0.4 0.2 0.8 0.1 0.1 0.3 2.8 0.4 0.0 0.1 0.2 0.1 1.5 0.2 1.2 0.6 3.4 74.1 0.2 0.6 0.1 0.6 2.9 2.8 0.2 0.2 3.6 0.9 0.5 57.2 0.2 0.2 0.7 0.8 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 2.1 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 5.3 0.0 0.0 0.0 0.0 1.5 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.1 16.4 86.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 2.4 6.0 0.4 0.2 0.8 0.4 0.0 1.2 0.5 0.0 0.0 0.0 0.0 0.0 4.2 0.6 0.0 0.0 0.0 0.0 155.1 0.0 1.7 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 2.7 2.5 0.1 0.0 0.0 0.0 8.5 0.0 0.0 0.2 1.9 0.0 0.0 0.0 0.0 0.1 CLIC6 "CLIC1L, CLIC5" ENSG00000159212 "Chloride intracellular channel 6" Q96NY7 21 34669389-34718227 "Predicted intracellular proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "brain: 63.3;retina: 85.1;stomach 1: 45.1" "Cell type enhanced" "Detected in many" 13 "Cholangiocytes: 30.6;Ciliated cells: 72.3;Club cells: 52.4" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 12 "pons and medulla: 63.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;NTERA-2: 5.9;T-47d: 12.0;THP-1: 5.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065285 Enhanced NA NA "HPA065285: AB_2685454" "prognostic favorable (6.11e-5)" "unprognostic (2.17e-2)" "unprognostic (1.65e-2)" "unprognostic (4.27e-2)" "unprognostic (2.93e-2)" "unprognostic (2.67e-2)" "unprognostic (2.78e-2)" "prognostic favorable (3.15e-5)" "unprognostic (4.90e-3)" "unprognostic (1.53e-1)" "unprognostic (5.52e-2)" "unprognostic (3.26e-2)" "unprognostic (1.66e-2)" "unprognostic (1.16e-2)" "unprognostic (3.48e-1)" "unprognostic (1.99e-1)" "unprognostic (1.43e-3)" 7.7 0.0 0.8 3.0 1.7 0.0 5.7 0.6 2.3 8.7 1.8 12.4 0.6 0.9 1.0 5.2 1.2 6.1 4.5 6.3 5.4 1.0 0.9 0.6 6.4 0.4 0.4 0.5 2.3 1.2 0.0 1.3 0.6 63.3 4.0 1.3 85.1 10.9 3.8 1.9 2.3 1.1 1.9 0.6 0.7 45.1 1.1 0.6 2.4 8.2 0.9 1.8 7.5 2.0 0.3 0.1 0.4 0.0 0.2 0.5 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 1.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.9 0.0 0.0 0.1 0.1 0.0 0.1 0.0 4.4 0.2 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.4 1.7 12.0 5.3 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.4 0.0 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.5 0.1 0.2 0.0 0.0 0.0 0.1 0.8 1.7 0.6 2.3 5.4 1.0 0.4 0.5 63.3 0.6 6.0 20.2 0.0 4.6 0.6 0.0 5.3 30.6 72.3 52.4 8.7 0.0 0.0 1.7 6.3 0.0 0.0 0.2 0.0 0.8 0.0 3.8 9.0 1.1 0.0 0.1 0.0 4.7 0.0 0.0 0.0 0.3 0.0 6.8 1.0 1.0 0.0 15.9 0.0 2.8 0.0 0.0 0.0 0.4 0.2 0.1 0.4 0.0 0.0 3.3 13.7 CLUL1 ENSG00000079101 "Clusterin like 1" Q15846 18 596988-650334 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 45.2" "Cell type enriched" "Detected in many" 7 "Rod photoreceptor cells: 335.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Hep G2: 24.6" "Not detected" "Not detected" "CAB025264, HPA075240" Enhanced Approved "Endoplasmic reticulum,Plasma membrane" "Secreted in other tissues" NA NA "Endoplasmic reticulum" "Plasma membrane" "CAB025264: , HPA075240: AB_2732286" "unprognostic (1.75e-2)" "unprognostic (9.15e-2)" "unprognostic (1.50e-1)" "unprognostic (1.51e-1)" "unprognostic (7.81e-3)" "unprognostic (3.00e-3)" "unprognostic (1.96e-1)" "unprognostic (2.97e-3)" "unprognostic (8.38e-3)" "unprognostic (3.76e-2)" "unprognostic (4.85e-3)" "unprognostic (4.96e-3)" "unprognostic (6.36e-4)" "unprognostic (1.32e-1)" "unprognostic (7.89e-2)" "unprognostic (1.29e-3)" "unprognostic (2.37e-2)" 0.5 1.4 5.0 0.5 3.8 4.3 3.1 4.5 6.6 2.1 1.0 1.4 1.0 0.6 1.9 0.7 1.6 2.4 2.5 0.4 5.9 6.4 7.5 0.7 1.8 0.8 4.9 2.0 7.4 1.6 2.5 6.1 0.7 5.1 12.0 0.0 45.2 3.1 1.6 0.1 0.8 1.7 0.4 5.3 0.1 3.9 3.4 2.8 0.3 9.4 0.1 0.4 2.1 0.3 1.0 1.3 2.1 0.3 0.1 2.0 0.5 2.6 3.9 7.5 5.1 0.0 0.0 4.5 2.9 0.2 0.0 0.0 3.1 1.5 3.1 0.7 0.0 2.7 1.1 0.0 0.4 0.0 2.5 7.0 5.2 2.1 24.6 0.0 1.7 1.0 0.2 0.0 0.0 0.0 1.3 0.3 7.7 7.3 9.1 0.0 0.8 3.1 5.6 0.5 3.2 1.8 6.3 3.5 11.0 0.8 0.8 6.6 4.6 2.9 1.8 2.2 6.3 2.4 0.8 0.6 3.0 4.4 2.1 1.4 5.2 9.1 6.5 2.4 3.4 2.6 0.9 0.3 0.2 0.2 0.0 0.1 1.0 0.4 0.2 0.5 0.1 0.1 0.8 2.1 0.1 0.0 1.3 2.0 0.5 5.0 3.8 4.5 5.7 5.9 6.4 4.9 2.0 5.1 2.8 0.0 1.6 0.0 3.4 0.0 23.9 0.1 0.0 4.0 2.3 0.0 19.6 0.4 1.7 0.2 0.4 0.2 0.0 0.0 0.2 0.1 0.1 8.5 0.0 0.0 0.2 15.9 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 46.9 0.0 0.0 1.1 0.3 335.8 6.5 0.0 8.4 4.5 0.1 0.3 0.0 0.0 1.4 CNGB3 "ACHM1, ACHM3, RMCH" ENSG00000170289 "Cyclic nucleotide gated channel beta 3" Q9NQW8 8 86553977-86743675 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel" "Disease mutation, Stargardt disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 68.9" "Cell type enriched" "Detected in some" 21 "Cone photoreceptor cells: 149.2" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "SCLC-21H: 21.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA057244 Enhanced NA NA "HPA057244: AB_2683380" "unprognostic (5.35e-1)" "unprognostic (1.68e-3)" "unprognostic (1.22e-1)" "unprognostic (2.42e-1)" "unprognostic (3.62e-2)" "unprognostic (2.58e-1)" "unprognostic (6.25e-2)" "unprognostic (1.18e-1)" "unprognostic (2.91e-1)" "unprognostic (2.17e-1)" "unprognostic (3.82e-1)" "unprognostic (9.28e-2)" "unprognostic (2.77e-4)" "unprognostic (1.40e-4)" "unprognostic (1.66e-2)" "unprognostic (8.76e-2)" "unprognostic (1.84e-1)" 0.2 0.1 0.4 0.4 0.2 7.9 0.2 0.2 1.0 0.9 0.1 0.1 0.1 0.9 0.7 0.4 0.2 2.8 0.1 0.3 0.2 0.2 0.2 0.1 0.1 0.3 0.6 0.1 1.0 1.5 0.0 0.6 0.1 1.8 0.1 0.0 68.9 0.3 0.1 0.1 2.4 0.4 0.1 0.8 0.1 0.6 5.4 0.1 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.2 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.4 0.1 0.1 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.4 0.0 1.4 0.1 0.0 0.0 3.1 0.3 0.0 0.0 0.4 0.0 1.6 21.6 0.0 0.0 0.7 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.3 0.5 0.2 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.4 0.2 0.2 1.0 0.2 0.2 0.6 0.1 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.8 0.8 0.0 0.0 0.0 0.0 149.2 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.2 0.0 0.1 1.0 0.0 0.3 0.0 0.0 0.0 0.0 COL9A1 ENSG00000112280 "Collagen type IX alpha 1 chain" P20849 6 70215061-70303083 "Disease related genes, Predicted secreted proteins" "Deafness, Stickler syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 29.6;retina: 52.6" "Cell type enhanced" "Detected in some" 27 "Early spermatids: 18.1;Horizontal cells: 33.4;Muller glia cells: 88.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "AF22: 23.7;NTERA-2: 8.0" "Not detected" "Not detected" HPA074749 Enhanced "Secreted to extracellular matrix" NA NA "HPA074749: AB_2732266" "unprognostic (2.18e-2)" "unprognostic (2.16e-1)" "unprognostic (2.25e-2)" "unprognostic (3.48e-3)" "unprognostic (5.72e-2)" "unprognostic (5.32e-4)" "unprognostic (3.24e-3)" "unprognostic (8.79e-2)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (8.27e-2)" "unprognostic (2.52e-1)" "unprognostic (5.69e-2)" "unprognostic (1.54e-1)" "unprognostic (2.09e-1)" "unprognostic (2.78e-1)" "unprognostic (3.62e-2)" 0.7 0.6 8.5 0.7 7.5 0.5 0.6 3.6 4.7 0.6 1.1 7.2 0.0 1.8 1.1 0.8 0.8 0.7 1.1 5.6 8.4 9.4 1.1 0.5 0.6 0.6 10.3 1.7 0.6 0.5 0.9 3.3 0.6 5.6 29.6 1.4 52.6 3.0 1.1 0.6 0.6 2.0 0.9 5.3 0.6 2.6 4.1 6.9 0.0 1.0 0.2 0.7 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 7.5 3.6 4.7 8.4 9.4 10.3 1.7 5.6 6.9 0.0 0.0 0.0 0.1 0.0 0.2 3.5 0.0 0.0 0.0 0.0 3.9 0.0 1.7 0.0 18.1 0.0 0.2 0.0 0.2 0.0 0.0 1.7 0.0 0.0 0.1 33.4 1.2 0.0 0.0 9.0 0.0 0.0 0.0 0.0 0.4 88.9 0.0 0.0 0.4 0.0 1.8 0.0 1.4 0.6 0.7 0.0 0.0 0.0 1.1 0.1 CPLX4 CPX-IV ENSG00000166569 "Complexin 4" Q7Z7G2 18 59275156-59318649 "Predicted intracellular proteins" "Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 10 "retina: 61.9" "Group enriched" "Detected in some" 5 "Bipolar cells: 55.6;Cone photoreceptor cells: 106.0;Rod photoreceptor cells: 128.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "cerebellum: 6.3" "Cell type enhanced" "Detected in single" "neutrophil: 1.7" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HeLa: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA047627 Enhanced NA NA "HPA047627: " "unprognostic (1.85e-1)" "unprognostic (4.46e-1)" "unprognostic (4.20e-2)" "unprognostic (4.05e-2)" "unprognostic (9.90e-3)" 0.1 0.3 0.2 0.0 0.1 2.8 0.1 6.3 0.2 0.1 0.1 0.1 0.0 0.2 0.1 0.8 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.2 0.3 0.0 0.1 0.2 0.0 0.2 0.0 0.4 0.1 0.0 61.9 0.3 0.0 0.3 1.9 0.1 0.0 0.2 0.3 0.1 1.2 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.6 0.7 1.7 0.3 0.8 0.7 0.1 0.2 0.8 0.5 0.8 0.7 0.2 0.9 0.9 0.0 0.1 0.0 0.3 0.6 0.5 0.1 0.2 0.2 1.1 0.2 0.0 1.2 0.3 0.0 0.2 1.6 0.9 0.0 0.0 0.3 0.3 0.6 0.0 0.0 0.0 0.0 0.4 0.1 0.7 0.7 0.4 0.3 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.9 0.4 0.2 0.0 0.9 0.0 0.6 0.1 0.3 0.6 0.6 0.2 0.9 0.0 0.8 0.4 0.4 0.1 0.2 0.7 0.4 0.3 0.1 0.3 0.0 0.3 0.1 0.4 0.3 0.0 0.6 0.2 0.7 1.7 0.8 0.1 0.7 0.2 0.1 0.2 0.1 6.3 0.1 0.1 0.1 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 55.6 0.3 0.0 0.0 0.0 0.0 106.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 128.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 CRABP1 "CRABP, CRABP-I, CRABPI, RBP5" ENSG00000166426 "Cellular retinoic acid binding protein 1" P29762 15 78340324-78348230 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 40.1;retina: 73.2;thyroid gland: 80.6" "Cell type enriched" "Detected in some" 23 "Muller glia cells: 4142.9" "Cancer enhanced" "Detected in many" "ovarian cancer: 117.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 13 "myeloid DC: 1.2" "Lineage enriched" "Detected in single" 13 "dendritic cells: 1.2" "Group enriched" "Detected in some" 8 "AF22: 146.8;NTERA-2: 43.9" "Group enriched" "Detected in many" 5 "amygdala: 6.6;basal ganglia: 20.9;hypothalamus: 15.5;olfactory region: 15.7;pons and medulla: 7.8" "Low region specificity" "Detected in many" HPA017203 Enhanced Supported NA NA "HPA017203: AB_1846512" "unprognostic (1.23e-1)" "unprognostic (3.76e-3)" "unprognostic (1.46e-1)" "prognostic unfavorable (4.72e-4)" "unprognostic (2.01e-1)" "unprognostic (4.35e-2)" "unprognostic (1.05e-1)" "unprognostic (1.35e-1)" "unprognostic (2.45e-2)" "unprognostic (9.79e-2)" "unprognostic (1.21e-1)" "unprognostic (2.79e-2)" "unprognostic (9.37e-2)" "unprognostic (2.17e-1)" "unprognostic (1.07e-1)" "unprognostic (2.69e-1)" 0.7 1.3 6.3 1.8 25.6 0.6 24.8 2.8 12.4 1.2 1.9 3.3 0.3 0.9 1.5 1.9 0.7 0.5 1.2 0.7 1.1 21.9 4.2 0.5 0.8 0.6 16.9 4.5 0.7 0.7 0.5 6.3 7.0 40.1 1.0 1.3 73.2 0.6 24.8 0.5 12.3 2.3 1.3 7.3 21.1 1.9 0.6 2.4 0.4 80.6 2.4 1.0 0.7 0.4 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 146.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.1 0.0 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 7.8 0.0 43.9 0.1 0.1 0.0 0.0 0.0 0.0 0.2 12.3 8.3 0.0 0.0 0.0 3.7 0.2 5.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.3 25.6 2.8 12.4 1.1 21.9 16.9 4.5 40.1 2.4 0.0 0.0 0.0 0.0 8.7 31.5 0.0 0.0 0.0 0.0 0.0 31.4 0.7 59.7 0.0 0.0 0.0 0.2 0.0 0.0 0.4 7.4 0.3 0.0 0.0 1.3 9.5 0.0 0.0 0.0 0.0 0.0 0.0 182.2 0.0 0.0 4142.9 0.0 0.0 0.0 0.5 73.8 0.0 0.0 0.0 1.5 2.3 1.1 0.0 0.0 0.0 CRB1 "LCA8, RP12" ENSG00000134376 "Crumbs 1, cell polarity complex component" P82279 1 197268204-197478455 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 155.1;Muller glia cells: 100.9;Rod photoreceptor cells: 136.0" "Cancer enriched" "Detected in single" 12 "glioma: 2.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "basophil: 9.4" "Lineage enriched" "Detected in single" 22 "granulocytes: 9.4" "Cell line enriched" "Detected in some" 8 "HeLa: 17.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA061250, HPA063127" Approved Uncertain Vesicles "Intracellular and membrane" NA NA Vesicles "HPA061250: AB_2684458, HPA063127: AB_2684944" "unprognostic (1.96e-1)" "unprognostic (5.38e-3)" "unprognostic (2.92e-3)" "unprognostic (1.50e-2)" "unprognostic (5.13e-1)" "unprognostic (3.28e-2)" "unprognostic (2.38e-1)" "unprognostic (2.49e-2)" "unprognostic (1.05e-1)" "unprognostic (1.48e-3)" "unprognostic (2.59e-1)" "unprognostic (2.01e-3)" "unprognostic (1.78e-3)" "unprognostic (1.56e-1)" "unprognostic (3.36e-2)" "unprognostic (2.96e-1)" 1.1 1.1 11.9 0.9 11.0 1.8 1.2 31.4 20.4 0.9 0.9 10.4 0.0 0.9 0.8 1.2 1.1 2.0 1.0 1.2 11.4 6.2 1.1 0.9 1.0 1.0 4.0 8.9 2.6 1.7 0.7 1.9 0.9 14.1 1.0 0.9 9.0 0.8 0.9 2.4 0.9 0.9 0.8 8.7 0.9 1.5 7.3 9.6 0.0 1.3 0.0 0.8 0.9 0.1 0.1 0.0 9.4 0.0 0.1 0.4 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 1.0 17.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 2.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.4 0.3 0.1 0.0 0.0 0.0 0.0 11.9 11.0 31.4 10.5 11.4 6.2 4.0 8.9 14.1 9.6 0.0 0.0 0.0 0.2 0.2 12.7 1.2 0.0 0.0 0.0 0.0 155.1 0.0 0.0 0.0 1.4 0.0 0.0 23.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.9 1.7 0.0 0.0 0.0 0.0 100.9 0.0 0.0 0.4 0.0 136.0 0.0 0.0 0.7 0.1 0.3 0.0 0.0 0.0 0.0 CRB2 "FLJ16786, FLJ38464" ENSG00000148204 "Crumbs 2, cell polarity complex component" Q5IJ48 9 123356170-123380324 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Gastrulation "Developmental protein" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.9;Cone photoreceptor cells: 111.9;Rod photoreceptor cells: 97.1" "Group enriched" "Detected in some" 7 "glioma: 9.4;ovarian cancer: 5.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 7 "AF22: 27.4" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA043674 Approved Supported "Intracellular and membrane" NA NA 240000 "HPA043674: AB_10962974" "unprognostic (1.38e-2)" "unprognostic (2.39e-2)" "unprognostic (1.26e-1)" "unprognostic (2.83e-4)" "unprognostic (2.85e-2)" "unprognostic (1.14e-2)" "unprognostic (2.31e-1)" "unprognostic (3.69e-4)" "unprognostic (1.20e-1)" "unprognostic (7.28e-3)" "unprognostic (4.66e-3)" "unprognostic (3.09e-1)" "unprognostic (5.56e-5)" "unprognostic (1.31e-1)" "unprognostic (1.55e-1)" "unprognostic (4.38e-2)" "unprognostic (3.38e-1)" 1.3 0.6 6.8 1.9 8.7 1.3 1.0 3.0 16.2 0.5 2.4 21.5 0.0 0.9 2.4 0.9 0.7 3.4 0.5 0.6 9.7 3.7 5.7 0.5 0.6 2.4 7.3 17.4 0.9 0.5 0.5 1.3 0.7 7.4 0.6 1.7 5.1 0.6 0.6 0.5 1.0 1.0 1.3 9.5 1.8 1.1 1.1 7.7 0.0 0.6 0.0 2.3 0.7 0.2 0.3 0.0 0.7 0.0 0.0 0.2 0.0 0.0 0.1 27.4 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.1 0.3 0.8 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.4 0.0 0.0 3.7 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.6 0.9 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 6.8 8.7 3.0 8.2 9.7 3.7 7.3 17.4 7.4 7.7 0.0 0.0 0.0 0.0 0.2 30.9 2.2 0.0 0.0 0.0 1.8 111.9 0.0 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 2.3 0.0 1.1 0.0 0.2 3.2 2.9 0.0 0.0 6.2 1.7 0.0 0.0 0.0 2.8 4.9 0.0 0.0 0.0 0.0 97.1 0.0 0.4 0.1 0.1 0.5 0.2 0.0 3.1 0.1 CRX "CORD2, CRD, LCA7, OTX3" ENSG00000105392 "Cone-rod homeobox" O43186 19 47819779-47843330 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Differentiation, Neurogenesis, Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Cone-rod dystrophy, Disease mutation, Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 42 "retina: 125.2" "Group enriched" "Detected in many" 7 "Bipolar cells: 121.9;Cone photoreceptor cells: 269.0;Rod photoreceptor cells: 472.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "NTERA-2: 3.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA036762, HPA036763" Enhanced NA NA "HPA036762: AB_10673663, HPA036763: AB_10670922" "unprognostic (1.09e-2)" "unprognostic (1.25e-2)" "unprognostic (1.58e-1)" "unprognostic (2.56e-2)" "unprognostic (3.22e-2)" "unprognostic (2.69e-1)" "unprognostic (2.77e-2)" "unprognostic (3.71e-1)" "unprognostic (3.82e-2)" "unprognostic (1.33e-2)" "unprognostic (1.95e-10)" "unprognostic (9.27e-2)" "unprognostic (1.82e-2)" "unprognostic (8.94e-2)" "unprognostic (1.78e-3)" 0.1 0.1 0.1 0.3 0.1 1.0 0.1 0.1 0.1 0.2 0.1 0.0 0.0 0.1 0.2 0.2 0.4 0.1 0.5 0.3 0.3 0.2 0.1 1.8 0.1 0.2 0.2 0.0 0.4 0.7 0.0 0.1 0.0 0.9 0.1 0.0 125.2 0.4 0.0 2.9 0.9 0.3 0.0 0.1 0.1 0.2 1.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 1.3 1.0 2.9 0.6 0.9 0.6 0.3 0.2 0.6 0.3 0.2 0.1 0.0 0.8 0.5 0.0 0.1 0.0 0.3 0.5 0.4 0.3 0.0 0.3 0.5 0.2 0.0 0.1 0.2 0.3 0.6 0.7 0.6 0.0 0.7 0.5 0.0 0.0 0.1 0.1 0.3 0.0 0.2 0.2 0.9 0.0 0.4 0.2 0.8 3.1 0.0 0.0 0.4 0.3 0.0 0.0 0.7 0.4 0.3 0.6 0.7 0.0 0.8 0.3 0.5 0.0 1.1 0.3 0.3 0.9 0.6 0.2 0.4 0.1 0.3 0.3 2.1 0.6 0.5 0.4 0.3 0.5 0.6 0.4 0.4 0.2 1.3 0.6 0.5 2.9 0.9 0.4 1.0 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.2 0.2 0.0 0.9 0.0 6.0 17.6 0.0 1.9 0.8 121.9 0.5 2.5 17.4 25.0 0.0 269.0 0.1 0.0 0.0 0.6 1.0 0.0 0.0 0.0 0.1 0.6 1.2 9.3 0.5 0.2 30.2 0.0 1.8 0.6 0.0 4.4 1.6 0.0 0.0 0.0 42.1 0.0 0.0 0.7 0.0 472.4 0.0 0.0 0.1 0.4 1.0 0.0 0.0 0.0 1.7 EFEMP1 "DHRD, FBLN3, FBNL, MTLV, S1-5" ENSG00000115380 "EGF containing fibulin extracellular matrix protein 1" Q12805 2 55865967-55924139 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "Cytotrophoblasts: 1167.9;Syncytiotrophoblasts: 744.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HSkMC: 64.6;hTERT-RPE1: 129.3;HUVEC TERT2: 263.2;TIME: 233.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB016368, HPA049806, HPA070841, HPA071588" Supported Supported Mitochondria "Secreted to extracellular matrix" NA NA 1800000000 Mitochondria "CAB016368: AB_2277777, HPA049806: , HPA070841: AB_2686319, HPA071588: " "unprognostic (8.21e-2)" "unprognostic (7.68e-2)" "unprognostic (9.01e-3)" "prognostic unfavorable (4.72e-4)" "unprognostic (3.43e-2)" "unprognostic (1.73e-2)" "unprognostic (4.86e-2)" "unprognostic (1.38e-1)" "unprognostic (3.46e-1)" "unprognostic (9.07e-2)" "unprognostic (1.55e-2)" "unprognostic (1.50e-1)" "prognostic unfavorable (3.89e-8)" "unprognostic (3.15e-3)" "unprognostic (4.94e-2)" "unprognostic (3.09e-1)" "prognostic unfavorable (6.68e-5)" 63.1 14.1 13.6 14.1 35.1 0.1 45.5 8.0 12.8 14.8 20.4 22.0 16.6 6.2 20.1 31.9 22.0 38.6 37.1 55.4 8.2 9.7 16.3 3.5 38.5 24.5 12.5 15.5 52.9 10.9 3.3 6.6 84.5 25.8 47.5 22.9 116.9 26.8 40.5 15.6 13.8 12.0 29.9 8.6 10.1 12.6 9.3 13.5 0.9 57.4 18.1 7.3 45.5 41.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.0 0.2 0.4 0.0 20.0 13.0 0.0 12.5 13.4 1.5 1.1 0.0 1.2 0.0 8.1 15.1 1.3 20.9 0.0 15.0 0.5 0.0 0.0 0.0 5.3 0.0 55.0 0.0 0.0 64.6 6.9 1.5 17.2 129.3 263.2 0.0 0.0 0.0 5.6 1.9 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.1 0.0 17.3 6.5 0.0 0.4 20.2 0.0 233.1 0.1 7.0 25.8 8.0 0.7 0.0 0.0 4.8 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.6 35.1 8.0 8.8 8.2 9.7 12.5 15.5 25.8 13.5 232.3 83.7 0.0 78.5 70.5 1.6 12.3 10.2 99.0 89.9 26.2 0.0 1167.9 8.3 27.4 0.3 12.2 0.0 0.0 23.4 127.3 186.9 9.1 2.3 0.4 83.0 0.0 0.0 68.7 0.6 0.8 39.4 4.3 16.9 1.0 0.0 149.0 2.2 0.0 0.0 6.9 3.9 0.0 22.5 0.0 0.2 27.7 744.0 0.0 0.0 3.9 EGFLAM "AGRINL, AGRNL, FLJ39155, PIKA" ENSG00000164318 "EGF like, fibronectin type III and laminin G domains" Q63HQ2 5 38258409-38465021 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 54.7" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 113.9;Leydig cells: 143.8;Sertoli cells: 84.1;Smooth muscle cells: 78.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 7.2;HBEC3-KT: 8.7;hTERT-HME1: 11.6;HUVEC TERT2: 11.1;LHCN-M2: 25.6;U-2 OS: 11.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA066577 Approved "Secreted - unknown location" NA NA "HPA066577: " "unprognostic (2.05e-1)" "unprognostic (4.81e-2)" "unprognostic (1.01e-1)" "unprognostic (1.38e-3)" "unprognostic (1.08e-2)" "unprognostic (3.63e-3)" "unprognostic (6.31e-2)" "unprognostic (2.83e-1)" "unprognostic (2.08e-2)" "unprognostic (1.71e-3)" "unprognostic (1.12e-1)" "unprognostic (5.80e-2)" "prognostic unfavorable (4.47e-5)" "unprognostic (7.02e-6)" "unprognostic (2.60e-1)" "unprognostic (9.90e-2)" "unprognostic (1.04e-2)" 18.6 10.4 0.8 3.1 2.6 0.0 25.9 1.5 0.7 7.8 4.0 1.5 5.1 0.8 9.3 9.2 6.3 3.9 4.0 7.8 0.6 1.1 4.8 3.5 1.5 11.0 1.3 0.6 16.6 1.4 2.1 3.0 25.7 3.5 9.9 1.5 19.8 6.6 11.1 54.7 2.9 2.3 3.5 2.2 8.1 1.8 9.1 1.3 4.9 4.6 19.4 4.2 6.0 6.9 0.1 0.0 0.0 0.2 0.0 0.0 0.0 2.1 0.0 4.6 0.1 0.5 0.1 0.0 2.0 0.0 0.3 0.0 0.0 0.0 0.1 7.2 0.0 0.1 0.0 0.0 8.7 0.0 0.0 1.1 0.0 4.1 0.0 2.0 0.0 0.0 3.9 0.0 0.0 11.6 0.0 11.1 0.0 0.0 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 2.7 0.0 2.6 0.1 1.0 0.0 0.1 0.0 0.1 11.2 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 2.6 1.5 0.7 0.6 1.1 1.3 0.6 3.5 1.3 0.0 0.0 0.0 0.2 2.4 1.0 2.0 0.0 0.0 0.0 0.0 113.9 0.4 3.3 0.4 41.7 3.3 0.0 0.0 0.9 0.4 12.7 0.2 0.0 0.0 0.6 0.0 0.0 1.3 0.0 39.1 143.8 0.6 5.0 0.0 0.0 1.5 0.9 0.0 29.0 2.9 30.1 84.1 78.8 8.1 3.1 1.8 0.5 0.0 0.0 0.3 FMN1 "DKFZP686C2281, FLJ45135, FMN, LD, MGC125288, MGC125289" ENSG00000248905 "Formin 1" Q68DA7 15 32765545-33194733 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 21.9" "Cell type enhanced" "Detected in many" 11 "Bipolar cells: 121.0;Cone photoreceptor cells: 208.1;Rod photoreceptor cells: 98.9" "Cancer enriched" "Detected in many" 9 "melanoma: 14.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "Karpas-707: 9.5;RH-30: 12.8;SK-MEL-30: 13.3;T-47d: 11.6;U-138 MG: 7.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA005465, HPA046786" Supported Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA005465: AB_1859515, HPA046786: AB_10963545" "unprognostic (1.57e-1)" "unprognostic (5.92e-3)" "unprognostic (1.96e-1)" "unprognostic (2.10e-3)" "unprognostic (3.67e-2)" "unprognostic (3.00e-2)" "unprognostic (1.56e-2)" "unprognostic (2.84e-2)" "unprognostic (3.44e-1)" "unprognostic (3.31e-2)" "unprognostic (7.41e-3)" "unprognostic (3.53e-1)" "unprognostic (4.89e-2)" "unprognostic (2.89e-2)" "unprognostic (3.73e-1)" "unprognostic (4.32e-1)" "unprognostic (7.61e-2)" 7.0 2.1 3.7 3.9 5.3 2.2 4.9 0.6 12.1 8.9 8.5 1.8 2.6 2.6 2.2 4.8 3.9 5.1 4.0 2.4 3.3 2.0 4.7 1.4 7.7 3.3 5.9 7.3 1.1 2.5 2.6 8.0 5.1 4.6 3.8 6.9 21.9 6.4 2.5 2.2 9.2 4.3 3.7 6.4 3.0 11.7 12.4 4.6 1.8 4.7 1.5 2.0 2.7 6.8 0.6 1.8 2.8 0.7 0.1 0.7 0.1 1.6 1.8 0.3 0.2 0.0 0.2 2.0 2.3 1.9 0.6 1.7 0.2 2.2 0.2 0.8 2.8 1.6 1.4 0.0 1.5 1.8 0.0 0.1 1.3 0.4 0.1 0.1 0.0 0.1 0.7 0.0 2.8 0.0 1.3 0.0 0.0 0.0 9.5 4.1 1.7 0.0 0.0 0.5 3.2 0.1 0.2 12.8 2.2 0.8 0.6 0.1 0.3 0.0 1.5 13.3 0.4 11.6 0.0 1.6 7.4 1.2 6.8 0.7 0.0 0.0 0.4 3.5 0.0 4.6 2.8 0.7 0.0 0.3 0.0 0.5 0.0 0.7 0.6 1.4 0.6 0.4 0.0 0.1 0.1 0.0 1.8 0.1 0.1 3.7 5.3 0.6 12.1 3.3 2.0 5.9 7.3 4.6 4.6 38.7 42.2 0.5 2.3 3.3 121.0 3.2 12.7 38.8 27.3 0.0 208.1 9.7 10.0 4.9 11.6 0.7 5.9 0.0 1.6 3.5 1.1 6.3 22.1 0.5 9.0 44.5 8.6 0.0 28.5 9.5 0.9 16.2 32.1 5.4 16.7 4.3 7.1 9.3 0.7 1.1 98.9 0.0 0.9 19.5 14.9 3.0 15.3 1.3 7.9 4.0 FSCN2 "RFSN, RP30" ENSG00000186765 "Fascin actin-bundling protein 2, retinal" O14926 17 81528396-81537130 "Disease related genes, Predicted intracellular proteins" Actin-binding "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 21.9" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 23.6;Exocrine glandular cells: 10.3;Rod photoreceptor cells: 20.5" "Cancer enhanced" "Detected in many" "thyroid cancer: 3.6" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "EFO-21: 5.2;T-47d: 5.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA079270 Enhanced NA NA "HPA079270: " "unprognostic (3.50e-3)" "unprognostic (6.55e-2)" "unprognostic (2.73e-4)" "unprognostic (1.08e-3)" "unprognostic (1.11e-2)" "unprognostic (2.11e-2)" "unprognostic (6.49e-3)" "unprognostic (3.49e-1)" "unprognostic (1.64e-3)" "unprognostic (1.25e-2)" "unprognostic (1.20e-1)" "unprognostic (1.27e-1)" "unprognostic (3.21e-1)" "unprognostic (1.91e-1)" "unprognostic (1.53e-1)" "unprognostic (1.74e-1)" "unprognostic (2.11e-1)" 0.6 0.0 0.6 0.6 0.6 0.1 0.7 1.0 0.8 1.7 0.6 0.6 0.6 0.5 1.7 1.2 0.6 1.1 0.6 0.6 0.6 0.6 0.8 0.6 1.1 0.6 0.6 0.6 1.2 6.8 7.0 1.3 0.9 0.6 0.9 0.2 21.9 4.2 1.1 0.6 1.2 0.6 0.6 0.6 0.6 2.0 0.6 0.6 0.6 6.2 0.6 0.6 0.6 0.6 0.9 0.7 0.0 0.1 0.0 0.6 0.0 1.9 1.2 0.8 1.4 0.4 0.0 1.4 0.8 1.4 0.0 0.2 1.0 1.4 1.4 5.2 1.3 0.9 1.5 0.0 0.0 0.0 2.0 1.2 0.0 1.0 0.5 0.7 0.3 0.0 0.4 0.0 0.0 0.2 1.7 0.2 0.0 0.3 1.3 0.0 2.5 0.0 0.5 0.3 1.1 0.4 1.0 0.6 0.5 0.5 0.6 1.6 0.1 0.1 0.1 1.8 1.0 5.6 0.0 1.6 1.8 0.4 0.2 0.5 0.1 0.3 0.1 2.2 0.0 0.9 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.7 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.6 1.0 0.8 0.6 0.6 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 3.7 1.0 0.0 0.0 0.0 0.0 23.6 0.1 1.7 0.4 0.4 0.0 0.0 0.0 10.3 0.2 0.0 0.1 0.0 0.0 0.1 3.2 0.0 0.0 0.0 2.3 0.3 0.0 0.0 1.8 0.0 1.8 4.1 0.0 0.0 0.0 20.5 0.0 0.0 0.1 0.2 0.0 0.7 0.0 0.0 0.0 GNAT1 CSNBAD3 ENSG00000114349 "G protein subunit alpha transducin 1" P11488 3 50191612-50196516 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" Transducer "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 39 "retina: 171.9" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 1622.9" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.4;MCF7: 2.4;RT4: 2.6;SCLC-21H: 1.1" "Not detected" "Not detected" HPA045393 Enhanced NA NA "HPA045393: AB_2679310" "unprognostic (3.08e-1)" "unprognostic (1.81e-1)" "unprognostic (8.56e-3)" "unprognostic (3.32e-2)" "unprognostic (2.13e-1)" "unprognostic (7.72e-2)" "unprognostic (2.82e-3)" "unprognostic (6.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.87e-1)" "unprognostic (3.02e-1)" "unprognostic (9.48e-3)" 0.3 0.5 0.3 0.0 0.3 0.1 0.0 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.1 0.2 0.0 0.3 0.3 0.1 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 171.9 0.0 0.0 0.0 0.8 0.0 0.0 0.5 0.0 0.1 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.8 1.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 1.1 0.0 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.1 0.3 0.3 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 177.2 0.3 0.0 0.0 0.0 0.0 227.8 0.0 0.0 0.0 10.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 26.2 0.6 0.0 0.0 0.0 0.0 228.8 0.1 0.0 0.0 0.0 1622.9 0.0 0.0 1.7 0.4 0.0 0.1 0.0 0.0 0.1 GNG13 "G(gamma)13, h2-35" ENSG00000127588 "G protein subunit gamma 13" Q9P2W3 16 798041-800733 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 78.6;retina: 22.9" "Cell type enriched" "Detected in some" 20 "Bipolar cells: 323.3" "Low cancer specificity" "Detected in some" "Region enriched" "Detected in many" 7 "cerebellum: 78.6" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 11.2;HEK 293: 9.9;HeLa: 5.9;MCF7: 13.9" "Region enhanced" "Detected in all" "cerebellum: 1054.1" "Group enriched" "Detected in many" 6 "cerebellum: 43.5;olfactory region: 18.2" HPA046272 Enhanced NA NA "HPA046272: AB_10960062" "unprognostic (1.84e-1)" "unprognostic (2.75e-1)" "unprognostic (3.78e-2)" "unprognostic (2.48e-1)" "unprognostic (2.57e-2)" "unprognostic (5.41e-2)" "unprognostic (8.47e-2)" "unprognostic (9.16e-3)" "unprognostic (4.04e-2)" "unprognostic (1.78e-1)" "unprognostic (6.77e-2)" "unprognostic (7.12e-2)" "unprognostic (1.55e-1)" "unprognostic (3.38e-1)" 0.2 0.2 1.8 0.7 3.3 0.9 0.3 78.6 11.3 0.2 2.9 3.4 0.0 5.4 0.2 0.7 0.2 0.2 0.3 0.2 1.1 1.6 0.2 0.2 0.3 0.6 1.3 2.7 0.3 0.2 0.2 0.3 0.4 2.7 0.4 0.6 22.9 0.2 0.2 0.2 0.5 5.1 0.4 1.9 0.4 0.8 1.5 0.2 0.2 0.3 0.0 0.6 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.9 0.5 1.2 0.0 0.0 0.9 1.0 0.0 0.0 0.0 11.2 0.3 1.2 0.3 0.0 0.1 1.7 0.0 0.0 0.0 1.3 9.9 1.4 5.9 0.0 0.0 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.9 0.9 0.0 13.9 1.3 0.8 1.3 0.1 1.2 3.0 3.2 0.7 0.0 1.7 1.0 0.9 1.0 0.4 0.2 0.4 0.8 0.1 0.0 1.5 1.4 1.9 0.3 0.5 2.5 4.5 0.1 2.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 3.3 78.6 11.3 1.1 1.6 1.3 2.7 2.7 0.2 0.0 0.0 0.0 0.1 0.0 323.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.6 5.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 15.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GNGT1 GNG1 ENSG00000127928 "G protein subunit gamma transducin 1" P63211 7 93591573-93911265 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 13 "retina: 107.2" "Cell type enriched" "Detected in some" 5 "Rod photoreceptor cells: 1939.7" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "EFO-21: 12.5;HeLa: 4.2;SK-BR-3: 4.0;SuSa: 6.1;T-47d: 6.8;U-266/70: 3.9;U-266/84: 5.2" "Not detected" "Not detected" HPA042721 Enhanced NA NA "HPA042721: AB_10806370" "unprognostic (1.30e-1)" "unprognostic (2.55e-4)" "unprognostic (3.32e-4)" "unprognostic (5.01e-2)" "unprognostic (2.54e-2)" "unprognostic (1.84e-1)" "unprognostic (3.73e-2)" "unprognostic (4.55e-1)" "unprognostic (2.23e-4)" "unprognostic (1.40e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.0 0.5 0.3 0.1 1.9 0.0 0.0 0.0 0.4 0.0 2.6 0.1 0.1 0.1 7.9 0.3 0.0 0.0 107.2 1.0 0.0 0.0 0.4 0.0 0.1 0.3 0.1 0.4 0.7 0.0 0.0 0.1 0.0 0.0 1.4 0.0 0.5 0.5 1.6 0.2 0.1 1.2 0.6 1.4 0.2 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.9 0.0 0.1 12.5 0.0 0.2 0.1 0.2 0.0 0.0 0.1 0.4 0.0 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.2 0.6 0.1 1.9 0.1 0.0 2.0 0.2 0.1 0.0 0.0 0.6 0.3 1.5 3.6 1.3 0.2 4.0 0.1 6.1 6.8 0.2 0.2 0.0 3.7 0.2 0.0 3.9 5.2 0.0 0.2 0.0 0.0 1.6 0.0 0.1 0.7 0.1 0.9 0.5 1.0 0.9 0.3 0.4 0.8 0.8 1.3 0.1 0.2 0.5 1.2 0.6 0.0 0.0 0.0 0.0 0.3 0.1 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 300.7 0.0 0.0 1.4 1.2 0.0 363.2 0.4 1.7 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 187.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 352.7 0.0 0.0 0.0 3.7 1939.7 0.0 0.0 0.0 0.2 0.0 5.9 0.0 0.0 0.0 GNGT2 GNG9 ENSG00000167083 "G protein subunit gamma transducin 2" O14610 17 49202791-49210574 "Predicted intracellular proteins, RAS pathway related proteins, Transporters" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Group enriched" "Detected in many" 5 "blood: 29.1;lymphoid tissue: 21.1;retina: 46.7" "Cell type enhanced" "Detected in many" 18 "Cone photoreceptor cells: 68.7;Kupffer cells: 22.4;Macrophages: 17.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 29.1" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "Daudi: 36.4;HDLM-2: 31.2;HUVEC TERT2: 9.4;RH-30: 11.6;TIME: 9.1;U-698: 11.2" "Low region specificity" "Detected in some" HPA043381 Enhanced NA NA "HPA043381: AB_2678455" "unprognostic (9.11e-2)" "unprognostic (4.09e-3)" "unprognostic (1.99e-2)" "unprognostic (4.62e-5)" "unprognostic (1.34e-1)" "unprognostic (3.20e-3)" "unprognostic (1.75e-1)" "unprognostic (7.37e-2)" "unprognostic (1.30e-2)" "unprognostic (2.11e-2)" "unprognostic (2.08e-1)" "unprognostic (1.14e-1)" "prognostic unfavorable (3.11e-4)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "unprognostic (6.92e-2)" "unprognostic (1.23e-1)" 2.7 2.1 2.7 9.4 3.7 1.3 1.8 0.7 2.2 2.1 2.3 2.0 0.4 2.6 1.6 1.2 1.8 1.7 3.3 2.4 2.5 1.9 3.0 2.6 6.2 12.2 3.2 0.4 1.7 1.2 0.1 1.4 1.9 2.2 2.2 3.3 46.7 1.6 1.1 0.6 0.6 4.9 2.9 4.5 21.1 1.7 0.8 2.5 6.0 2.5 1.4 16.6 3.6 5.1 2.0 9.7 0.9 29.1 10.6 14.4 5.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.7 0.7 0.5 0.0 0.0 36.4 0.3 0.1 0.0 0.0 0.0 0.0 2.1 31.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 9.4 4.5 0.0 0.2 0.8 0.0 2.7 2.2 0.3 0.0 0.0 7.0 11.6 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 9.1 0.0 5.8 0.0 0.0 0.1 1.6 11.2 0.1 0.1 0.0 0.0 4.3 0.4 14.4 21.5 12.6 1.9 2.4 10.2 9.7 2.0 1.5 5.9 0.9 10.6 29.1 0.8 1.8 5.4 2.7 3.7 0.7 2.2 2.5 1.9 3.2 0.4 2.2 2.5 0.0 1.4 5.6 0.0 0.3 2.3 0.6 0.0 0.0 1.2 0.0 68.7 0.0 3.3 0.0 0.6 4.7 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 11.1 0.0 0.0 2.5 22.4 6.5 0.6 17.7 0.0 7.2 0.0 3.3 0.0 0.0 0.0 0.0 12.3 6.5 0.0 0.0 0.0 0.1 0.2 14.0 0.0 0.0 GPR61 BALGR ENSG00000156097 "G protein-coupled receptor 61" Q9BZJ8 1 109539872-109548406 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;pituitary gland: 6.3;retina: 6.3" "Group enriched" "Detected in some" 6 "Bipolar cells: 13.7;Cone photoreceptor cells: 5.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "eosinophil: 1.1;naive CD8 T-cell: 1.0" "Group enriched" "Detected in many" 11 "granulocytes: 1.1;T-cells: 1.0" "Cell line enhanced" "Detected in some" "JURKAT: 1.6;Karpas-707: 1.0;U-266/70: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA007326, HPA026088" Supported NA NA "HPA007326: AB_1849308, HPA026088: AB_10602323" "unprognostic (1.70e-1)" "unprognostic (1.61e-1)" "unprognostic (1.91e-1)" "unprognostic (2.01e-1)" "unprognostic (4.40e-2)" "unprognostic (1.70e-2)" "unprognostic (7.51e-2)" "unprognostic (3.63e-3)" "unprognostic (2.94e-2)" "unprognostic (4.50e-2)" "unprognostic (1.46e-4)" "unprognostic (3.27e-1)" "unprognostic (4.08e-4)" "unprognostic (1.33e-1)" "unprognostic (1.07e-1)" "unprognostic (6.72e-2)" "unprognostic (3.85e-2)" 0.5 4.0 4.9 0.7 8.2 0.7 0.5 6.4 10.6 0.5 0.6 0.2 0.0 0.8 0.8 0.6 0.7 0.5 0.7 0.9 5.4 3.9 0.6 0.6 0.5 0.8 1.7 8.3 0.6 0.5 0.5 6.3 0.6 4.9 0.6 0.5 6.3 0.7 0.5 2.3 0.8 1.0 0.5 1.2 0.6 0.6 1.7 1.2 0.0 3.6 0.0 0.5 0.7 0.3 0.0 0.0 1.1 0.0 0.0 1.0 0.0 0.3 0.5 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.3 0.0 0.0 0.0 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.1 0.0 1.6 0.1 1.0 0.0 0.4 0.1 0.2 0.2 0.0 0.2 0.3 0.3 0.0 0.0 0.1 0.5 0.1 0.2 0.0 0.0 0.5 0.1 0.0 0.2 0.2 0.3 0.5 0.0 2.3 0.4 0.2 0.0 0.3 0.1 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.0 0.1 0.0 0.0 0.0 0.1 0.0 4.9 8.2 6.4 10.6 5.4 3.9 1.7 8.3 4.9 1.2 0.0 0.0 0.0 0.0 0.0 13.7 0.4 0.0 0.0 0.0 0.0 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 GRK1 "GPRK1, RHOK, RK" ENSG00000185974 "G protein-coupled receptor kinase 1" Q15835 13 113667155-113737735 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 12 "retina: 51.5" "Group enriched" "Detected in some" 26 "Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 86.9" "Cancer enhanced" "Detected in single" "thyroid cancer: 0.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "SCLC-21H: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA035200, HPA059376" Enhanced NA NA "HPA035200: AB_2674515, HPA059376: AB_2683996" "unprognostic (7.93e-2)" "unprognostic (2.50e-1)" "unprognostic (1.87e-1)" "unprognostic (1.24e-5)" "unprognostic (1.76e-3)" "unprognostic (1.53e-1)" "unprognostic (3.59e-2)" "unprognostic (2.21e-2)" "unprognostic (1.84e-3)" "unprognostic (2.00e-2)" "unprognostic (4.02e-2)" "unprognostic (6.91e-2)" "unprognostic (6.18e-2)" "unprognostic (6.11e-2)" 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 51.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.2 0.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.5 0.0 0.0 0.0 0.0 53.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 86.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 GRK7 GPRK7 ENSG00000114124 "G protein-coupled receptor kinase 7" Q8WTQ7 3 141778148-141818490 "Enzymes, Predicted intracellular proteins" "Sensory transduction, Vision" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "blood: 2.4" "Cell type enriched" "Detected in some" 168 "Cone photoreceptor cells: 310.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BEWO: 4.1;HeLa: 1.5;U-937: 1.8" "Not detected" "Not detected" "HPA075093, HPA078232" Enhanced Approved Mitochondria NA NA Mitochondria "HPA075093: , HPA078232: " "unprognostic (1.11e-1)" "unprognostic (1.70e-2)" "unprognostic (3.35e-3)" "unprognostic (1.22e-2)" "unprognostic (1.13e-1)" "unprognostic (1.60e-1)" "unprognostic (1.39e-2)" "unprognostic (5.08e-2)" "unprognostic (1.21e-1)" "unprognostic (1.31e-2)" "unprognostic (3.46e-2)" "unprognostic (1.20e-1)" "unprognostic (2.53e-8)" "unprognostic (3.08e-1)" "unprognostic (1.99e-1)" "unprognostic (3.11e-1)" "unprognostic (2.91e-1)" 0.2 0.5 0.3 0.5 0.4 1.5 0.2 0.9 0.3 0.2 0.1 0.4 0.3 0.0 0.3 0.3 0.0 0.2 0.3 0.3 0.2 0.0 0.2 0.2 0.2 0.6 0.3 0.7 0.2 0.2 0.3 0.0 0.4 0.2 1.6 1.5 0.4 0.0 0.2 0.4 0.1 1.0 0.1 0.3 0.1 0.3 0.7 0.2 2.4 0.4 0.5 0.6 0.1 0.0 0.1 0.1 0.6 0.4 0.0 4.1 0.1 0.0 0.0 0.1 0.2 0.6 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.1 0.5 0.5 0.2 1.5 0.2 0.0 0.4 0.3 0.1 1.1 0.0 0.1 0.0 0.0 0.3 0.2 0.2 0.0 0.2 0.2 0.7 0.4 0.2 0.2 0.2 0.1 0.2 0.0 0.5 0.3 0.4 0.2 0.0 0.0 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.2 0.1 1.8 0.2 0.2 0.4 0.3 0.4 0.2 0.6 0.6 0.5 0.3 0.1 0.7 0.5 0.5 2.4 0.5 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0.1 0.3 1.0 0.2 0.0 0.0 0.0 0.0 310.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 1.0 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 GRM6 "CSNB1B, GPRC1F, mGlu6, MGLUR6" ENSG00000113262 "Glutamate metabotropic receptor 6" O15303 5 178978327-178996206 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Receptor, Transducer" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 22.0" "Cell type enriched" "Detected in some" 31 "Bipolar cells: 422.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" HPA014511 Enhanced NA NA "HPA014511: AB_2669025" "unprognostic (1.85e-1)" "unprognostic (1.54e-1)" "unprognostic (8.41e-2)" "unprognostic (1.27e-1)" "unprognostic (4.16e-1)" "unprognostic (2.25e-3)" "unprognostic (7.72e-2)" "unprognostic (2.32e-2)" "unprognostic (2.12e-3)" "unprognostic (6.27e-2)" "unprognostic (3.34e-4)" "unprognostic (2.58e-1)" "unprognostic (3.36e-4)" "unprognostic (1.23e-1)" "unprognostic (6.45e-2)" "unprognostic (7.59e-3)" "unprognostic (1.97e-1)" 0.3 0.5 0.6 0.4 0.6 1.6 0.3 1.9 1.6 0.4 0.4 0.3 0.3 0.3 0.6 0.5 0.3 0.5 0.7 0.4 0.5 1.2 0.4 0.4 0.4 0.5 0.8 0.3 0.7 0.9 0.1 2.9 0.3 1.2 1.1 0.1 22.0 0.6 0.3 1.3 1.8 0.3 0.3 0.3 0.5 0.3 2.2 0.3 0.3 0.9 0.3 0.3 0.3 0.3 0.9 1.1 2.4 0.4 0.6 0.6 0.1 0.5 0.3 0.7 1.3 0.3 0.1 0.7 0.2 0.0 0.1 0.0 0.5 0.9 0.9 0.6 0.0 0.6 0.7 0.0 0.1 0.0 0.2 0.7 0.5 0.7 1.0 0.2 0.8 1.0 0.1 0.3 0.1 0.5 0.3 0.0 0.9 0.9 1.7 0.0 1.0 0.2 0.8 0.6 0.5 0.6 0.6 0.3 0.8 0.1 0.6 0.9 1.2 0.5 0.7 0.5 1.1 0.9 1.1 0.9 0.5 0.5 0.4 0.5 0.7 0.6 0.4 0.4 0.7 0.3 1.9 0.4 0.5 0.6 0.3 0.4 0.4 0.4 0.3 0.2 0.9 0.4 0.4 2.4 0.6 0.2 1.1 0.2 0.1 0.6 0.6 1.9 0.5 0.5 1.2 0.8 0.3 1.2 0.3 0.0 0.3 0.0 0.1 0.3 422.6 1.4 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.8 0.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 3.2 0.0 0.0 0.0 0.9 0.0 0.2 0.0 1.0 0.0 3.7 0.1 0.0 0.0 0.0 13.7 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.1 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42180056 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 91.2;testis: 62.2" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 628.3;Late spermatids: 331.5;Rod photoreceptor cells: 949.8" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Cell type enriched" "Detected in single" 84 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in single" 84 "dendritic cells: 8.4" "Group enriched" "Detected in some" 8 "NTERA-2: 7.2;SH-SY5Y: 9.0" "Not detected" "Not detected" "Not detected" "Not detected" "HPA005561, HPA075056" Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA005561: AB_2667361, HPA075056: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.2 0.2 2.7 0.3 10.0 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 1.5 5.4 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 91.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 62.2 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.7 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 2.7 10.0 0.1 0.8 1.5 5.4 1.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 118.0 0.3 0.0 0.0 0.0 0.0 628.3 0.4 0.0 0.0 108.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 62.0 0.0 0.0 0.0 331.5 1.7 0.0 0.0 9.0 0.0 125.6 0.0 0.0 1.8 0.0 949.8 0.0 0.0 2.8 1.9 0.0 0.2 0.0 0.0 0.0 GUCA1B "GCAP2, RP48" ENSG00000112599 "Guanylate cyclase activator 1B" Q9UMX6 6 42184401-42194916 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "retina: 88.4" "Group enriched" "Detected in some" 10 "Cone photoreceptor cells: 78.5;Rod photoreceptor cells: 52.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTCEpi: 8.6;U-698: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA055479 Enhanced NA NA "HPA055479: AB_2732598" "unprognostic (1.61e-1)" "unprognostic (3.28e-1)" "unprognostic (1.14e-6)" "unprognostic (5.39e-2)" "unprognostic (1.73e-2)" "unprognostic (2.87e-3)" "unprognostic (6.06e-3)" "unprognostic (1.12e-1)" "unprognostic (1.34e-1)" "unprognostic (5.57e-1)" "unprognostic (1.66e-1)" "unprognostic (1.72e-2)" "unprognostic (3.28e-7)" "unprognostic (4.50e-2)" "unprognostic (2.20e-1)" "unprognostic (1.76e-2)" "unprognostic (2.59e-3)" 1.8 0.9 1.9 1.4 2.5 2.7 2.9 6.6 2.5 1.8 1.4 1.4 1.4 0.7 2.8 2.8 1.4 2.6 1.4 1.4 1.8 1.6 1.4 1.9 1.4 1.4 2.0 1.4 3.5 1.4 0.7 1.4 1.4 1.4 1.4 1.1 88.4 1.4 1.7 6.0 7.0 1.4 2.8 1.9 2.3 0.6 2.7 1.4 1.4 1.4 1.4 2.2 1.4 1.4 0.7 0.7 0.5 0.1 0.0 1.2 0.0 0.2 1.6 3.5 1.0 2.4 2.4 0.8 1.4 1.9 2.3 1.7 3.6 1.0 3.7 1.8 0.3 0.2 1.1 3.6 0.8 2.2 3.0 1.2 0.8 0.0 0.5 0.7 2.8 1.1 0.9 8.6 1.7 2.9 0.9 0.2 2.8 2.2 2.7 0.3 2.1 1.4 2.0 0.1 0.5 0.7 0.3 1.5 0.0 1.0 1.2 1.3 2.4 0.0 0.4 0.2 0.6 0.3 2.4 0.0 0.5 3.5 0.8 1.2 5.4 2.3 8.4 0.6 1.1 0.5 0.0 0.1 0.0 0.1 0.0 0.7 0.6 0.2 0.0 0.0 0.7 0.0 1.2 0.5 0.0 0.0 0.7 0.1 0.0 1.9 2.5 6.6 1.7 1.8 1.6 2.0 1.4 1.4 1.4 0.0 0.0 0.0 0.1 0.2 3.8 0.2 0.0 0.0 0.0 0.0 78.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 4.5 0.1 0.0 0.0 0.0 52.8 0.0 0.3 0.5 0.3 0.1 0.0 0.0 0.0 0.1 HCN1 "BCNG-1, BCNG1, HAC-2" ENSG00000164588 "Hyperpolarization activated cyclic nucleotide gated potassium channel 1" O60741 5 45254950-45696498 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Sodium transport, Transport" "Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 26.4;retina: 16.1" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 125.7;Rod photoreceptor cells: 184.3" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NTERA-2: 1.7;WM-115: 4.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019195 Enhanced NA NA "HPA019195: AB_2670094" "unprognostic (1.30e-1)" "unprognostic (3.62e-1)" "unprognostic (1.64e-1)" "unprognostic (9.24e-3)" "unprognostic (6.82e-2)" "unprognostic (1.10e-1)" "unprognostic (9.63e-3)" "unprognostic (4.11e-3)" "unprognostic (6.78e-2)" "unprognostic (1.16e-2)" "unprognostic (7.42e-2)" "unprognostic (3.68e-3)" 1.0 2.8 6.0 1.0 13.0 1.3 1.2 9.8 26.4 0.9 1.0 0.5 0.0 0.9 1.1 0.9 1.1 1.0 1.0 4.6 8.1 4.5 0.9 1.0 1.0 1.0 2.6 11.1 1.1 1.7 0.9 4.0 0.9 9.2 1.0 1.0 16.1 1.0 0.9 3.6 1.6 1.1 0.9 1.2 1.1 1.1 1.2 0.0 0.0 1.1 0.0 0.9 0.9 0.3 0.6 0.2 0.6 0.2 0.3 0.4 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.5 0.0 0.3 0.1 0.4 1.7 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.0 0.2 0.0 0.1 0.8 0.0 0.1 0.1 0.0 0.0 0.2 0.3 4.7 0.5 0.2 0.1 0.4 0.1 0.1 0.1 0.1 0.1 0.0 0.6 0.2 0.3 0.6 0.3 0.1 0.2 0.0 0.0 6.0 13.0 9.8 26.4 8.1 4.5 2.6 11.1 9.2 0.0 0.0 0.0 0.0 0.0 0.1 25.3 3.6 0.0 0.0 0.0 0.0 125.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 6.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.0 0.1 0.0 0.0 0.0 184.3 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.3 IMPG1 "GP147, IPM150, SPACR" ENSG00000112706 "Interphotoreceptor matrix proteoglycan 1" Q17R60 6 75921115-76072678 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Heparin-binding, Receptor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 110.5" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 634.2;Rod photoreceptor cells: 409.1" "Not detected" "Not detected" "Region enriched" "Detected in some" 5 "basal ganglia: 10.3" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 2.1;AF22: 3.0;HaCaT: 4.1;TIME: 2.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA027142, HPA030332, HPA030333" Enhanced "Secreted in other tissues" NA NA "HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433" "unprognostic (6.65e-2)" "unprognostic (4.13e-2)" "unprognostic (1.20e-1)" "unprognostic (8.69e-2)" "unprognostic (1.22e-1)" "unprognostic (5.49e-3)" "unprognostic (5.97e-2)" "unprognostic (3.56e-3)" "unprognostic (1.89e-2)" "unprognostic (2.20e-1)" "unprognostic (1.45e-1)" "unprognostic (1.12e-3)" "unprognostic (2.84e-1)" "unprognostic (1.73e-2)" "unprognostic (2.09e-1)" "unprognostic (6.01e-2)" "unprognostic (1.96e-2)" 0.6 0.0 0.4 0.4 10.3 0.0 0.4 1.0 2.8 0.4 0.4 0.4 0.4 2.8 0.4 0.4 0.4 0.1 1.1 0.5 0.5 0.4 0.8 0.4 0.5 0.4 0.5 0.4 0.4 5.4 0.0 0.4 0.6 0.4 0.7 0.0 110.5 0.6 0.4 0.6 4.0 2.3 0.4 0.4 0.5 0.7 0.9 0.4 0.4 0.8 0.4 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.1 3.0 0.0 0.0 0.6 1.6 0.8 0.0 0.0 0.0 1.8 0.6 0.0 0.3 0.0 0.1 4.1 0.0 0.0 0.0 0.1 1.5 0.7 0.1 0.7 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.2 0.6 0.1 0.0 0.0 0.6 0.9 0.0 0.0 0.1 0.0 0.0 0.7 0.7 1.2 0.0 1.8 0.4 0.6 0.0 0.3 2.4 0.4 0.0 0.0 0.2 0.7 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 10.3 1.0 1.9 0.5 0.4 0.5 0.4 0.4 0.4 0.0 0.0 0.0 0.0 0.0 44.9 0.2 0.0 0.0 0.0 0.0 634.2 0.1 3.3 0.0 1.5 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.2 28.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 49.3 0.0 0.0 0.0 0.0 409.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 IMPG2 "IPM200, RP56" ENSG00000081148 "Interphotoreceptor matrix proteoglycan 2" Q9BZV3 3 101222546-101320560 "Disease related genes, Predicted membrane proteins" "Heparin-binding, Receptor" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "retina: 72.1" "Group enriched" "Detected in some" 29 "Cone photoreceptor cells: 486.9;Rod photoreceptor cells: 298.9" "Cancer enriched" "Detected in single" 12 "ovarian cancer: 2.7" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in some" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA008779, HPA015907" Enhanced NA NA "HPA008779: AB_2668138, HPA015907: AB_2669323" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.40e-1)" "unprognostic (9.58e-3)" "unprognostic (1.28e-1)" "unprognostic (4.80e-5)" "unprognostic (6.66e-4)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (6.59e-2)" "unprognostic (7.51e-3)" "unprognostic (1.28e-1)" "unprognostic (4.50e-9)" "unprognostic (7.12e-2)" "unprognostic (2.70e-1)" "unprognostic (2.81e-2)" "unprognostic (6.08e-2)" 0.2 0.3 0.2 0.4 0.4 0.2 0.2 0.2 0.2 0.2 0.3 0.3 0.1 0.1 0.3 0.3 0.1 16.5 0.2 0.3 0.3 0.6 0.3 0.1 0.1 0.4 0.5 0.1 0.4 0.2 0.1 0.4 0.1 0.4 0.2 0.2 72.1 0.2 0.1 0.2 0.2 0.4 0.3 0.2 0.6 0.5 0.2 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.6 0.1 1.0 0.1 1.1 0.3 0.0 0.1 0.0 1.1 1.3 0.4 1.0 0.1 0.1 0.2 0.3 0.5 0.0 0.1 0.1 1.0 0.1 0.4 0.0 0.3 0.1 1.1 0.4 0.3 0.6 0.4 0.1 0.1 0.3 2.0 1.3 0.7 0.2 0.0 0.6 1.8 0.2 0.0 1.2 0.9 0.1 0.2 0.2 0.0 0.0 0.3 0.2 0.0 0.1 0.7 0.3 1.6 0.2 0.0 0.0 0.1 0.8 0.2 0.4 1.4 1.2 0.6 0.4 0.7 0.6 1.1 0.2 0.0 0.0 1.2 0.6 0.1 0.3 0.3 0.1 0.1 0.2 0.2 0.1 0.0 0.6 0.2 0.3 1.0 1.1 0.1 0.1 0.1 0.0 0.2 0.4 0.2 0.2 0.3 0.6 0.5 0.1 0.4 0.1 0.0 0.0 0.0 0.0 0.1 13.2 0.6 0.0 0.0 0.0 0.0 486.9 0.0 1.7 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.3 0.0 0.6 0.0 0.0 1.8 0.0 13.7 0.1 0.0 0.7 0.0 298.9 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 IQCB1 "KIAA0036, NPHP5, SLSN5" ENSG00000173226 "IQ motif containing B1" Q15051 3 121769763-121835079 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Calmodulin-binding "Ciliopathy, Leber congenital amaurosis, Nephronophthisis, Senior-Loken syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 7 "Spermatocytes: 111.8;Spermatogonia: 63.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "U-698: 48.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042028 Approved Approved Supported "Microtubules,Cytokinetic bridge,Mitotic spindle" NA NA "Microtubules, Cytokinetic bridge, Mitotic spindle" "HPA042028: AB_2677806" "unprognostic (3.82e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.16e-1)" "unprognostic (4.10e-2)" "unprognostic (1.24e-2)" "unprognostic (1.69e-2)" "prognostic unfavorable (3.08e-5)" "prognostic favorable (3.67e-4)" "unprognostic (1.42e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "unprognostic (6.78e-3)" "unprognostic (1.50e-3)" "unprognostic (2.59e-3)" "unprognostic (2.75e-1)" "unprognostic (1.67e-1)" "unprognostic (4.75e-3)" 11.5 10.8 9.9 25.1 12.6 16.6 21.9 14.7 16.8 14.4 11.8 8.8 16.9 11.0 14.7 19.4 13.1 15.9 11.5 10.4 10.1 10.1 10.6 9.0 15.0 20.6 12.5 14.5 19.8 22.7 13.9 20.7 12.1 12.4 16.2 15.6 10.9 14.4 30.2 11.4 14.2 14.0 14.6 11.4 19.3 11.2 40.1 12.5 16.2 11.4 9.5 23.0 16.7 14.1 18.9 7.6 8.9 10.4 8.6 10.0 4.9 14.0 3.8 18.8 21.1 3.0 4.6 22.1 6.7 4.1 7.6 9.2 12.9 6.8 28.4 9.4 3.8 11.7 10.8 11.5 5.4 11.4 5.5 9.3 18.8 7.5 10.6 7.8 23.3 5.7 2.9 10.4 5.2 11.7 3.9 5.7 12.2 11.2 10.6 8.4 7.1 15.2 16.5 15.8 8.4 6.9 15.1 8.9 9.0 4.4 6.3 10.0 8.1 6.5 4.6 11.6 6.4 4.1 18.3 4.8 7.2 8.7 3.5 8.7 25.7 16.3 48.3 6.9 10.7 6.5 2.5 5.2 8.9 6.3 9.9 9.0 18.9 8.3 7.6 7.6 17.5 10.0 6.3 2.1 8.6 10.4 7.2 8.7 4.9 9.9 12.6 14.7 16.8 10.1 10.1 12.5 14.5 12.4 12.5 6.0 15.9 17.1 15.3 16.8 14.7 7.7 15.3 62.9 27.3 10.4 25.5 23.4 3.3 8.8 2.8 9.0 5.9 0.0 11.3 6.9 13.9 12.8 8.1 5.6 9.1 12.7 6.9 6.2 10.0 5.3 14.4 10.5 13.5 17.2 8.9 11.8 10.6 9.1 12.7 5.8 27.3 12.9 11.7 111.8 63.7 18.1 11.8 13.3 12.6 14.8 ITGB8 ENSG00000105855 "Integrin subunit beta 8" P26012 7 20330702-20415754 "Cancer-related genes, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 99.3;Ciliated cells: 78.9;Glandular cells: 109.9;Urothelial cells: 146.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 105 "basophil: 13.8" "Lineage enriched" "Detected in single" 105 "granulocytes: 13.8" "Cell line enhanced" "Detected in many" "AF22: 16.6;EFO-21: 21.4;RPTEC TERT1: 33.2;WM-115: 47.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027796, HPA027797" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Plasma membrane, Cytosol" "HPA027796: AB_10600299, HPA027797: AB_10600879" "unprognostic (8.32e-3)" "unprognostic (1.42e-1)" "unprognostic (1.03e-1)" "unprognostic (3.37e-3)" "unprognostic (5.63e-2)" "unprognostic (3.53e-1)" "unprognostic (1.75e-1)" "unprognostic (1.46e-1)" "unprognostic (4.36e-2)" "unprognostic (1.75e-2)" "unprognostic (2.49e-3)" "unprognostic (8.47e-2)" "prognostic favorable (1.77e-4)" "unprognostic (2.90e-1)" "unprognostic (1.56e-1)" "unprognostic (4.63e-2)" "unprognostic (6.92e-3)" 4.7 4.1 18.0 5.8 20.0 1.2 12.7 7.8 24.3 22.1 4.6 19.4 9.0 4.6 10.5 19.0 8.8 10.4 11.7 3.9 19.4 12.5 28.1 1.7 3.7 1.3 29.3 14.5 7.1 17.5 8.1 7.7 10.7 22.8 9.6 4.4 37.5 16.6 13.1 0.9 8.5 6.0 7.0 23.1 0.8 6.2 8.7 24.0 0.0 3.4 1.3 9.0 6.8 9.9 0.0 0.0 13.8 0.1 0.0 0.1 0.0 10.2 0.4 16.6 2.1 1.4 5.9 0.0 0.0 0.1 0.1 0.6 0.1 2.6 0.0 21.4 0.7 0.6 11.4 0.7 1.6 0.2 0.0 0.2 0.0 8.0 0.0 0.7 0.0 0.0 0.7 4.7 0.2 0.9 10.2 0.8 0.0 0.0 3.1 0.3 0.0 0.0 0.0 1.2 0.1 1.8 0.0 1.4 0.0 33.2 0.9 0.2 0.7 3.2 0.0 8.3 0.3 0.2 0.0 1.1 4.3 2.8 1.2 2.1 3.9 0.0 0.0 1.0 0.0 47.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 18.0 20.0 7.8 14.2 19.4 12.5 29.3 14.5 22.8 24.0 11.9 3.7 0.8 99.3 29.5 5.2 3.1 43.3 78.9 30.7 36.6 0.0 12.5 6.6 22.1 2.3 1.9 4.6 0.0 15.3 0.9 3.2 109.9 1.1 0.0 3.1 1.6 32.6 1.3 1.5 3.5 40.9 12.4 3.3 55.1 6.8 26.0 24.5 6.2 42.1 44.6 1.2 0.0 1.4 0.5 0.7 10.8 4.1 0.5 7.3 146.8 KCNB1 Kv2.1 ENSG00000158445 "Potassium voltage-gated channel subfamily B member 1" Q14721 20 49293394-49484297 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Exocytosis, Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 25.9;retina: 22.4" "Group enriched" "Detected in some" 7 "Bipolar cells: 119.5;Cone photoreceptor cells: 200.3;Rod photoreceptor cells: 366.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 3.6;CACO-2: 5.1;hTCEpi: 3.2;U-2 OS: 4.4" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001979, HPA042434" Enhanced NA NA "CAB001979: , HPA042434: AB_2677996" "unprognostic (4.51e-1)" "unprognostic (1.72e-1)" "unprognostic (6.54e-3)" "unprognostic (4.87e-2)" "unprognostic (1.94e-1)" "unprognostic (1.82e-1)" "unprognostic (8.09e-2)" "unprognostic (6.22e-2)" "unprognostic (5.31e-1)" "unprognostic (8.32e-2)" "unprognostic (1.87e-3)" "unprognostic (1.37e-1)" "unprognostic (1.31e-2)" "unprognostic (2.07e-3)" "unprognostic (8.17e-2)" "unprognostic (9.35e-2)" "unprognostic (5.25e-4)" 16.9 3.6 11.4 1.3 14.6 0.8 2.4 8.1 25.9 2.3 5.1 1.8 0.7 1.2 6.8 2.3 3.9 9.0 1.9 1.9 6.6 5.3 1.3 3.5 1.2 0.8 3.3 12.5 1.2 1.2 0.9 2.5 1.0 2.5 4.8 1.9 22.4 1.7 6.5 6.2 1.1 1.8 9.6 1.2 1.2 3.9 1.5 2.4 0.0 1.0 0.1 0.8 4.0 0.9 0.4 0.3 1.2 0.2 0.3 0.7 0.0 0.0 0.1 0.8 0.0 3.6 0.3 0.1 0.0 0.4 0.4 0.0 5.1 0.0 0.0 0.0 0.1 1.3 0.1 0.0 0.1 0.3 0.1 0.2 0.0 0.1 0.0 0.0 2.6 0.0 0.6 3.2 0.0 0.1 0.2 0.0 0.0 0.0 1.9 1.2 0.3 0.0 2.4 0.1 0.0 0.9 0.0 1.0 0.0 0.0 0.0 2.3 1.9 1.6 2.3 0.0 0.0 1.7 0.0 0.0 2.2 4.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.7 0.2 1.2 0.3 0.1 0.3 0.1 0.0 11.4 14.6 8.1 25.9 6.6 5.3 3.3 12.5 2.5 2.4 0.0 2.1 0.0 0.1 0.7 119.5 1.2 2.5 5.3 1.2 0.0 200.3 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.4 0.1 3.5 4.7 0.1 17.5 0.0 0.0 0.0 0.4 4.0 0.1 0.0 0.0 0.0 26.9 0.1 0.0 32.5 0.0 366.4 0.0 3.4 0.2 0.3 0.3 0.1 0.0 0.0 0.0 KCNC1 Kv3.1 ENSG00000129159 "Potassium voltage-gated channel subfamily C member 1" P48547 11 17734774-17856804 "Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Disease mutation, Epilepsy, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 12 "brain: 67.5" "Cell type enriched" "Detected in some" 4 "Bipolar cells: 36.6" "Cancer enhanced" "Detected in some" "glioma: 1.1" "Region enhanced" "Detected in all" "cerebellum: 67.5" "Cell type enhanced" "Detected in some" "basophil: 5.8" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "RH-30: 7.5;SCLC-21H: 7.1;SH-SY5Y: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047634, HPA048249" Enhanced Approved "Nucleoplasm,Nuclear membrane,Vesicles,Cytosol" NA NA "Nucleoplasm, Nuclear membrane" "Vesicles, Cytosol" "HPA047634: AB_2680109, HPA048249: " "unprognostic (1.79e-2)" "unprognostic (2.68e-1)" "unprognostic (1.33e-1)" "unprognostic (4.09e-3)" "unprognostic (1.12e-1)" "unprognostic (8.02e-2)" "unprognostic (2.40e-1)" "unprognostic (1.27e-1)" "unprognostic (8.37e-2)" "unprognostic (2.14e-1)" "unprognostic (7.04e-5)" "unprognostic (5.89e-2)" "unprognostic (7.32e-4)" "unprognostic (1.29e-1)" "unprognostic (5.44e-2)" "unprognostic (1.05e-2)" "unprognostic (7.83e-2)" 0.7 2.3 8.2 1.0 10.0 2.9 0.9 67.5 33.3 3.0 1.0 1.0 0.0 1.4 1.5 0.6 1.1 0.9 1.3 0.6 5.6 4.9 0.9 1.1 1.0 1.2 3.3 12.6 1.1 0.9 0.6 1.4 0.7 19.5 1.2 0.8 0.7 1.2 0.7 1.7 1.8 1.2 0.8 1.9 1.0 1.3 2.9 2.0 0.0 1.5 0.0 0.8 2.4 0.5 1.7 0.8 5.8 0.8 0.7 1.1 0.3 0.4 0.1 3.1 1.2 0.5 0.0 0.1 0.0 0.0 0.1 0.0 0.2 1.0 0.0 0.2 0.0 0.9 1.1 1.8 0.0 0.3 0.3 2.1 0.6 3.0 0.2 0.4 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.8 0.5 1.4 0.0 0.5 0.5 1.2 1.5 0.0 0.0 0.8 7.5 0.9 0.0 0.4 7.1 4.4 0.4 0.5 0.0 0.4 0.6 0.5 0.1 0.2 2.3 0.3 0.3 0.5 0.6 1.0 0.5 0.3 1.0 5.8 0.7 1.1 1.1 0.7 0.7 0.7 0.9 0.5 0.2 1.7 0.7 0.8 3.8 0.7 0.8 0.8 0.4 0.3 8.2 10.0 67.5 33.3 5.6 4.9 3.3 12.6 19.5 2.0 0.0 0.0 0.0 0.0 0.0 36.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 7.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 1.6 7.5 0.0 0.0 8.4 0.3 0.0 0.0 1.0 0.0 1.5 0.2 0.0 0.0 0.1 7.4 0.0 0.4 5.4 4.5 0.0 0.0 0.0 0.0 0.0 KCNV2 Kv8.2 ENSG00000168263 "Potassium voltage-gated channel modifier subfamily V member 2" Q8TDN2 9 2717502-2730037 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 82.3" "Group enriched" "Detected in some" 5 "Cone photoreceptor cells: 485.0;Rod photoreceptor cells: 393.2" "Cancer enriched" "Detected in single" 78 "testis cancer: 6.2" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "naive B-cell: 1.4" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "Daudi: 1.6;HDLM-2: 2.9;HEK 293: 1.4;HeLa: 2.3" "Not detected" "Not detected" "Not detected" "Not detected" HPA031131 Enhanced NA NA "HPA031131: AB_10609996" "unprognostic (5.06e-2)" "unprognostic (1.47e-3)" "unprognostic (3.45e-3)" "unprognostic (6.41e-2)" "unprognostic (1.31e-1)" "unprognostic (2.28e-2)" "unprognostic (1.12e-3)" "unprognostic (5.38e-2)" "unprognostic (1.39e-2)" "unprognostic (1.69e-1)" "unprognostic (5.21e-2)" "unprognostic (2.35e-1)" "unprognostic (7.96e-8)" "unprognostic (3.01e-1)" "unprognostic (4.90e-2)" "unprognostic (9.90e-2)" "unprognostic (1.06e-2)" 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 82.3 0.2 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.0 9.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.1 0.1 0.0 0.6 0.0 0.2 0.7 0.2 0.4 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.9 0.0 1.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.9 1.4 0.8 2.3 0.3 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.5 0.7 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.4 0.3 0.0 0.1 0.2 0.1 0.1 0.6 0.0 0.0 0.7 0.4 0.6 0.3 0.3 0.2 0.2 0.3 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.1 0.0 1.4 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.8 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.1 0.2 0.0 0.0 0.0 0.0 485.0 0.0 0.0 0.0 85.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.8 0.0 0.0 0.0 19.8 0.6 0.0 0.0 0.0 0.0 36.6 0.0 0.0 1.1 0.0 393.2 12.9 0.0 5.9 11.4 0.0 0.0 0.0 0.0 0.0 LRIT2 "AC022389.4, LRRC22" ENSG00000204033 "Leucine rich repeat, Ig-like and transmembrane domains 2" A6NDA9 10 84220495-84225589 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "retina: 25.4;skin 1: 8.5" "Group enriched" "Detected in some" 6 "Bipolar cells: 5.9;Cone photoreceptor cells: 7.9;Rod photoreceptor cells: 16.6" "Not detected" "Not detected" "Region enriched" "Detected in single" 6 "basal ganglia: 3.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA037788 Enhanced NA NA "HPA037788: AB_10672393" "unprognostic (3.12e-1)" "unprognostic (1.09e-3)" "unprognostic (3.99e-1)" "unprognostic (9.44e-2)" "unprognostic (2.36e-1)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" 0.1 0.2 0.2 0.1 3.4 0.0 0.1 0.1 2.2 0.1 1.6 0.1 0.1 0.0 0.1 0.1 0.4 0.0 0.1 0.1 0.3 0.3 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 25.4 0.1 0.1 0.1 8.5 0.7 0.1 0.1 0.3 0.0 0.3 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 3.4 0.1 0.5 0.3 0.3 0.3 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 5.9 0.2 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 16.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 LRIT3 "CSNB1F, FIGLER4, FLJ44691" ENSG00000183423 "Leucine rich repeat, Ig-like and transmembrane domains 3" Q3SXY7 4 109848202-109872315 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 17.1" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 31.4;Muller glia cells: 15.4;Rod photoreceptor cells: 9.6" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "hTCEpi: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA013454 Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA013454: AB_1853277" "unprognostic (5.41e-2)" "unprognostic (6.82e-2)" "unprognostic (4.20e-2)" "unprognostic (6.50e-2)" "unprognostic (3.42e-1)" "unprognostic (7.67e-3)" "unprognostic (1.54e-1)" "unprognostic (5.25e-2)" "unprognostic (3.16e-2)" "unprognostic (4.49e-2)" "unprognostic (6.92e-3)" "unprognostic (3.34e-3)" "unprognostic (2.14e-1)" "unprognostic (4.01e-2)" "unprognostic (1.69e-1)" "unprognostic (1.35e-1)" "unprognostic (1.14e-2)" 0.6 0.6 0.7 0.6 1.2 0.4 1.7 2.0 1.3 1.2 0.6 0.6 0.6 0.3 0.7 1.8 0.6 1.0 0.6 0.6 0.8 0.7 4.4 0.7 0.6 0.6 0.6 0.6 0.6 0.7 0.7 0.6 0.6 0.6 0.9 0.5 17.1 0.8 0.6 1.6 3.2 0.6 0.6 0.6 0.8 0.2 1.3 0.6 0.6 0.8 0.6 0.6 0.6 0.6 0.1 0.3 0.5 0.0 0.0 0.9 0.0 0.0 0.0 0.8 0.0 0.4 0.1 0.1 0.0 0.0 0.2 0.2 0.3 0.0 0.6 0.6 0.0 0.0 0.1 1.3 0.1 0.2 0.3 1.6 0.3 0.4 0.2 0.1 1.3 0.0 0.0 2.0 0.1 0.3 0.2 0.1 1.3 0.3 0.6 0.0 0.0 0.9 1.0 0.2 0.8 0.2 0.6 0.0 0.2 1.0 0.3 0.5 0.0 0.0 0.4 0.0 0.3 0.1 1.2 0.0 0.3 0.3 0.6 0.3 0.6 1.0 0.0 0.3 0.9 0.3 0.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.7 0.0 0.1 0.9 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.7 1.2 2.0 1.3 0.8 0.7 0.6 0.6 0.6 0.6 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 0.0 31.4 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.1 0.0 0.0 0.0 9.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 MGARP "C4orf49, CESP-1, HUMMR, OSAP" ENSG00000137463 "Mitochondria localized glutamic acid rich protein" Q8TDB4 4 139266163-139280338 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 88.9;retina: 30.7" "Group enriched" "Detected in some" 9 "Bipolar cells: 140.5;Horizontal cells: 197.0;Muller glia cells: 424.1" "Cancer enhanced" "Detected in some" "renal cancer: 4.1" "Group enriched" "Detected in many" 4 "basal ganglia: 4.5;cerebellum: 8.0" "Cell type enhanced" "Detected in some" "memory CD4 T-cell: 1.7;naive CD4 T-cell: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "BJ: 10.7;fHDF/TERT166: 15.9;HHSteC: 12.9;HUVEC TERT2: 32.4" "Low region specificity" "Detected in some" "HPA015994, HPA070835" Enhanced Supported Mitochondria NA NA Mitochondria "HPA015994: AB_2630370, HPA070835: " "unprognostic (2.68e-1)" "unprognostic (1.73e-1)" "unprognostic (8.18e-2)" "unprognostic (4.25e-2)" "unprognostic (3.54e-2)" "unprognostic (3.11e-2)" "unprognostic (3.42e-2)" "unprognostic (1.02e-3)" "unprognostic (2.90e-2)" "unprognostic (4.96e-2)" "unprognostic (1.50e-2)" "unprognostic (1.31e-1)" "unprognostic (4.08e-2)" "unprognostic (1.47e-2)" "unprognostic (9.91e-2)" "unprognostic (2.09e-2)" "unprognostic (2.36e-1)" 3.2 88.9 1.0 0.5 4.5 0.4 1.2 8.0 1.2 3.6 1.0 2.1 1.1 0.4 2.6 3.0 0.5 0.8 1.3 6.1 0.8 1.4 1.0 0.4 0.5 0.6 1.0 0.0 20.1 0.5 0.4 15.3 0.5 1.5 2.0 0.5 30.7 0.4 2.0 0.6 0.5 0.4 2.3 0.7 0.6 0.4 5.9 0.5 0.0 0.5 0.0 0.5 2.1 1.0 0.5 0.0 0.0 0.3 0.5 1.7 0.3 0.0 0.5 0.3 0.2 0.8 0.4 0.0 10.7 0.0 1.6 0.0 0.0 0.1 0.0 0.1 15.9 4.6 0.2 2.3 0.0 0.9 0.0 1.0 0.0 0.0 0.1 12.9 0.1 0.1 3.9 0.3 1.7 0.1 3.8 32.4 0.1 0.2 0.2 2.6 0.0 0.4 0.2 0.6 0.2 0.0 0.0 0.0 0.0 0.3 0.1 0.3 0.6 0.0 0.0 0.1 0.2 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.4 0.3 0.3 4.5 0.4 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 1.7 0.4 0.0 0.3 1.6 0.7 0.0 0.5 0.2 0.0 0.3 0.3 1.0 4.5 8.0 1.2 0.8 1.4 1.0 0.0 1.5 0.5 0.0 0.0 0.0 0.7 1.4 140.5 2.5 0.0 0.0 0.0 0.0 7.9 0.2 1.7 0.0 0.2 0.2 0.0 0.0 0.0 0.1 2.4 0.3 0.0 0.0 0.5 197.0 0.0 0.6 0.0 0.0 15.8 0.0 0.0 0.0 0.0 424.1 0.1 0.0 23.3 7.6 28.7 0.0 0.4 0.7 0.3 0.6 0.2 0.0 0.0 0.3 MLANA MART1 ENSG00000120215 Melan-A Q16655 9 5890802-5910606 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "retina: 191.5" "Cell type enriched" "Detected in some" 25 "Melanocytes: 1629.7" "Cancer enriched" "Detected in single" 556 "melanoma: 277.0" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enriched" "Detected in single" 385 "SK-MEL-30: 123.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "CAB000057, HPA048662" Enhanced NA NA "CAB000057: AB_442107, HPA048662: AB_2680485" "unprognostic (2.52e-2)" "unprognostic (6.87e-2)" "unprognostic (5.20e-2)" "unprognostic (5.61e-2)" "unprognostic (2.58e-2)" "unprognostic (1.46e-1)" "unprognostic (4.53e-1)" "unprognostic (3.32e-1)" "unprognostic (2.82e-2)" "unprognostic (1.71e-3)" "unprognostic (3.60e-3)" "unprognostic (1.20e-1)" "unprognostic (1.45e-2)" "unprognostic (1.60e-1)" "unprognostic (8.01e-2)" "unprognostic (5.78e-2)" "unprognostic (9.43e-2)" 0.1 0.1 0.1 0.2 0.1 0.6 1.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.2 0.0 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 191.5 1.2 0.1 0.2 31.5 0.1 0.1 0.8 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.2 0.3 2.1 1.6 3.5 1.2 1.8 1.5 0.3 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 123.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 3.5 1.2 0.8 1.4 0.8 1.1 1.4 1.3 1.2 0.4 2.1 1.4 1.5 2.9 1.8 1.1 1.6 0.6 0.3 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.3 0.1 0.0 0.0 0.0 0.0 65.5 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1629.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.7 0.0 0.0 12.7 0.0 0.0 0.0 0.0 MPP1 "DXS552E, PEMP" ENSG00000130830 "Membrane palmitoylated protein 1" Q00013 X 154778684-154821007 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 11 "Cytotrophoblasts: 338.8;Erythroid cells: 163.5;Hofbauer cells: 251.9;Syncytiotrophoblasts: 380.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "eosinophil: 46.4;neutrophil: 45.3" "Group enriched" "Detected in all" 7 "dendritic cells: 12.7;granulocytes: 46.4;monocytes: 20.9" "Cell line enhanced" "Detected in many" "HEL: 59.4;REH: 37.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA076675 Enhanced Supported "Plasma membrane,Centriolar satellite" NA NA 4300000 "Plasma membrane" "Centriolar satellite" "HPA076675: " "unprognostic (2.15e-1)" "unprognostic (4.06e-2)" "unprognostic (4.52e-2)" "unprognostic (1.83e-3)" "unprognostic (7.14e-2)" "unprognostic (2.60e-2)" "unprognostic (7.47e-2)" "unprognostic (1.54e-1)" "unprognostic (1.82e-1)" "unprognostic (7.79e-2)" "unprognostic (3.77e-3)" "unprognostic (1.70e-3)" "prognostic favorable (4.60e-6)" "unprognostic (6.69e-2)" "unprognostic (2.53e-2)" "unprognostic (4.68e-2)" "unprognostic (6.67e-3)" 18.7 18.2 12.7 14.4 19.2 52.9 9.9 25.8 30.9 7.1 18.3 10.0 15.1 32.0 8.9 9.5 6.1 10.0 13.5 14.1 14.3 13.0 23.3 20.4 18.2 11.9 15.9 13.5 7.2 18.9 19.5 6.5 45.6 28.8 9.1 10.1 6.4 17.1 10.9 14.6 6.3 42.7 11.0 15.8 27.4 7.9 4.1 7.4 27.1 8.3 6.4 6.9 10.0 7.1 1.6 12.7 46.4 20.9 2.0 3.8 15.8 11.3 2.3 5.3 5.3 5.5 5.8 17.1 4.3 6.5 7.2 8.9 6.4 1.0 8.8 8.4 4.7 19.3 1.3 6.0 1.9 5.7 9.4 10.6 59.4 1.6 6.8 8.3 12.1 34.5 5.6 2.5 7.9 2.0 7.4 16.3 12.0 25.6 1.4 8.1 0.0 27.4 16.0 0.5 1.0 7.8 37.5 1.3 4.2 4.1 0.9 1.3 2.1 3.5 0.3 3.7 5.5 0.9 7.1 7.5 6.6 3.6 14.5 11.5 10.4 14.2 3.4 9.3 17.0 3.1 9.0 20.9 46.4 1.2 16.7 1.4 1.6 1.4 1.3 12.7 0.7 3.8 1.9 45.3 2.0 20.3 3.5 0.7 15.8 12.7 19.2 25.8 30.9 14.3 13.0 15.9 13.5 28.8 7.4 3.0 15.7 7.6 4.2 7.7 10.2 15.7 25.5 4.0 11.4 7.0 3.9 338.8 18.3 8.9 0.5 15.7 22.0 163.5 2.4 10.5 13.4 3.6 87.8 9.6 251.9 15.9 11.1 9.2 95.5 1.9 8.1 69.1 10.1 33.3 4.1 14.8 4.2 4.3 12.4 51.8 6.7 0.0 12.0 0.7 2.5 5.3 380.0 8.9 4.6 0.7 MPP5 "FLJ12615, PALS1" ENSG00000072415 "Membrane palmitoylated protein 5" Q8N3R9 14 67241109-67335819 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A-431: 54.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000993, HPA063890" Enhanced Uncertain "Nucleoplasm,Plasma membrane,Cytosol" NA NA Nucleoplasm "Plasma membrane, Cytosol" "HPA000993: AB_1079407, HPA063890: AB_2732707" "unprognostic (3.65e-1)" "unprognostic (3.82e-3)" "unprognostic (4.56e-2)" "unprognostic (9.20e-2)" "unprognostic (9.86e-2)" "unprognostic (1.36e-1)" "prognostic unfavorable (5.62e-4)" "unprognostic (1.48e-1)" "unprognostic (1.02e-1)" "unprognostic (1.37e-1)" "unprognostic (1.93e-3)" "unprognostic (9.89e-3)" "prognostic favorable (1.71e-12)" "unprognostic (2.28e-1)" "unprognostic (1.82e-1)" "unprognostic (6.90e-2)" "unprognostic (6.87e-2)" 7.1 9.2 14.8 6.8 29.2 7.0 10.1 9.4 18.0 9.0 12.5 15.9 13.7 18.5 6.9 20.8 14.4 7.2 9.0 7.3 16.4 17.0 28.8 17.2 11.5 4.5 30.6 10.2 6.4 8.6 22.9 11.4 27.9 20.5 15.8 11.6 7.6 15.9 18.6 14.6 8.6 18.7 11.9 23.3 6.2 9.7 8.2 25.4 6.8 24.1 6.9 5.8 9.1 9.1 3.6 2.4 3.7 2.8 6.7 4.4 1.2 54.9 8.8 8.9 7.2 5.2 4.7 7.9 16.8 8.8 12.3 8.3 8.7 16.9 4.7 8.0 13.6 4.3 11.5 5.1 9.7 18.9 2.2 3.5 4.3 9.3 6.0 6.0 1.6 3.3 5.0 3.7 7.1 9.1 8.9 6.8 5.4 4.5 2.1 19.6 7.4 5.2 2.0 3.0 8.0 6.0 4.7 14.2 5.6 11.2 13.7 5.0 3.6 10.4 10.2 5.8 8.2 10.5 3.3 10.6 15.7 33.4 5.5 7.3 3.2 2.9 7.2 10.5 3.7 5.4 0.4 2.2 3.7 1.7 2.8 1.4 3.6 2.0 1.9 2.4 1.9 4.4 2.4 0.8 6.7 2.3 2.4 1.1 1.2 14.8 29.2 9.4 18.0 16.4 17.0 30.6 10.2 20.5 25.4 59.6 21.6 6.0 21.7 18.7 9.4 22.4 12.7 9.4 17.0 21.0 41.2 18.5 11.6 19.2 4.4 14.3 41.0 0.0 23.5 8.9 16.6 25.6 4.7 16.8 14.2 3.2 5.2 16.5 9.6 3.9 7.5 7.2 3.3 7.2 18.4 24.1 20.2 31.6 10.6 28.4 34.5 6.5 19.6 8.3 33.8 15.2 14.6 4.4 19.5 31.5 MSI1 ENSG00000135097 "Musashi RNA binding protein 1" O43347 12 120341330-120369180 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 27.3;skeletal muscle: 23.2" "Cell type enhanced" "Detected in many" 12 "Cone photoreceptor cells: 51.1;Early spermatids: 46.0;Late spermatids: 40.7;Muller glia cells: 68.3;Rod photoreceptor cells: 92.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 43.8;HAP1: 20.0;NTERA-2: 22.8;SCLC-21H: 32.5;SH-SY5Y: 15.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA074923, HPA075573" Enhanced Approved Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "HPA074923: , HPA075573: " "unprognostic (1.21e-1)" "unprognostic (3.46e-3)" "unprognostic (1.85e-1)" "unprognostic (1.09e-1)" "unprognostic (3.89e-1)" "unprognostic (3.18e-2)" "unprognostic (1.20e-1)" "unprognostic (1.46e-1)" "unprognostic (1.90e-2)" "unprognostic (2.75e-2)" "prognostic favorable (5.99e-4)" "unprognostic (3.66e-1)" "unprognostic (1.46e-3)" "unprognostic (7.61e-2)" "unprognostic (7.35e-2)" "unprognostic (2.70e-2)" "unprognostic (1.19e-1)" 0.8 6.8 8.7 0.6 7.4 0.4 1.2 3.9 14.2 1.9 1.5 8.6 2.2 7.8 4.3 2.7 1.5 3.1 1.4 4.0 11.3 5.9 0.7 1.0 1.0 0.6 4.7 6.1 2.9 7.3 1.3 12.8 1.4 4.6 4.5 1.5 27.3 1.3 2.5 23.2 0.5 5.2 2.2 4.7 0.7 3.1 12.5 5.4 0.0 1.3 0.0 0.4 0.9 0.9 0.1 0.4 0.6 0.2 0.2 0.3 0.0 0.0 0.5 43.8 11.1 0.0 0.0 5.6 0.0 0.0 0.3 0.5 7.7 0.2 0.0 0.6 0.0 0.2 0.1 20.0 0.0 0.1 0.2 4.5 0.0 0.1 0.9 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.1 22.8 0.2 0.2 0.1 0.0 0.1 0.0 0.0 32.5 15.8 0.0 0.3 0.3 4.4 6.7 0.0 0.0 0.1 6.0 0.0 0.0 0.5 0.1 0.0 0.1 0.1 0.4 0.3 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.3 0.1 0.6 0.2 0.2 0.4 0.1 0.0 8.7 7.4 3.9 7.2 11.3 5.9 4.7 6.1 4.6 5.4 0.0 0.0 0.0 1.0 0.9 20.9 2.6 0.0 0.0 0.0 0.0 51.1 0.0 1.7 1.0 46.0 0.3 0.5 0.0 4.5 0.5 0.5 5.5 0.0 0.0 0.1 3.2 9.7 0.0 0.0 40.7 0.3 0.0 0.0 1.0 0.7 68.3 2.0 5.5 0.4 0.0 92.6 12.9 2.1 7.0 1.3 0.0 0.3 0.0 2.5 0.3 MTNR1B ENSG00000134640 "Melatonin receptor 1B" P49286 11 92969720-92985066 "FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 3.0;lymphoid tissue: 1.9;placenta: 4.5;testis: 2.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 20 "GAMG: 10.6;SuSa: 2.9" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "midbrain: 0.8;pons and medulla: 1.2" HPA074024 Supported NA NA "HPA074024: " "unprognostic (3.61e-1)" "unprognostic (1.43e-1)" 0.1 0.0 0.3 0.0 3.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 2.0 0.0 1.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 MYO3A DFNB30 ENSG00000095777 "Myosin IIIA" Q8NEV4 10 25934071-26212536 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Hearing, Sensory transduction, Vision" "Actin-binding, Kinase, Motor protein, Myosin, Serine/threonine-protein kinase, Transferase" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pituitary gland: 8.1;testis: 12.5" "Cell type enhanced" "Detected in some" 23 "Early spermatids: 127.9;Late spermatids: 34.5;Muller glia cells: 68.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 4 "basal ganglia: 5.0;cerebral cortex: 1.9;hypothalamus: 1.3;pons and medulla: 5.4" "Cell type enriched" "Detected in single" 12 "naive B-cell: 1.1" "Lineage enriched" "Detected in single" 12 "B-cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 2.3;CAPAN-2: 2.2;HEK 293: 2.7;SCLC-21H: 2.5;U-2 OS: 4.4;U-698: 11.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA051893, HPA075413" Enhanced Supported "Plasma membrane,Actin filaments,Cytoplasmic bodies" No No "Actin filaments, Cytoplasmic bodies" "Plasma membrane" "HPA051893: , HPA075413: " "unprognostic (5.00e-3)" "unprognostic (3.36e-2)" "unprognostic (1.53e-1)" "unprognostic (3.20e-3)" "unprognostic (2.96e-1)" "unprognostic (4.37e-2)" "unprognostic (5.29e-2)" "unprognostic (2.74e-1)" "unprognostic (4.31e-2)" "unprognostic (1.03e-1)" "unprognostic (5.66e-3)" "unprognostic (7.96e-3)" "unprognostic (6.34e-2)" "unprognostic (1.46e-2)" "unprognostic (6.62e-2)" "unprognostic (9.69e-2)" 0.8 0.7 0.4 0.3 5.0 0.5 1.5 0.3 1.9 2.1 0.6 0.1 0.7 0.4 0.3 3.2 0.9 1.1 0.3 0.3 0.5 1.3 0.9 0.2 1.0 0.3 0.2 0.0 0.5 2.1 0.2 8.1 0.2 5.4 0.5 1.1 3.8 0.2 0.6 0.3 2.2 0.6 1.0 0.4 0.3 0.9 12.5 0.8 0.0 1.3 1.4 0.9 0.5 0.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.6 1.5 0.0 0.0 1.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 5.0 0.3 1.9 0.5 1.3 0.2 0.0 5.4 0.8 0.0 0.3 0.0 0.3 1.5 0.9 0.6 0.0 0.0 4.5 0.0 0.0 0.0 1.7 0.5 127.9 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 1.7 0.0 0.0 34.5 1.1 0.0 0.0 0.0 0.2 68.5 0.3 0.0 1.1 1.4 3.4 0.0 0.0 20.0 5.8 0.9 0.0 0.0 0.0 0.1 NPVF "C7orf9, RFRP" ENSG00000105954 "Neuropeptide VF precursor" Q9HCQ7 7 25224570-25228486 "Predicted secreted proteins" Neuropeptide "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 30 "brain: 9.5;lymphoid tissue: 2.9;retina: 7.0" "Cell type enriched" "Detected in some" 44 "Muller glia cells: 336.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 95 "hypothalamus: 9.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 17 "hypothalamus: 7.2" "Region enriched" "Detected in some" 4 "hypothalamus: 3.8" HPA041733 Enhanced "Secreted in other tissues" NA NA "HPA041733: AB_10794524" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 336.5 0.0 0.0 0.0 0.0 7.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 NRL "D14S46E, NRL-MAF, RP27" ENSG00000129535 "Neural retina leucine zipper" P54845 14 24080107-24115014 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 16 "retina: 124.5" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2618.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "U-266/70: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "CAB026066, HPA064599" Enhanced Supported Nucleoplasm,Cytosol NA NA Nucleoplasm Cytosol "CAB026066: , HPA064599: AB_2685295" "unprognostic (2.71e-2)" "unprognostic (8.17e-4)" "unprognostic (4.60e-2)" "unprognostic (1.80e-1)" "unprognostic (7.23e-2)" "unprognostic (1.99e-2)" "unprognostic (5.29e-2)" "unprognostic (1.88e-5)" "unprognostic (3.59e-2)" "unprognostic (7.84e-3)" "unprognostic (1.75e-3)" "unprognostic (3.49e-2)" "unprognostic (2.38e-5)" "unprognostic (2.56e-2)" "unprognostic (1.10e-1)" "unprognostic (1.73e-1)" "unprognostic (1.35e-3)" 1.5 2.7 4.4 2.3 4.1 1.0 1.8 2.1 2.8 1.9 1.3 1.7 1.7 3.2 1.4 7.9 1.3 1.4 1.2 2.7 3.8 3.1 3.5 3.9 1.7 1.9 3.9 1.4 1.8 3.4 5.4 2.8 1.8 2.1 1.8 1.0 124.5 1.6 2.4 4.1 0.9 1.9 1.0 4.4 2.6 1.3 4.3 1.2 3.3 4.3 1.8 1.6 1.5 2.2 3.8 1.4 4.1 1.3 2.0 2.7 1.2 0.8 1.7 0.5 1.8 0.5 0.5 1.6 0.4 0.4 2.2 1.0 1.1 0.8 2.5 0.8 1.0 1.6 1.0 1.0 1.2 0.3 1.8 1.5 0.7 0.5 3.7 1.2 1.9 3.3 0.7 1.0 0.6 1.2 0.4 1.1 3.1 1.6 3.0 0.8 2.6 2.2 1.8 0.6 3.4 1.8 2.2 2.1 0.7 1.2 1.7 2.0 2.0 1.3 1.5 1.6 0.7 1.1 2.6 0.4 1.4 0.8 0.6 1.2 7.6 3.2 2.7 0.2 1.6 1.5 0.0 1.1 4.1 1.1 1.2 0.7 3.8 1.1 1.6 1.3 2.4 2.7 2.3 0.2 2.0 1.3 1.4 1.0 1.2 4.4 4.1 2.1 2.8 3.8 3.1 3.9 1.4 2.1 1.2 0.0 0.3 4.4 1.7 0.7 340.0 1.6 0.0 0.0 1.2 7.0 406.4 1.0 11.6 0.5 1.7 0.6 2.1 23.3 1.0 0.8 0.5 2.4 0.0 2.6 1.7 236.8 1.7 0.0 0.6 2.8 1.1 0.2 1.7 1.0 1.8 381.3 0.4 0.9 1.8 6.8 2618.0 0.0 0.5 8.2 3.4 0.4 2.1 1.5 0.9 1.6 OPN1SW "BCP, BOP, CBT" ENSG00000128617 "Opsin 1, short wave sensitive" P03999 7 128772491-128775790 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 11.4;retina: 23.9" "Cell type enriched" "Detected in some" 12 "Cone photoreceptor cells: 39.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "U-87 MG: 37.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013562, HPA014083" Enhanced Approved "Nucleoplasm,Nuclear bodies,Cytokinetic bridge,Cytosol" NA NA Nucleoplasm "Nuclear bodies, Cytokinetic bridge, Cytosol" "HPA013562: AB_2668850, HPA014083: AB_2668938" "unprognostic (2.88e-1)" "unprognostic (5.17e-2)" "unprognostic (2.22e-2)" "unprognostic (1.33e-2)" "unprognostic (2.55e-2)" "unprognostic (2.16e-1)" "prognostic unfavorable (8.50e-5)" "unprognostic (1.13e-1)" "unprognostic (1.27e-1)" "unprognostic (6.33e-2)" "unprognostic (3.79e-1)" "unprognostic (6.05e-2)" "prognostic unfavorable (2.26e-8)" "prognostic unfavorable (5.98e-8)" "unprognostic (2.53e-1)" "unprognostic (8.99e-2)" "prognostic unfavorable (9.33e-4)" 0.9 1.8 0.7 3.7 0.9 1.7 0.7 1.0 2.3 0.7 2.2 0.7 0.7 0.5 2.6 0.7 2.4 0.8 4.2 11.4 0.7 0.8 0.7 0.7 0.9 1.0 0.7 1.3 0.7 0.7 0.0 0.7 0.7 0.7 1.4 0.0 23.9 1.1 0.7 1.9 0.9 0.9 0.7 0.7 1.1 1.4 1.1 0.7 0.7 2.3 0.7 0.7 4.3 0.7 0.5 1.2 0.6 1.4 0.0 1.4 0.3 1.7 2.2 5.2 1.7 0.0 0.0 1.5 9.8 0.0 0.0 0.0 5.0 2.1 2.6 1.5 0.0 1.6 1.4 0.0 0.0 0.0 0.3 3.6 1.6 3.0 2.5 0.0 2.0 1.6 0.0 0.0 0.0 0.0 7.0 0.0 1.7 2.2 0.6 1.1 0.7 2.0 3.6 4.7 1.7 3.0 1.0 5.4 3.0 0.0 0.6 0.7 6.9 2.3 5.2 4.4 7.3 0.5 2.0 4.0 10.0 1.0 7.7 8.7 2.1 2.2 1.6 37.6 4.6 9.3 0.0 0.3 0.6 1.4 1.4 0.9 0.2 0.8 1.0 1.2 0.5 0.3 0.9 0.0 0.0 1.0 0.7 0.4 0.3 0.7 0.9 1.0 0.9 0.7 0.8 0.7 1.3 0.7 0.7 0.0 0.6 0.0 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 39.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 OPN4 "melanopsin, MOP" ENSG00000122375 "Opsin 4" Q9UHM6 10 86654557-86666848 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Biological rhythms, Sensory transduction" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 21.2;skeletal muscle: 14.6" "Cell type enriched" "Detected in single" 34 "Cardiomyocytes: 3.4" "Not detected" "Not detected" "Region enhanced" "Detected in many" "basal ganglia: 21.2" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "PC-3: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA039147 Approved NA NA "HPA039147: AB_10673304" "unprognostic (3.67e-3)" "unprognostic (1.40e-2)" "unprognostic (3.02e-2)" "unprognostic (1.62e-1)" "unprognostic (7.03e-3)" "unprognostic (2.89e-2)" "unprognostic (3.26e-1)" "unprognostic (9.54e-2)" "unprognostic (5.68e-2)" "unprognostic (8.88e-3)" "unprognostic (1.93e-6)" "unprognostic (4.10e-2)" "unprognostic (5.58e-2)" "unprognostic (6.76e-2)" 3.5 0.3 5.4 0.4 21.2 0.2 1.1 0.0 5.1 0.6 0.9 0.0 0.0 0.5 0.4 0.4 0.6 0.4 0.5 3.1 3.0 0.1 0.3 0.2 0.3 0.2 0.2 3.3 0.3 0.4 3.6 0.6 0.5 0.0 0.2 0.7 1.2 1.6 0.2 14.6 1.2 1.1 0.5 0.0 0.3 0.5 0.5 2.0 0.0 1.4 2.7 0.3 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.3 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 21.2 0.0 3.5 3.0 0.1 0.2 3.3 0.0 2.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OPN5 "dJ402H5.1, neuropsin, TMEM13" ENSG00000124818 "Opsin 5" Q6U736 6 47781982-47832780 "G-protein coupled receptors, Predicted membrane proteins" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 12 "testis: 7.3" "Group enriched" "Detected in some" 42 "Early spermatids: 22.0;Late spermatids: 19.1;Spermatocytes: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 1.0;Karpas-707: 1.0;SK-BR-3: 1.1" "Low region specificity" "Detected in single" "Region enriched" "Detected in single" 4 "hypothalamus: 1.3" HPA026084 Supported NA NA "HPA026084: AB_2671807" "unprognostic (1.95e-1)" "unprognostic (6.18e-2)" "unprognostic (4.84e-1)" "unprognostic (1.07e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 0.2 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 19.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 8.6 0.2 0.0 0.0 0.0 0.0 0.0 PAX6 "AN, AN2, D11S812E, WAGR" ENSG00000007372 "Paired box 6" P26367 11 31784779-31818062 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transcription factors" "Differentiation, Transcription, Transcription regulation" "Developmental protein, DNA-binding, Repressor" "Disease mutation, Peters anomaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 78.3;retina: 29.4" "Group enriched" "Detected in some" 5 "Horizontal cells: 249.5;Muller glia cells: 410.0" "Cancer enhanced" "Detected in some" "glioma: 2.5" "Region enriched" "Detected in all" 5 "cerebellum: 78.3" "Cell type enhanced" "Detected in some" "basophil: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "AF22: 9.4;AN3-CA: 12.1;HEK 293: 11.3;hTERT-RPE1: 32.3;U-251 MG: 9.9" "Group enriched" "Detected in many" 5 "cerebellum: 61.0;olfactory region: 41.2" "Low region specificity" "Detected in all" "HPA030775, CAB034143" Enhanced Supported Enhanced Nucleoplasm NA NA Nucleoplasm "CAB034143: AB_1127044, HPA030775: AB_10601243" "unprognostic (2.89e-1)" "unprognostic (2.98e-2)" "unprognostic (8.34e-2)" "unprognostic (3.85e-2)" "unprognostic (4.42e-2)" "unprognostic (7.82e-2)" "unprognostic (2.76e-1)" "unprognostic (1.91e-1)" "unprognostic (4.24e-3)" "unprognostic (1.68e-1)" "unprognostic (1.20e-2)" "unprognostic (3.91e-1)" "unprognostic (8.96e-2)" "unprognostic (1.32e-1)" "unprognostic (1.76e-1)" "unprognostic (1.57e-1)" "unprognostic (3.42e-3)" 0.8 2.0 12.6 0.8 10.4 1.1 1.0 78.3 23.5 0.8 1.1 9.3 0.0 3.5 0.8 1.8 0.8 0.8 0.8 0.8 16.0 3.7 0.9 0.9 0.7 0.9 3.9 9.1 0.8 15.8 0.8 4.6 0.8 10.8 0.8 1.4 29.4 0.8 0.9 1.9 1.6 2.0 0.8 16.1 0.8 19.4 2.8 9.8 0.0 0.8 0.0 1.0 1.1 0.3 0.2 0.2 1.6 0.4 0.4 0.5 0.1 0.0 0.1 9.4 12.1 2.9 4.0 3.6 0.0 0.0 0.1 0.0 0.7 2.2 0.0 3.8 1.2 5.5 0.2 1.0 0.0 0.2 0.0 11.3 5.3 8.8 5.0 0.0 0.2 0.0 0.0 0.4 0.0 0.2 32.3 0.0 3.3 4.2 0.0 0.1 0.0 2.2 0.3 0.2 0.0 6.1 0.0 4.4 0.0 0.5 0.3 0.4 0.0 0.2 0.0 0.0 0.0 2.7 0.0 0.0 3.2 0.2 0.0 9.9 0.0 0.1 0.0 5.0 0.0 0.0 1.6 0.0 0.1 0.0 0.1 0.5 0.0 0.1 0.0 0.2 0.2 0.2 0.3 1.0 0.4 0.4 0.2 0.1 0.1 12.6 10.4 78.3 12.2 16.0 3.7 3.9 9.1 10.8 9.8 0.0 0.0 0.0 0.0 0.5 15.4 4.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 249.5 71.5 0.0 0.0 0.2 0.0 0.0 0.0 1.0 0.1 410.0 4.1 0.6 0.0 0.0 27.5 0.0 0.3 3.7 2.9 0.0 0.0 0.0 0.0 0.0 PDC MEKA ENSG00000116703 Phosducin P20941 1 186443566-186461122 "Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 24 "retina: 56.6" "Group enriched" "Detected in some" 6 "Cone photoreceptor cells: 341.6;Rod photoreceptor cells: 807.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "ASC TERT1: 1.9;BJ: 1.9;BJ hTERT+: 3.6;hTERT-HME1: 1.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA062235 Enhanced NA NA "HPA062235: AB_2684720" "unprognostic (2.06e-2)" "unprognostic (3.31e-1)" "unprognostic (1.89e-1)" "unprognostic (5.90e-4)" "unprognostic (2.18e-1)" "unprognostic (7.53e-2)" "unprognostic (2.43e-2)" "unprognostic (1.26e-1)" "unprognostic (2.35e-1)" "unprognostic (2.39e-2)" "unprognostic (8.28e-3)" "unprognostic (4.07e-7)" "unprognostic (3.48e-2)" "unprognostic (2.11e-2)" "unprognostic (1.61e-1)" "unprognostic (1.67e-2)" 0.5 0.0 0.3 0.2 0.5 0.2 0.2 2.0 1.5 0.3 0.2 0.2 0.2 0.0 0.3 0.2 0.4 0.1 0.4 0.4 0.5 0.3 0.2 0.2 0.2 0.6 0.4 0.2 0.5 0.5 0.0 0.2 0.2 0.2 0.7 0.0 56.6 0.6 1.2 2.3 0.7 0.2 0.2 0.4 0.2 0.2 1.3 0.2 0.2 0.5 0.2 0.2 0.2 0.2 0.0 0.0 0.6 0.2 0.0 0.0 0.0 0.0 0.4 0.5 0.2 0.0 1.9 0.0 1.9 3.6 0.0 0.0 0.0 0.3 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.7 0.1 0.0 0.0 0.7 0.3 0.0 0.7 0.1 0.0 0.0 0.2 1.9 0.4 0.0 0.6 0.1 0.3 0.0 0.0 0.3 0.0 0.3 0.2 0.0 0.1 0.1 0.7 0.0 0.4 0.0 0.2 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.4 0.0 1.2 0.2 0.1 0.0 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.5 2.0 0.5 0.5 0.3 0.4 0.2 0.2 0.2 0.0 0.0 0.0 0.0 0.0 86.0 0.0 0.0 0.0 0.0 0.0 341.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 54.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 98.4 0.0 0.0 0.0 0.0 807.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PDE6A "PDEA, RP43" ENSG00000132915 "Phosphodiesterase 6A" P16499 5 149857955-149944793 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "retina: 153.4" "Cell type enriched" "Detected in many" 12 "Rod photoreceptor cells: 2864.0" "Not detected" "Not detected" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enriched" "Detected in some" 4 "CACO-2: 7.6" "Not detected" "Not detected" "Not detected" "Not detected" "HPA016970, HPA074677" Enhanced NA NA "HPA016970: AB_1855125, HPA074677: AB_2732264" "unprognostic (6.85e-2)" "unprognostic (8.84e-2)" "unprognostic (1.70e-2)" "unprognostic (4.11e-2)" "unprognostic (1.12e-2)" "unprognostic (5.72e-2)" "unprognostic (4.39e-3)" "unprognostic (8.83e-2)" "unprognostic (6.54e-2)" "unprognostic (5.91e-3)" "unprognostic (1.77e-2)" "unprognostic (9.21e-2)" "unprognostic (7.57e-5)" "unprognostic (9.93e-2)" "unprognostic (3.08e-1)" "unprognostic (1.31e-1)" "unprognostic (2.26e-2)" 0.2 2.3 0.2 0.2 0.2 0.9 0.2 0.3 0.2 0.2 1.8 0.2 0.3 0.2 0.2 20.1 2.4 0.1 0.2 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.2 4.6 0.2 0.2 0.2 1.0 153.4 1.4 0.2 0.2 1.6 0.2 0.2 0.2 0.2 0.1 3.1 0.2 0.2 0.4 0.3 0.5 0.2 0.2 1.5 0.8 3.3 0.8 1.2 0.8 0.1 0.4 0.8 0.6 0.6 0.3 0.3 0.6 0.3 0.1 0.4 0.1 7.6 0.8 0.9 1.4 0.2 1.4 0.7 0.2 0.4 0.5 0.6 0.3 1.0 1.1 0.6 0.2 0.8 0.6 0.3 1.1 0.9 0.6 0.6 0.2 0.4 0.3 1.4 1.5 0.4 0.5 0.9 0.5 0.2 0.5 0.3 0.8 0.7 0.5 1.0 0.8 1.1 0.0 0.7 0.2 0.6 1.0 0.5 1.4 0.8 1.7 0.8 0.5 0.6 0.4 0.5 0.8 0.8 0.6 3.3 0.8 0.5 0.6 0.4 0.5 0.7 0.6 0.5 0.2 1.5 0.7 0.8 2.8 1.2 0.5 0.8 0.4 0.1 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.2 0.2 0.2 0.0 7.2 0.0 0.5 1.0 117.9 3.6 0.0 5.3 4.5 0.0 229.7 0.9 0.0 0.0 7.0 0.6 3.9 0.0 0.2 1.9 0.6 0.3 3.5 0.8 0.3 71.5 0.0 2.5 0.3 4.0 1.1 0.5 0.0 1.0 0.2 162.2 0.1 2.9 0.4 0.0 2864.0 0.0 1.0 1.1 0.9 0.5 2.4 0.5 0.9 0.1 PDE6B "CSNB3, CSNBAD2, PDEB, rd1, RP40" ENSG00000133256 "Phosphodiesterase 6B" P35913 4 625584-670782 "Disease related genes, Enzymes, FDA approved drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Congenital stationary night blindness, Disease mutation, FDA approved drug targets, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.2;retina: 64.2" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 453.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "EFO-21: 8.0;JURKAT: 11.8;MOLT-4: 20.5;REH: 11.1;SCLC-21H: 14.0;SH-SY5Y: 8.2;U-266/84: 15.2" "Not detected" "Not detected" "Not detected" "Not detected" "HPA054148, HPA059929" Enhanced Approved Cytosol NA NA Cytosol "HPA054148: AB_2682401, HPA059929: AB_2684166" "unprognostic (2.43e-2)" "unprognostic (1.33e-4)" "unprognostic (2.45e-4)" "unprognostic (7.18e-3)" "unprognostic (1.88e-2)" "unprognostic (5.04e-3)" "unprognostic (7.32e-3)" "prognostic favorable (5.34e-4)" "unprognostic (9.70e-2)" "unprognostic (1.14e-1)" "unprognostic (1.37e-2)" "unprognostic (2.33e-2)" "unprognostic (4.09e-2)" "unprognostic (1.67e-2)" "unprognostic (2.26e-1)" "unprognostic (2.41e-3)" "unprognostic (1.85e-1)" 1.6 1.9 12.1 4.6 19.1 6.7 3.8 2.3 13.2 2.3 1.3 30.2 1.5 0.8 2.5 3.9 1.4 9.6 3.2 5.2 18.1 10.2 4.6 0.7 4.2 12.0 29.6 9.8 2.6 1.4 9.1 3.2 2.6 14.5 2.5 1.0 64.2 3.5 2.9 0.7 1.8 2.2 2.1 20.2 8.7 2.5 3.6 22.4 4.3 11.4 0.2 8.3 4.1 1.1 16.5 14.1 11.2 5.8 10.2 13.1 7.1 0.0 0.2 0.8 0.4 0.2 0.3 0.2 0.0 0.0 0.5 1.4 0.0 0.1 0.2 8.0 0.2 0.7 0.1 1.7 0.4 0.0 0.1 0.0 0.6 0.2 0.0 4.1 0.1 0.3 0.5 0.1 2.4 0.0 0.5 0.7 11.8 0.1 0.6 0.0 0.2 20.5 0.2 6.5 0.4 0.2 11.1 0.2 0.4 1.4 0.9 14.0 8.2 0.0 0.3 0.1 3.3 0.4 0.0 0.2 0.1 0.8 0.1 0.3 5.4 15.2 0.2 0.2 0.2 0.1 11.2 4.2 0.6 11.5 5.8 10.5 10.0 7.7 7.9 6.6 16.5 12.2 13.1 1.1 10.2 5.6 14.1 11.4 7.1 12.1 19.1 2.3 10.0 18.1 10.2 29.6 9.8 14.5 22.4 3.0 5.3 4.5 1.2 0.3 18.2 3.7 0.0 16.0 5.7 0.0 78.5 0.1 1.7 5.1 0.4 1.8 0.0 0.0 0.6 0.2 0.8 0.9 3.5 0.0 9.2 11.1 1.7 2.5 3.9 0.0 1.4 3.4 3.3 7.2 0.2 20.9 0.7 0.0 1.4 6.7 453.5 0.0 0.2 3.9 2.7 0.3 0.2 7.0 0.1 0.6 PDE6G "PDEG, RP57" ENSG00000185527 "Phosphodiesterase 6G" P18545 17 81650459-81663112 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 260.3" "Cell type enriched" "Detected in many" 6 "Rod photoreceptor cells: 2889.5" "Cancer enhanced" "Detected in many" "testis cancer: 10.6" "Not detected" "Not detected" "Group enriched" "Detected in many" 5 "basophil: 29.7;NK-cell: 57.8" "Group enriched" "Detected in all" 5 "granulocytes: 29.7;NK-cells: 57.8" "Cell line enhanced" "Detected in some" "Hep G2: 6.3;NB-4: 6.7;NTERA-2: 11.6;REH: 13.5;SuSa: 8.6" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (6.16e-2)" "unprognostic (1.95e-2)" "unprognostic (2.83e-2)" "unprognostic (3.51e-3)" "unprognostic (1.68e-1)" "unprognostic (1.46e-2)" "unprognostic (6.33e-2)" "unprognostic (3.80e-2)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (4.85e-2)" "unprognostic (5.01e-2)" "unprognostic (1.94e-2)" "unprognostic (5.71e-2)" "unprognostic (5.44e-2)" "unprognostic (2.73e-1)" "unprognostic (1.14e-1)" 0.9 1.3 0.4 2.9 0.5 4.7 0.7 0.5 0.6 0.4 0.8 0.5 0.4 0.0 0.4 0.5 0.6 0.3 1.6 0.5 0.5 0.7 3.8 2.6 2.0 13.8 0.6 0.5 0.5 0.4 0.0 0.5 8.6 0.5 0.5 0.5 260.3 0.5 0.4 0.6 0.8 2.8 0.4 0.8 17.9 0.7 2.2 0.5 2.5 0.6 0.4 4.6 2.1 0.4 1.3 8.6 29.7 7.7 57.8 2.4 3.7 0.2 0.3 0.5 0.0 0.3 0.0 0.0 0.3 1.1 1.2 1.3 0.1 0.8 0.6 0.2 0.7 0.6 0.1 0.2 0.2 2.8 0.2 0.0 0.9 0.1 6.3 0.9 0.1 0.2 0.0 0.2 1.2 0.0 2.4 3.3 0.4 0.1 0.3 1.3 0.8 0.1 6.7 11.6 0.0 0.4 13.5 0.1 2.0 0.0 0.0 0.1 0.3 0.0 0.3 0.5 8.6 0.1 0.8 1.3 0.4 0.1 0.2 0.3 0.1 0.6 1.0 1.6 2.7 0.2 29.7 5.1 8.6 1.2 7.7 0.4 0.8 0.3 0.6 8.6 1.3 0.7 2.4 0.7 57.8 4.2 0.8 0.0 3.7 0.4 0.5 0.5 0.6 0.5 0.7 0.6 0.5 0.5 0.5 0.0 1.1 1.4 0.0 0.8 338.0 0.0 0.0 0.0 0.0 5.2 486.9 0.2 1.7 0.4 0.6 0.0 0.0 0.0 0.2 0.3 0.2 0.1 24.1 0.0 18.8 247.9 0.0 3.1 3.8 1.6 0.0 3.2 3.3 19.8 0.0 402.2 0.3 0.0 0.0 0.3 2889.5 0.0 0.0 0.7 0.2 1.3 0.2 2.1 0.0 0.0 PDE6H ENSG00000139053 "Phosphodiesterase 6H" Q13956 12 14973022-14981865 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Sensory transduction, Vision" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "retina: 67.4" "Cell type enriched" "Detected in some" 6 "Cone photoreceptor cells: 783.4" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AN3-CA: 4.2;JURKAT: 1.0;MOLT-4: 2.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA045118 Supported Uncertain Vesicles NA NA Vesicles "HPA045118: AB_2732517" "unprognostic (1.47e-3)" "unprognostic (1.07e-2)" 0.1 1.3 1.2 0.2 1.5 9.4 0.1 0.1 4.2 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.2 0.1 1.0 2.1 0.1 0.1 0.2 0.2 2.2 0.1 0.1 0.1 0.0 0.1 2.5 0.7 0.1 0.1 67.4 0.1 0.1 0.1 0.0 0.1 0.1 0.5 0.8 0.0 0.1 0.1 0.2 0.1 0.1 0.2 0.3 0.1 0.0 0.0 0.6 0.7 0.0 0.0 1.4 0.2 0.0 0.8 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 1.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 1.4 1.2 1.5 0.1 4.2 1.0 2.1 2.2 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.0 47.5 0.0 0.0 0.0 0.0 0.0 783.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 0.0 0.0 0.0 0.0 1.0 22.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.0 0.0 0.0 0.0 0.0 141.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 PI16 "CD364, dJ90K10.5, MGC45378, MSMBBP" ENSG00000164530 "Peptidase inhibitor 16" Q6UXB8 6 36948263-36964837 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Protease inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 87.2" "Cell type enhanced" "Detected in many" 20 "Fibroblasts: 45.7;Leydig cells: 190.7;Peritubular cells: 140.7" "Cancer enhanced" "Detected in many" "glioma: 15.5" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "T-reg: 29.9" "Lineage enriched" "Detected in many" 5 "T-cells: 29.9" "Cell line enriched" "Detected in some" 6 "JURKAT: 26.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA076574 Approved "Secreted to blood" NA NA 3600000000 "HPA076574: AB_2732314" "unprognostic (6.24e-3)" "unprognostic (6.00e-3)" "unprognostic (7.34e-2)" "unprognostic (9.53e-2)" "unprognostic (3.38e-2)" "unprognostic (2.42e-1)" "unprognostic (2.71e-2)" "unprognostic (5.06e-2)" "unprognostic (6.48e-2)" "unprognostic (1.88e-1)" "unprognostic (3.25e-2)" "unprognostic (4.46e-2)" "unprognostic (1.59e-3)" "unprognostic (5.82e-2)" "unprognostic (2.31e-1)" "unprognostic (1.28e-1)" "unprognostic (8.76e-2)" 22.2 1.7 2.9 1.4 8.8 0.3 27.9 0.7 4.5 62.7 4.5 21.4 22.5 0.8 11.1 27.0 10.5 5.3 17.4 43.1 4.6 3.5 0.8 0.5 3.7 1.1 9.0 3.9 2.8 2.5 0.6 3.3 1.2 9.3 15.0 3.4 87.2 4.0 14.2 5.5 19.8 2.0 55.5 13.7 0.8 8.5 8.3 9.3 0.1 8.3 8.7 4.8 32.7 49.8 0.7 0.2 0.2 0.0 5.7 29.9 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 4.3 0.2 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 26.2 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.9 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.9 0.3 9.8 2.9 0.0 0.7 3.4 1.0 0.2 5.7 0.0 0.2 29.9 1.7 2.9 8.8 0.7 4.5 4.6 3.5 9.0 3.9 9.3 9.3 0.0 1.0 0.0 0.1 19.2 0.0 3.2 0.0 0.0 1.2 1.8 0.0 0.0 1.7 0.0 10.5 2.7 0.0 0.0 0.0 0.0 45.7 0.1 0.0 0.0 0.1 0.0 0.0 17.2 0.0 14.4 190.7 1.0 10.1 0.0 0.0 0.0 0.1 0.0 140.7 0.2 0.0 0.0 2.2 1.9 1.1 16.2 0.1 0.0 0.0 0.1 PLA2G5 ENSG00000127472 "Phospholipase A2 group V" P39877 1 20028179-20091190 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins" "Fatty acid metabolism, Lipid degradation, Lipid metabolism, Phagocytosis, Phospholipid degradation, Phospholipid metabolism" Hydrolase "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 48.3;retina: 58.3" "Cell type enhanced" "Detected in some" 21 "Cardiomyocytes: 79.9;Cone photoreceptor cells: 66.8;Leydig cells: 75.4;Peritubular cells: 68.9;Sertoli cells: 258.7" "Group enriched" "Detected in many" 5 "glioma: 13.0;prostate cancer: 3.5" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 23 "plasmacytoid DC: 2.3" "Lineage enriched" "Detected in single" 23 "dendritic cells: 2.3" "Cell line enhanced" "Detected in some" "EFO-21: 2.4;HaCaT: 1.1;hTEC/SVTERT24-B: 1.5;hTERT-RPE1: 1.4;U-138 MG: 3.1;U-2197: 6.7" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA053361 Approved "Secreted - unknown location" NA NA "HPA053361: AB_2682127" "unprognostic (2.78e-2)" "unprognostic (1.14e-2)" "unprognostic (5.68e-3)" "unprognostic (6.16e-2)" "unprognostic (2.01e-2)" "unprognostic (5.93e-2)" "unprognostic (2.12e-2)" "unprognostic (1.02e-1)" "unprognostic (2.15e-2)" "unprognostic (1.12e-1)" "unprognostic (2.02e-1)" "unprognostic (1.70e-3)" "unprognostic (6.00e-5)" "unprognostic (2.87e-2)" "unprognostic (3.00e-1)" "unprognostic (1.54e-1)" "unprognostic (4.97e-3)" 2.6 0.5 2.8 2.0 6.7 0.2 1.9 1.9 5.2 0.3 10.5 2.1 2.5 1.2 0.5 2.1 5.7 1.9 3.0 48.3 2.6 2.4 0.2 1.8 3.2 1.0 6.1 2.0 17.3 1.2 0.2 0.1 8.3 6.8 6.9 3.2 58.3 1.0 10.3 0.4 0.4 1.0 19.3 1.0 0.8 2.3 3.3 1.3 0.0 0.7 0.0 1.7 7.3 2.2 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 1.5 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 3.1 0.0 6.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 2.8 6.7 1.9 5.2 2.6 2.4 6.1 2.0 6.8 1.3 0.0 0.3 0.0 0.0 0.3 9.3 79.9 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.7 1.0 0.0 0.0 0.0 0.1 2.1 1.5 0.0 0.0 0.2 0.0 0.0 8.6 0.8 3.6 75.4 0.0 0.0 0.0 0.0 25.1 0.0 0.0 68.9 0.0 27.8 258.7 2.4 0.5 0.6 0.4 0.2 0.0 0.0 0.0 PLCB4 ENSG00000101333 "Phospholipase C beta 4" Q15147 20 9068763-9481242 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 44.9;retina: 40.2;salivary gland: 39.8" "Cell type enhanced" "Detected in many" 13 "Bipolar cells: 79.8;Cardiomyocytes: 57.6;Ciliated cells: 56.2;Horizontal cells: 155.7" "Cancer enhanced" "Detected in many" "colorectal cancer: 23.5" "Group enriched" "Detected in all" 4 "cerebellum: 44.9;pons and medulla: 11.9" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 6.6" "Lineage enriched" "Detected in single" 20 "dendritic cells: 6.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.2;hTERT-HME1: 18.7;LHCN-M2: 30.8;OE19: 17.8;RPTEC TERT1: 39.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA007951 Approved Approved Nucleoplasm,Microtubules NA NA Microtubules Nucleoplasm "HPA007951: AB_2667944" "unprognostic (3.88e-2)" "unprognostic (3.62e-1)" "unprognostic (1.19e-2)" "prognostic favorable (2.11e-4)" "unprognostic (1.44e-2)" "unprognostic (9.72e-3)" "unprognostic (3.32e-3)" "unprognostic (2.57e-2)" "unprognostic (7.75e-2)" "unprognostic (4.23e-2)" "unprognostic (5.21e-3)" "unprognostic (1.35e-1)" "unprognostic (4.64e-3)" "unprognostic (7.12e-2)" "unprognostic (1.37e-1)" "unprognostic (2.22e-1)" "unprognostic (4.45e-2)" 5.5 5.0 2.1 4.5 4.6 0.2 5.6 44.9 5.2 6.0 13.1 2.7 2.4 1.6 12.3 16.2 6.9 10.9 6.2 12.4 2.3 6.6 2.3 0.9 4.4 1.0 4.0 3.3 2.9 1.3 0.5 15.1 4.4 11.9 6.9 12.6 40.2 39.8 7.1 2.5 4.3 3.1 12.3 3.1 1.1 9.7 2.1 2.4 4.3 21.9 4.4 2.0 7.1 8.8 0.0 6.6 0.0 0.0 0.3 0.0 0.0 0.0 6.1 3.1 0.0 0.0 0.1 0.0 13.4 3.8 4.0 2.5 1.2 0.9 0.0 0.2 38.2 14.5 0.0 0.9 2.9 6.0 0.0 1.8 1.6 2.2 0.0 0.6 0.0 0.0 0.9 1.2 5.2 18.7 7.3 0.0 0.0 1.5 0.1 30.8 2.0 0.0 0.0 3.3 17.8 3.9 0.0 0.0 0.2 39.4 2.8 10.2 7.1 0.0 9.2 5.6 4.3 7.8 0.0 0.1 4.3 0.3 0.4 5.2 0.0 0.0 0.0 0.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 6.6 0.0 0.0 2.1 4.6 44.9 5.2 2.3 6.6 4.0 3.3 11.9 2.4 6.0 0.3 0.0 3.6 2.2 79.8 57.6 0.0 56.2 11.4 5.2 0.0 0.0 0.0 0.5 1.0 35.4 2.3 0.0 0.2 0.0 4.8 10.1 0.0 0.0 0.1 155.7 40.4 1.3 0.0 0.4 1.4 0.3 6.8 1.0 35.3 1.9 5.0 7.0 19.4 0.6 5.4 12.9 23.6 1.4 1.3 0.9 0.1 0.0 34.0 1.8 POU4F1 "BRN3A, RDC-1" ENSG00000152192 "POU class 4 homeobox 1" Q01851 13 78598362-78603560 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 4 "brain: 25.3" "Cell type enhanced" "Detected in some" 14 "Rod photoreceptor cells: 1.1;Spermatocytes: 1.6;Spermatogonia: 2.5" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 23 "pons and medulla: 25.3" "Cell type enriched" "Detected in single" 8 "plasmacytoid DC: 1.1" "Lineage enriched" "Detected in single" 8 "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "HEK 293: 10.9;HEL: 11.6;JURKAT: 9.3;REH: 8.2;RH-30: 14.0;SCLC-21H: 13.4;U-266/70: 12.6" "Group enriched" "Detected in some" 14 "midbrain: 3.0;pons and medulla: 2.2;thalamus: 2.4" "Group enriched" "Detected in some" 26 "midbrain: 3.1;pons and medulla: 7.4;thalamus: 2.5" HPA068024 Enhanced Approved NA NA "HPA068024: AB_2685943" "unprognostic (6.70e-2)" "unprognostic (2.38e-1)" "unprognostic (1.27e-4)" "unprognostic (1.03e-1)" "unprognostic (1.25e-2)" "unprognostic (1.05e-3)" "unprognostic (1.32e-1)" "unprognostic (6.30e-2)" "unprognostic (6.00e-2)" "unprognostic (1.70e-2)" "unprognostic (9.17e-2)" "unprognostic (8.98e-2)" "unprognostic (9.95e-2)" "unprognostic (1.53e-1)" "unprognostic (4.75e-3)" 0.1 0.0 1.1 2.3 1.0 1.2 1.0 0.2 0.4 0.1 0.1 0.0 0.0 0.4 0.0 0.2 0.2 0.0 0.0 0.2 1.0 1.0 0.0 0.5 0.1 2.3 0.7 0.0 0.0 0.1 0.1 0.0 0.9 25.3 0.0 0.3 6.3 0.2 0.0 1.8 0.4 0.3 0.0 2.5 0.3 0.3 4.4 0.4 2.7 0.0 0.2 3.5 0.3 0.1 0.1 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 2.1 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.5 0.0 3.9 0.0 0.0 0.0 10.9 11.6 0.0 1.4 0.0 5.7 3.4 0.0 0.1 0.0 0.0 0.0 0.0 9.3 2.3 0.0 0.5 0.0 0.8 1.0 0.0 1.5 0.0 8.2 14.0 0.0 0.0 0.0 13.4 0.2 0.0 0.0 0.5 0.2 0.0 1.1 0.1 0.0 0.0 0.2 0.0 12.6 3.8 0.0 0.0 6.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 1.1 1.0 0.2 0.4 1.0 1.0 0.7 0.0 25.3 0.4 0.0 0.0 0.0 0.0 0.1 0.7 0.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.4 0.0 1.1 0.0 0.0 1.6 2.5 0.4 0.0 0.0 0.0 0.0 PRKCZ PKC2 ENSG00000067606 "Protein kinase C zeta" Q05513 1 2050470-2185395 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Inflammatory response" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 43.6;placenta: 93.0" "Group enriched" "Detected in many" 4 "Late spermatids: 539.8;Syncytiotrophoblasts: 926.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 6 "eosinophil: 15.0" "Lineage enriched" "Detected in many" 6 "granulocytes: 15.0" "Cell line enhanced" "Detected in many" "BEWO: 23.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA021851 Enhanced Supported "Plasma membrane,Cytosol" NA NA Cytosol "Plasma membrane" "HPA021851: AB_1855433" "unprognostic (1.25e-2)" "unprognostic (2.61e-1)" "unprognostic (5.10e-2)" "unprognostic (1.14e-2)" "unprognostic (2.08e-1)" "unprognostic (3.61e-2)" "unprognostic (1.73e-2)" "unprognostic (5.13e-2)" "unprognostic (1.18e-1)" "unprognostic (3.10e-1)" "unprognostic (1.12e-1)" "unprognostic (2.86e-1)" "prognostic favorable (1.64e-9)" "unprognostic (3.57e-2)" "unprognostic (3.27e-2)" "unprognostic (1.39e-1)" "unprognostic (7.85e-2)" 1.2 7.8 15.9 3.0 31.8 1.4 3.9 39.8 43.6 3.2 8.6 17.1 2.3 20.0 1.7 5.5 10.1 6.5 3.1 6.4 15.5 6.4 11.3 6.8 22.3 5.0 12.2 23.6 1.9 8.5 9.8 12.0 93.0 27.3 5.8 7.5 2.6 7.0 3.0 0.4 8.8 18.4 1.2 8.4 6.9 6.1 17.5 13.5 0.6 14.1 0.9 5.0 4.0 4.6 0.4 0.3 15.0 0.3 0.8 2.6 0.3 7.3 4.7 1.7 8.7 0.0 0.0 23.0 0.5 0.2 5.5 0.3 11.9 16.0 0.0 14.6 1.8 4.8 12.9 9.9 12.3 3.9 0.5 11.0 0.0 7.6 15.8 1.6 0.0 5.7 0.3 7.4 0.0 4.2 0.0 0.0 1.9 3.2 0.1 0.1 9.0 0.4 0.0 3.3 20.2 11.4 0.0 0.0 2.5 9.4 7.8 12.0 9.7 6.0 13.4 2.5 14.9 9.4 2.0 0.0 0.0 6.9 0.0 0.0 3.5 0.6 0.1 0.6 0.1 8.3 0.3 0.0 15.0 0.6 0.3 2.6 0.3 1.0 0.6 0.0 0.4 0.8 0.4 1.2 0.8 0.0 0.3 0.8 0.3 15.9 31.8 39.8 43.6 15.5 6.4 12.2 23.6 27.3 13.5 113.2 71.1 0.8 10.2 11.6 22.8 1.2 2.5 21.4 26.1 7.0 3.9 84.1 6.6 10.9 181.6 6.0 56.7 0.0 9.3 48.8 3.1 16.4 8.1 12.5 12.7 58.8 9.8 6.7 1.0 539.8 8.9 3.3 6.8 5.4 22.1 15.6 12.2 31.6 8.1 19.0 21.6 0.0 2.2 15.8 26.8 11.7 926.6 7.7 25.3 11.9 PRPH2 "CACD2, rd2, RDS, RP7, TSPAN22" ENSG00000112619 "Peripherin 2" P23942 6 42696600-42722574 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Cell adhesion, Sensory transduction, Vision" "Cone-rod dystrophy, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 8 "retina: 117.8" "Group enriched" "Detected in some" 13 "Cone photoreceptor cells: 245.4;Rod photoreceptor cells: 471.5" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 3.4" "Lineage enriched" "Detected in single" 4 "granulocytes: 3.4" "Cell line enhanced" "Detected in some" "ASC diff: 4.3;ASC TERT1: 4.9;fHDF/TERT166: 7.1;HHSteC: 11.0;HSkMC: 8.5;LHCN-M2: 4.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA029458 Enhanced NA NA "HPA029458: AB_10602193" "unprognostic (2.37e-1)" "unprognostic (4.88e-2)" "unprognostic (6.67e-2)" "unprognostic (8.43e-2)" "unprognostic (1.15e-1)" "unprognostic (2.87e-3)" "unprognostic (4.73e-1)" "unprognostic (1.85e-1)" "unprognostic (6.87e-2)" "unprognostic (1.09e-1)" "unprognostic (1.44e-1)" "unprognostic (3.18e-2)" "unprognostic (7.07e-4)" "unprognostic (1.13e-3)" "unprognostic (1.59e-1)" "unprognostic (8.42e-2)" "unprognostic (8.96e-3)" 1.0 0.8 1.5 1.0 1.0 0.0 1.0 1.0 4.8 1.7 2.0 1.0 1.0 0.3 2.3 2.3 1.0 0.9 1.2 1.4 1.1 3.0 1.0 1.0 1.2 1.0 1.1 1.0 3.4 2.0 6.9 2.7 1.0 1.0 1.4 0.8 117.8 1.0 1.3 14.4 0.0 1.1 2.3 1.0 1.0 1.0 3.5 1.0 1.0 5.2 1.0 1.0 1.0 1.0 0.6 0.3 3.4 0.6 0.2 0.8 0.0 0.0 0.0 0.0 0.0 4.3 4.9 1.0 1.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.1 0.0 11.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 4.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.3 0.0 0.4 0.2 0.8 0.2 0.3 0.0 0.3 0.6 0.4 0.2 2.5 0.2 0.6 0.0 0.3 0.0 1.5 1.0 1.0 3.0 1.1 3.0 1.1 1.0 1.0 1.0 0.0 0.0 0.0 0.0 0.0 23.7 0.6 0.0 0.0 0.0 0.0 245.4 0.0 3.3 0.1 0.0 0.2 0.0 0.0 0.2 0.0 1.4 0.2 0.0 0.0 0.0 11.1 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 28.3 0.7 0.0 1.8 0.0 471.5 0.0 1.5 2.5 0.1 0.3 0.1 0.0 0.0 0.0 RARB "HAP, NR1B2, RRB2" ENSG00000077092 "Retinoic acid receptor beta" P10826 3 25174332-25597932 "Cancer-related genes, Disease related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "DNA-binding, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets, Microphthalmia, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.1" "Cell type enhanced" "Detected in many" 7 "Basal glandular cells: 17.9;Cone photoreceptor cells: 23.6;Ito cells: 20.3;Muller glia cells: 27.5" "Low cancer specificity" "Detected in all" "Region enhanced" "Detected in all" "basal ganglia: 22.6" "Low cell type specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "ASC diff: 7.0;HEK 293: 7.9;hTERT-RPE1: 41.7;WM-115: 18.1" "Region enriched" "Detected in many" 9 "basal ganglia: 97.9" "Low region specificity" "Detected in all" "CAB002617, HPA004174" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB002617: , HPA004174: AB_1079744" "unprognostic (2.04e-2)" "unprognostic (3.53e-2)" "unprognostic (1.93e-1)" "unprognostic (1.09e-1)" "unprognostic (1.56e-1)" "unprognostic (6.72e-2)" "unprognostic (1.30e-2)" "unprognostic (2.70e-2)" "unprognostic (2.43e-1)" "unprognostic (4.71e-2)" "unprognostic (1.62e-1)" "unprognostic (2.86e-1)" "prognostic favorable (3.43e-5)" "unprognostic (9.24e-3)" "unprognostic (2.28e-1)" "unprognostic (9.99e-2)" "unprognostic (6.56e-3)" 3.9 7.1 2.4 2.3 22.6 0.0 6.8 1.5 9.1 13.4 6.0 2.2 6.8 1.7 14.4 7.5 8.1 6.2 5.3 13.6 2.6 2.2 17.5 6.2 5.6 5.6 2.0 3.7 12.2 1.5 12.8 18.9 13.9 3.2 13.0 2.3 39.1 13.7 11.8 2.5 1.4 2.4 14.7 4.6 7.7 4.8 1.7 4.8 0.0 10.0 2.9 4.6 12.1 10.2 1.0 0.4 0.1 0.6 0.1 0.8 0.0 0.0 0.9 0.6 3.1 7.0 1.8 0.0 0.8 0.4 0.0 0.3 0.1 0.0 0.0 0.1 1.2 0.1 0.2 0.0 0.1 0.0 0.0 7.9 0.0 0.0 0.5 0.1 0.1 0.0 3.7 0.0 0.0 0.0 41.7 6.6 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.3 4.2 0.0 0.1 0.0 4.9 0.0 0.0 0.0 0.5 0.0 1.1 3.4 0.1 0.0 0.0 2.8 0.1 18.1 0.0 0.6 0.0 0.8 0.1 0.3 0.3 0.5 0.5 0.4 1.0 0.6 0.8 0.1 0.1 0.1 0.4 0.0 0.0 2.4 22.6 1.5 9.1 2.6 2.2 2.0 3.7 3.2 4.8 0.0 0.3 0.0 17.9 0.1 4.2 9.3 7.6 6.7 12.5 10.4 23.6 0.1 0.0 1.4 1.3 3.8 0.0 0.0 0.8 0.1 3.1 5.5 0.0 2.0 0.3 4.8 0.0 20.3 4.1 0.4 0.0 0.0 0.0 0.0 0.0 27.5 1.1 0.0 0.0 0.5 6.1 0.0 9.2 0.2 1.1 0.1 0.2 0.0 0.0 7.1 RB1 "OSRC, PPP1R130, RB" ENSG00000139687 "RB transcriptional corepressor 1" P06400 13 48303726-48599436 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Host-virus interaction, Transcription, Transcription regulation" "Chromatin regulator, DNA-binding, Repressor" "Cancer-related genes, Disease mutation, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "monocytes: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MOLT-4: 58.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000095, CAB016687, HPA050082" Supported Supported Nucleoplasm NA NA Nucleoplasm "CAB000095: , CAB016687: AB_1622010, HPA050082: AB_2681008" "unprognostic (4.24e-3)" "unprognostic (1.00e-1)" "unprognostic (3.62e-2)" "unprognostic (4.67e-2)" "unprognostic (2.04e-2)" "unprognostic (3.86e-1)" "unprognostic (4.69e-2)" "unprognostic (7.08e-2)" "unprognostic (1.59e-1)" "prognostic unfavorable (6.92e-4)" "unprognostic (4.06e-2)" "unprognostic (9.40e-2)" "unprognostic (4.67e-2)" "unprognostic (1.79e-1)" "unprognostic (9.99e-2)" "unprognostic (2.31e-1)" "unprognostic (1.70e-1)" 19.6 21.5 14.9 23.2 18.4 14.7 28.1 25.6 19.4 18.0 13.2 11.5 19.0 12.3 16.8 19.5 27.9 12.7 15.3 19.5 15.4 15.3 18.1 12.1 25.4 30.1 17.0 11.8 15.2 11.6 12.8 17.2 21.5 16.0 15.5 15.3 11.6 20.0 17.4 27.9 20.3 14.3 16.8 23.6 29.4 13.7 14.4 15.3 39.1 19.9 15.8 25.3 17.4 23.6 20.5 10.3 13.2 12.2 3.6 4.6 4.0 9.1 4.9 13.5 14.5 6.7 7.8 6.1 18.0 15.0 19.0 16.2 4.2 16.2 11.8 4.2 12.0 10.5 12.7 17.5 14.5 29.0 16.5 6.7 21.7 10.2 7.2 7.1 18.6 20.6 4.3 8.9 12.3 15.8 15.9 13.1 29.2 7.2 9.7 21.7 4.3 58.2 9.4 6.6 20.8 5.4 25.0 13.5 13.5 19.7 8.9 0.6 13.8 17.8 8.9 14.7 12.5 9.7 24.3 10.1 11.8 7.7 14.3 16.2 4.3 1.2 0.1 6.2 11.7 15.9 11.0 9.7 5.0 4.6 12.2 3.7 17.4 3.8 4.6 9.3 20.5 3.2 3.8 13.2 3.6 12.1 10.3 4.5 4.0 14.9 18.4 25.6 19.4 15.4 15.3 17.0 11.8 16.0 15.3 3.0 18.7 56.5 18.3 25.2 14.4 15.9 17.8 20.1 14.8 29.6 27.5 5.9 13.3 15.8 20.6 33.6 15.9 0.0 10.4 8.0 15.4 21.4 11.5 14.7 64.6 17.5 16.8 38.6 83.9 10.6 24.2 88.8 25.3 107.4 18.5 21.8 13.3 9.9 26.9 21.1 18.5 19.4 20.6 27.9 14.3 33.4 3.7 20.8 15.0 14.4 RBP3 "D10S64, D10S65, D10S66, RP66" ENSG00000265203 "Retinol binding protein 3" P10745 10 47348371-47357875 "Disease related genes, Enzymes, Potential drug targets, Predicted secreted proteins" Transport "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 45 "retina: 135.2" "Group enriched" "Detected in some" 12 "Cone photoreceptor cells: 1949.7;Rod photoreceptor cells: 1076.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "HaCaT: 2.7;HDLM-2: 2.5;SH-SY5Y: 2.1" "Not detected" "Not detected" "Not detected" "Not detected" "HPA041301, HPA044239" Enhanced "Secreted in other tissues" NA NA "HPA041301: AB_2677398, HPA044239: AB_2678868" "unprognostic (3.48e-2)" "unprognostic (4.78e-3)" "unprognostic (1.36e-2)" "unprognostic (4.02e-2)" "unprognostic (1.40e-1)" "unprognostic (1.58e-2)" "unprognostic (5.09e-2)" "unprognostic (5.14e-3)" "unprognostic (7.44e-2)" "unprognostic (1.23e-1)" "unprognostic (4.68e-3)" 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 135.2 0.0 0.0 0.0 0.5 1.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 2.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 125.3 0.3 0.0 0.0 0.0 0.0 1949.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 104.8 0.0 0.0 0.0 0.0 1076.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RCVRN RCV1 ENSG00000109047 Recoverin P35243 17 9896320-9905621 "Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 75 "retina: 208.6" "Group enriched" "Detected in some" 4 "Cone photoreceptor cells: 447.7;Rod photoreceptor cells: 1089.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "WM-115: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA015783, CAB022363" Enhanced NA NA "CAB022363: , HPA015783: AB_2669298" "unprognostic (1.65e-1)" "unprognostic (1.86e-1)" "unprognostic (1.39e-2)" "unprognostic (1.55e-2)" "unprognostic (1.32e-1)" "unprognostic (7.95e-3)" "unprognostic (4.82e-2)" "unprognostic (1.18e-1)" "unprognostic (1.06e-1)" "unprognostic (5.34e-2)" "unprognostic (1.24e-1)" "unprognostic (1.94e-4)" "unprognostic (1.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.41e-2)" "unprognostic (9.23e-2)" 1.4 0.0 1.1 0.8 1.4 0.9 0.2 1.5 2.7 0.5 0.3 0.2 0.1 0.7 0.5 0.2 0.1 0.3 0.5 0.8 1.0 0.7 0.1 0.1 0.4 0.2 0.3 0.1 0.3 0.1 0.0 0.1 0.1 0.7 0.1 0.1 208.6 0.1 0.3 0.1 0.7 0.4 0.6 0.2 0.8 0.6 0.3 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 1.4 1.5 2.7 1.0 0.7 0.3 0.1 0.7 0.1 0.0 0.0 0.0 0.0 0.1 186.3 0.4 0.0 0.0 0.0 0.0 447.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.4 101.7 0.0 0.0 0.0 0.2 2.3 0.0 1.7 0.0 0.0 187.9 0.0 0.0 0.7 0.0 1089.5 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.0 RD3 "C1orf36, LCA12" ENSG00000198570 "Retinal degeneration 3" Q7Z3Z2 1 211476522-211492917 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 25 "Bipolar cells: 87.9;Cone photoreceptor cells: 94.2;Rod photoreceptor cells: 61.9" "Cancer enhanced" "Detected in single" "testis cancer: 0.7" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 14 "HEL: 3.6;HMC-1: 9.5;SH-SY5Y: 13.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA029941, HPA029943" Approved NA NA "HPA029941: AB_2732449, HPA029943: AB_2732450" "unprognostic (1.42e-1)" "unprognostic (2.75e-2)" "unprognostic (1.14e-2)" "unprognostic (6.07e-2)" "unprognostic (2.96e-2)" "unprognostic (2.18e-1)" "unprognostic (9.54e-2)" "unprognostic (7.87e-2)" "unprognostic (1.15e-1)" "unprognostic (4.80e-2)" "unprognostic (4.58e-2)" "unprognostic (2.86e-2)" 2.0 2.0 0.1 0.2 0.4 1.2 0.1 0.1 1.0 1.1 0.3 0.1 0.1 0.4 1.2 2.3 1.4 0.6 0.6 2.8 0.1 0.8 1.2 0.1 1.2 0.1 0.1 0.1 0.1 0.2 0.0 1.3 0.1 0.1 0.6 0.0 1.0 0.3 0.2 0.1 1.0 0.8 0.4 0.1 0.2 0.7 0.1 0.1 0.1 0.1 0.1 0.1 1.3 0.4 0.0 0.1 0.9 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.1 9.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.1 0.5 13.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.1 0.2 0.1 0.0 0.0 0.1 0.4 0.1 1.0 0.1 0.8 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 87.9 0.4 0.0 0.0 0.0 0.0 94.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 61.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RDH13 SDR7C3 ENSG00000160439 "Retinol dehydrogenase 13" Q8NBN7 19 55039108-55071291 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 10 "Syncytiotrophoblasts: 175.4;Urothelial cells: 72.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042006 Approved Supported Mitochondria,Cytosol "Intracellular and membrane" NA NA "Mitochondria, Cytosol" "HPA042006: AB_10960270" "unprognostic (9.26e-2)" "unprognostic (1.14e-2)" "unprognostic (1.08e-1)" "unprognostic (2.15e-2)" "unprognostic (8.74e-2)" "unprognostic (1.08e-2)" "unprognostic (2.48e-1)" "unprognostic (3.60e-2)" "unprognostic (1.82e-1)" "unprognostic (9.42e-3)" "unprognostic (1.61e-1)" "unprognostic (2.45e-3)" "prognostic favorable (2.09e-4)" "unprognostic (2.19e-2)" "unprognostic (2.23e-1)" "unprognostic (2.12e-2)" "unprognostic (1.66e-3)" 4.4 6.8 4.0 6.0 6.6 5.5 4.2 8.7 9.4 7.5 8.3 3.5 9.0 5.1 5.0 5.0 17.6 4.2 7.1 11.4 3.0 5.4 8.8 7.5 5.6 5.1 4.7 5.2 3.8 10.7 8.8 6.1 34.0 10.0 5.7 4.0 6.4 11.6 13.1 9.4 18.0 6.9 5.2 2.2 6.8 9.5 4.4 3.0 2.1 7.2 8.6 8.9 8.5 10.2 7.4 6.0 5.4 6.7 6.1 8.5 3.5 3.1 3.6 0.6 1.9 0.4 0.4 5.8 2.9 0.3 2.1 1.5 5.4 3.6 1.8 2.4 0.7 0.4 3.2 3.8 2.3 0.2 1.6 10.1 2.0 4.7 3.7 0.9 4.8 1.4 1.3 0.9 1.9 1.4 0.7 2.8 1.6 4.0 1.0 0.7 5.2 0.8 3.1 0.8 6.9 4.7 2.5 1.0 10.0 1.3 5.5 2.2 2.7 2.8 8.0 3.6 0.6 3.9 4.7 2.9 0.3 1.1 0.2 3.9 2.0 3.6 2.2 1.5 3.4 2.0 4.1 4.1 5.4 8.5 6.7 7.7 6.1 7.0 7.7 4.5 7.4 8.4 6.8 2.6 6.1 5.9 6.0 5.7 3.5 4.0 6.6 8.7 9.4 3.0 5.4 4.7 5.2 10.0 3.0 14.9 16.2 5.1 19.9 9.5 17.3 22.2 28.1 6.7 11.4 14.0 39.3 30.2 10.0 12.3 18.5 6.5 27.1 0.0 5.7 26.9 6.0 23.1 8.1 6.0 9.9 23.8 11.5 16.5 4.1 11.2 3.4 5.0 6.8 1.8 19.8 10.0 11.4 26.2 3.2 3.4 27.0 6.5 5.1 1.4 9.6 15.3 175.4 8.7 21.9 72.9 RGS9 "MGC111763, MGC26458, PERRS, RGS9L" ENSG00000108370 "Regulator of G protein signaling 9" O75916 17 65100812-65227703 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 47.3" "Group enriched" "Detected in many" 7 "Cone photoreceptor cells: 306.3;Rod photoreceptor cells: 472.2" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in all" 6 "basal ganglia: 47.3" "Group enriched" "Detected in many" 6 "gdT-cell: 11.0;MAIT T-cell: 2.8;memory CD8 T-cell: 7.4;naive CD8 T-cell: 3.6;NK-cell: 3.7" "Group enriched" "Detected in many" 74 "NK-cells: 3.7;T-cells: 11.0" "Group enriched" "Detected in some" 4 "HDLM-2: 23.2;HEL: 9.5" "Region enriched" "Detected in many" 9 "basal ganglia: 222.4" "Region enriched" "Detected in all" 9 "basal ganglia: 79.8" "HPA013550, HPA014137" Enhanced Supported Approved Nucleoplasm,Vesicles NA NA "Nucleoplasm, Vesicles" "HPA013550: , HPA014137: AB_2668943" "unprognostic (4.43e-3)" "unprognostic (7.49e-3)" "unprognostic (5.12e-2)" "unprognostic (3.09e-5)" "unprognostic (1.07e-1)" "unprognostic (1.14e-1)" "unprognostic (3.17e-1)" "unprognostic (1.93e-1)" "unprognostic (1.20e-1)" "unprognostic (4.88e-2)" "prognostic favorable (1.35e-4)" "unprognostic (1.07e-1)" "unprognostic (5.07e-2)" "unprognostic (4.94e-2)" "unprognostic (3.69e-1)" "unprognostic (1.51e-1)" "unprognostic (1.49e-1)" 1.1 1.9 3.3 4.4 47.3 1.0 2.3 4.1 8.9 3.4 5.2 7.2 2.7 3.3 4.2 7.2 4.1 9.5 3.9 1.3 5.4 7.4 2.0 5.0 5.9 5.3 3.5 3.7 6.7 3.7 7.3 7.9 3.0 4.5 8.6 3.4 24.1 3.2 9.2 1.6 1.5 3.6 4.0 3.4 4.3 3.7 1.7 6.6 0.4 4.2 0.5 7.5 5.1 2.4 0.0 0.0 0.0 0.0 3.7 11.0 1.4 0.2 0.0 1.1 0.1 0.1 0.2 0.0 0.0 2.1 0.0 0.2 0.1 0.0 0.7 1.6 0.0 0.0 0.1 0.0 0.1 0.2 23.2 0.5 9.5 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 3.7 0.0 0.1 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.4 0.0 0.0 0.2 3.6 0.0 0.0 0.2 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 11.0 0.0 2.8 0.0 1.0 7.4 0.0 0.0 0.0 3.6 0.0 3.7 0.0 0.0 0.0 1.4 3.3 47.3 4.1 4.5 5.4 7.4 3.5 3.7 4.5 6.6 3.0 1.0 0.0 0.9 0.3 21.5 0.4 0.0 1.4 2.3 1.8 306.3 0.0 3.3 6.8 0.6 0.3 0.0 0.0 2.8 0.1 2.3 0.2 0.0 0.0 0.1 49.3 57.3 1.8 0.0 1.7 0.9 3.2 1.7 33.3 2.2 27.8 3.9 0.0 4.6 8.1 472.2 0.0 0.9 0.0 0.4 0.1 0.1 9.2 0.4 0.1 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Group enriched" "Detected in some" 13 "Bipolar cells: 30.8;Cone photoreceptor cells: 53.0;Rod photoreceptor cells: 70.9" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "HEL: 10.7;HMC-1: 2.8" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" NA NA "Plasma membrane" "HPA049791: AB_2680884" "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.4 0.2 0.2 0.3 0.4 0.5 0.1 0.5 0.1 1.8 0.1 0.1 0.5 0.2 10.7 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.2 0.0 0.1 0.9 1.5 0.2 0.5 0.0 1.7 0.0 0.1 2.0 0.2 0.4 0.2 0.0 0.1 0.4 0.1 0.0 1.1 0.1 0.0 1.1 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 0.0 0.0 0.0 0.1 0.0 30.8 3.9 0.0 0.0 0.0 1.8 53.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.2 1.6 0.0 0.6 0.8 0.9 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.4 70.9 0.0 0.0 0.2 0.4 0.0 0.0 0.0 0.2 0.0 RHO "CSNBAD1, OPN2, RP4" ENSG00000163914 Rhodopsin P08100 3 129528640-129535169 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Vision" "G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer" "Congenital stationary night blindness, Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 151 "retina: 415.0" "Cell type enriched" "Detected in some" 7 "Rod photoreceptor cells: 2822.4" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebellum: 1.6;cerebral cortex: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA013440, CAB022486, CAB034887, CAB034888" Enhanced NA NA "CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844" "unprognostic (4.32e-2)" "unprognostic (1.21e-1)" "unprognostic (1.68e-1)" "unprognostic (1.83e-1)" "unprognostic (2.87e-1)" "unprognostic (1.94e-1)" "unprognostic (9.19e-11)" "unprognostic (4.24e-2)" "unprognostic (1.84e-1)" "unprognostic (2.91e-1)" 0.2 0.0 0.0 0.0 0.3 0.0 0.1 1.6 2.7 0.1 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.5 0.0 0.0 0.2 0.2 0.2 0.1 0.1 0.1 0.0 0.0 0.3 0.0 0.0 0.4 0.2 0.0 0.0 0.1 415.0 0.3 0.2 0.0 1.8 0.0 0.3 0.0 0.1 0.1 0.5 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.9 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.6 2.7 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 290.1 0.6 0.0 0.0 0.0 0.0 428.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 206.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 393.2 0.0 0.0 0.0 0.0 2822.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RLBP1 CRALBP ENSG00000140522 "Retinaldehyde binding protein 1" P12271 15 89209869-89221751 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Transport, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 14 "retina: 164.1" "Cell type enriched" "Detected in some" 43 "Muller glia cells: 2424.2" "Group enriched" "Detected in some" 30 "glioma: 3.7;melanoma: 7.4" "Group enriched" "Detected in many" 4 "amygdala: 6.9;basal ganglia: 10.6;cerebral cortex: 7.0;hippocampal formation: 3.7" "Group enriched" "Detected in some" 7 "basophil: 3.3;neutrophil: 1.9" "Lineage enriched" "Detected in single" 9 "granulocytes: 3.3" "Cell line enriched" "Detected in single" 48 "SK-MEL-30: 21.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA042051, HPA044083" Enhanced Approved Supported Nucleoplasm,Centrosome,Cytosol NA NA Cytosol "Nucleoplasm, Centrosome" "HPA042051: AB_2732495, HPA044083: AB_2678802" "unprognostic (3.19e-2)" "unprognostic (2.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.25e-1)" "unprognostic (8.68e-2)" "unprognostic (1.76e-1)" "unprognostic (8.24e-3)" "unprognostic (5.21e-2)" "unprognostic (3.17e-1)" "unprognostic (2.63e-2)" "unprognostic (1.76e-1)" "unprognostic (2.78e-1)" "unprognostic (1.13e-1)" "unprognostic (8.42e-2)" 0.2 0.7 6.9 0.6 10.6 0.6 0.2 0.6 11.5 0.2 0.8 0.3 0.1 0.9 0.2 1.0 0.3 0.2 0.3 0.2 3.7 1.3 0.2 0.2 0.3 0.3 1.6 0.6 0.2 0.2 0.2 1.7 0.3 0.4 0.2 0.8 164.1 0.2 0.2 0.5 0.3 0.6 0.5 0.5 0.3 0.2 1.1 0.1 0.1 0.2 0.1 0.2 0.2 0.1 0.0 0.0 3.3 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 21.9 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 3.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.1 6.9 10.6 0.6 7.0 3.7 1.3 1.6 0.6 0.4 0.1 0.0 0.0 0.0 0.0 0.0 17.2 0.3 0.0 0.0 0.0 0.0 37.3 3.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 2424.2 0.0 0.0 0.0 0.0 56.9 0.0 0.0 0.1 0.0 0.0 16.7 0.0 0.0 0.0 ROM1 "ROM, TSPAN23" ENSG00000149489 "Retinal outer segment membrane protein 1" Q03395 11 62611722-62615120 "Disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "retina: 108.1" "Cell type enriched" "Detected in many" 4 "Rod photoreceptor cells: 2384.7" "Cancer enriched" "Detected in all" 6 "glioma: 14.9" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 5.6" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HSkMC: 17.9;U-266/84: 18.8" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA028910, HPA073279" Enhanced Approved "Plasma membrane,Cytosol" No No "Plasma membrane, Cytosol" "HPA028910: AB_2672824, HPA073279: " "unprognostic (1.54e-2)" "unprognostic (1.37e-2)" "unprognostic (4.24e-2)" "unprognostic (1.11e-1)" "unprognostic (1.65e-1)" "unprognostic (2.02e-1)" "unprognostic (4.05e-1)" "prognostic favorable (2.20e-4)" "unprognostic (2.20e-1)" "unprognostic (9.87e-2)" "unprognostic (7.65e-3)" "unprognostic (3.50e-2)" "prognostic unfavorable (2.85e-6)" "unprognostic (2.61e-1)" "unprognostic (4.65e-1)" "unprognostic (1.02e-1)" "unprognostic (7.24e-2)" 9.4 4.6 16.3 2.3 15.0 0.9 3.6 5.7 18.8 4.9 3.1 5.1 3.3 2.0 3.8 5.7 4.7 7.4 5.2 2.7 14.7 9.2 2.4 3.2 3.0 2.3 18.1 4.7 13.2 3.2 4.8 2.1 1.6 8.7 3.8 3.0 108.1 2.5 5.9 2.2 3.7 1.7 6.3 21.6 2.5 2.4 3.7 7.7 0.7 3.0 2.2 2.6 3.1 9.2 1.1 0.8 0.8 1.2 5.6 3.2 1.4 2.1 1.2 2.2 4.6 3.2 15.7 0.4 1.4 2.5 3.1 2.0 0.6 3.6 2.0 10.0 8.1 1.3 2.8 1.0 2.8 0.8 3.6 1.8 1.8 5.4 2.6 9.3 0.7 0.6 17.9 4.1 3.2 6.4 10.5 4.8 0.9 2.7 4.6 6.2 5.4 1.1 1.5 0.5 1.1 3.3 1.1 1.8 12.8 3.4 1.2 2.3 3.4 3.5 4.1 1.6 0.3 5.6 0.9 5.4 5.1 1.9 6.0 1.6 2.1 18.8 1.6 9.5 2.1 1.0 0.0 1.2 0.8 0.9 0.3 2.4 0.7 3.2 0.8 0.6 1.1 1.5 1.8 0.4 5.6 1.1 0.8 0.9 1.4 16.3 15.0 5.7 8.4 14.7 9.2 18.1 4.7 8.7 7.7 0.0 4.1 0.0 4.4 3.3 268.3 2.4 0.0 2.7 1.2 5.2 559.6 0.8 1.7 1.3 2.1 8.0 1.6 0.0 2.7 0.2 3.5 2.6 1.1 0.6 1.0 162.1 4.1 11.1 1.8 5.9 17.5 1.0 3.3 1.0 2.8 315.6 1.7 3.4 5.3 4.0 2384.7 0.0 3.4 0.9 2.7 0.9 0.6 0.0 2.9 2.0 RP1 "DCDC4A, ORP1" ENSG00000104237 "RP1, axonemal microtubule associated" P56715 8 54509422-54871720 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation, Sensory transduction, Vision" "Disease mutation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "fallopian tube: 15.4;lung: 28.7;retina: 49.2" "Cell type enhanced" "Detected in some" 29 "Ciliated cells: 212.8;Cone photoreceptor cells: 314.2;Rod photoreceptor cells: 1078.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 2.3;HDLM-2: 7.1;hTERT-RPE1: 2.8;RPTEC TERT1: 14.5;U-2197: 3.3" "Not detected" "Not detected" HPA042257 Enhanced NA NA "HPA042257: AB_10797385" "unprognostic (3.19e-3)" "unprognostic (2.63e-3)" "unprognostic (1.16e-1)" "unprognostic (1.58e-2)" "unprognostic (1.70e-1)" "unprognostic (9.16e-3)" "unprognostic (6.24e-2)" "unprognostic (4.56e-2)" "unprognostic (4.13e-5)" "unprognostic (2.48e-1)" "unprognostic (2.16e-5)" "unprognostic (8.92e-2)" "unprognostic (6.18e-2)" "unprognostic (1.89e-2)" "unprognostic (8.96e-2)" 0.2 0.1 0.1 0.0 0.1 0.0 0.9 0.1 0.1 0.6 0.1 0.0 0.0 0.0 0.4 0.3 0.1 15.4 0.0 0.1 0.1 0.1 3.6 0.1 28.7 0.0 0.1 0.0 3.9 0.1 0.0 0.6 0.3 0.1 0.1 0.0 49.2 0.1 0.0 0.1 0.2 0.1 0.0 0.1 0.3 0.6 1.7 0.0 0.0 0.1 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 2.3 0.0 0.2 0.0 1.0 0.0 0.0 7.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 2.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.6 0.0 0.0 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.2 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 14.9 3.7 0.0 0.0 0.0 59.5 0.4 0.0 212.8 55.7 5.2 314.2 0.0 3.3 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.2 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 83.8 0.2 0.0 0.0 0.2 1078.1 0.0 0.0 3.4 1.6 0.0 0.0 0.0 0.0 0.1 RP1L1 DCDC4B ENSG00000183638 "RP1 like 1" 8 10606349-10712187 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 34.0" "Group enriched" "Detected in some" 22 "Cone photoreceptor cells: 88.4;Rod photoreceptor cells: 62.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 1.4;TIME: 2.0;U-2 OS: 1.4" "HPA024686, HPA024744" Enhanced NA NA "HPA024686: AB_2671650, HPA024744: AB_2671668" "unprognostic (3.27e-1)" "unprognostic (9.97e-2)" "unprognostic (1.24e-1)" "unprognostic (6.41e-2)" "unprognostic (2.04e-1)" "unprognostic (1.36e-1)" "unprognostic (2.37e-1)" "unprognostic (1.98e-5)" "unprognostic (3.57e-1)" "unprognostic (5.22e-2)" "unprognostic (2.08e-4)" "unprognostic (8.52e-2)" "unprognostic (5.77e-2)" "unprognostic (6.29e-2)" "unprognostic (1.70e-1)" "unprognostic (2.02e-2)" "unprognostic (2.82e-1)" 0.5 0.5 0.1 0.1 0.1 1.6 0.5 0.1 0.1 0.7 0.1 0.1 0.1 0.0 0.4 0.1 0.6 0.2 0.3 0.4 0.1 0.0 0.3 0.1 0.7 0.1 0.1 0.1 0.2 0.2 0.0 1.7 0.7 0.1 0.2 0.1 34.0 0.5 0.1 0.3 2.0 0.1 0.1 0.1 0.1 0.1 0.6 0.1 0.1 0.1 0.1 0.1 0.1 1.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.4 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.2 0.2 0.0 0.0 0.9 0.3 0.1 0.5 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.6 0.1 0.1 0.5 0.0 0.9 0.0 0.8 0.0 0.7 0.2 0.0 0.1 0.2 0.6 0.8 0.2 0.4 0.4 0.0 0.0 0.0 0.1 0.6 0.4 0.0 0.3 0.0 0.0 0.0 0.0 2.0 0.0 1.4 0.1 0.3 0.7 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.7 0.6 3.5 0.8 0.0 0.0 0.0 0.0 88.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.3 0.1 0.0 0.4 0.0 62.2 0.0 0.4 0.0 0.7 0.6 0.0 0.0 0.0 0.6 RPGRIP1 "CORD13, LCA6, RGI1, RPGRIP" ENSG00000092200 "RPGR interacting protein 1" Q96KN7 14 21287939-21351301 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Ciliopathy, Cone-rod dystrophy, Disease mutation, Glaucoma, Leber congenital amaurosis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 21 "blood: 10.8;testis: 34.8" "Group enriched" "Detected in some" 15 "Cone photoreceptor cells: 217.9;Early spermatids: 139.5;Late spermatids: 75.5;Rod photoreceptor cells: 123.4" "Cancer enhanced" "Detected in single" "testis cancer: 1.0" "Not detected" "Not detected" "Cell type enhanced" "Detected in some" "neutrophil: 10.8" "Group enriched" "Detected in many" 11 "dendritic cells: 4.1;granulocytes: 10.8;monocytes: 4.4" "Cell line enhanced" "Detected in many" "RT4: 8.7" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA042955, HPA060190" Supported Supported NA NA "HPA042955: AB_2678239, HPA060190: AB_2684218" "unprognostic (9.02e-4)" "unprognostic (3.64e-2)" "unprognostic (1.89e-1)" "unprognostic (1.86e-1)" "unprognostic (7.35e-2)" "unprognostic (1.82e-2)" "unprognostic (2.99e-2)" "unprognostic (1.14e-1)" "unprognostic (2.92e-1)" "unprognostic (1.99e-1)" "unprognostic (3.94e-3)" "unprognostic (2.33e-1)" "unprognostic (7.31e-3)" "unprognostic (2.86e-2)" "unprognostic (2.87e-1)" "unprognostic (3.13e-1)" "unprognostic (1.83e-2)" 0.1 0.0 0.1 0.2 0.1 0.5 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.5 0.1 1.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.2 0.2 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 0.8 0.0 34.8 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.2 4.1 10.8 4.4 0.5 0.2 1.3 0.6 1.8 2.0 0.9 0.0 0.0 2.5 0.7 0.0 0.0 0.9 1.3 1.2 2.5 0.6 0.0 1.0 0.5 0.7 0.0 0.0 0.8 1.1 1.4 1.8 0.5 0.1 2.1 0.7 1.0 0.0 0.0 0.0 1.1 0.0 1.9 1.6 0.3 0.0 0.8 0.8 1.2 3.1 1.2 0.7 0.9 1.6 1.9 0.0 8.7 1.5 1.3 1.6 2.0 0.4 1.5 0.7 1.1 0.7 0.6 0.5 1.8 1.4 2.1 2.0 2.5 0.9 1.3 0.6 2.0 4.4 0.1 0.1 2.0 0.1 0.1 0.1 0.0 4.1 0.2 0.2 0.0 10.8 0.5 0.1 0.0 0.0 1.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.0 1.6 0.0 0.0 0.0 0.8 0.7 0.0 1.4 0.0 0.0 217.9 0.8 0.0 0.0 139.5 0.4 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.8 0.7 0.0 0.0 0.6 1.3 75.5 1.7 0.9 0.0 0.0 0.0 3.8 0.0 0.0 0.4 0.0 123.4 0.0 0.0 9.3 2.0 0.1 1.3 0.0 0.0 0.1 RS1 "RS, XLRS1" ENSG00000102104 "Retinoschisin 1" O15537 X 18639910-18672109 "Disease related genes, Predicted secreted proteins" "Cell adhesion, Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 11 "retina: 54.9" "Group enriched" "Detected in some" 8 "Cone photoreceptor cells: 151.2;Rod photoreceptor cells: 121.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "HeLa: 1.0" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA059546 Enhanced "Secreted in other tissues" NA NA "HPA059546: AB_2684058" "unprognostic (8.31e-2)" "unprognostic (1.79e-1)" "unprognostic (4.99e-2)" "unprognostic (2.39e-2)" "unprognostic (1.86e-1)" "unprognostic (4.80e-1)" "unprognostic (2.74e-1)" "unprognostic (2.68e-2)" "unprognostic (1.00e-1)" "unprognostic (1.74e-1)" "unprognostic (4.77e-3)" "unprognostic (4.14e-1)" "unprognostic (7.03e-2)" "unprognostic (1.06e-1)" "unprognostic (3.06e-2)" "unprognostic (5.12e-2)" "unprognostic (2.04e-4)" 0.1 0.0 1.0 0.1 2.3 0.0 0.1 0.6 3.2 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 1.0 0.4 0.4 0.1 5.1 0.4 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 54.9 0.1 0.1 0.2 0.2 0.1 0.1 0.1 0.3 0.0 0.1 0.1 0.1 0.5 0.1 0.2 0.1 0.1 0.5 0.1 0.5 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.4 0.0 0.1 0.9 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.5 0.1 0.0 0.1 0.0 0.1 0.0 0.5 0.2 0.1 0.1 0.1 0.0 1.0 2.3 0.6 2.4 1.0 0.4 0.1 0.1 0.1 0.1 6.0 0.0 0.0 0.0 0.0 12.9 0.8 0.0 0.0 0.0 0.0 151.2 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 11.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.9 0.0 0.0 0.0 0.0 121.9 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 SAG "ARRESTIN, RP47" ENSG00000130561 "S-antigen visual arrestin" P10523 2 233307816-233347055 "Disease related genes, Predicted intracellular proteins" "Congenital stationary night blindness, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 26 "retina: 215.8" "Cell type enriched" "Detected in some" 6 "Rod photoreceptor cells: 5320.5" "Not detected" "Not detected" "Region enriched" "Detected in single" 39 "basal ganglia: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA004946 Enhanced NA NA "HPA004946: AB_2667304" "unprognostic (4.76e-2)" "unprognostic (1.94e-2)" "unprognostic (4.52e-3)" "unprognostic (3.95e-1)" "unprognostic (8.54e-2)" "unprognostic (2.89e-2)" "unprognostic (3.86e-2)" "unprognostic (2.26e-2)" "unprognostic (1.78e-1)" "unprognostic (4.54e-1)" "unprognostic (4.57e-2)" "unprognostic (3.02e-1)" "unprognostic (1.12e-9)" "unprognostic (2.56e-1)" "unprognostic (1.61e-1)" "unprognostic (2.85e-1)" "unprognostic (1.03e-5)" 0.0 0.0 0.2 0.0 8.4 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 215.8 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 8.4 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.2 490.5 0.8 0.0 0.0 0.0 0.0 818.8 1.4 0.0 0.0 32.2 0.4 0.6 0.0 0.0 0.1 0.2 0.9 0.0 0.0 0.1 319.4 0.0 0.0 1.9 85.0 0.9 0.3 0.0 0.0 0.0 667.1 0.0 0.0 0.0 0.0 5320.5 12.9 0.5 1.5 1.1 0.5 0.3 1.0 0.0 1.3 SCUBE1 ENSG00000159307 "Signal peptide, CUB domain and EGF like domain containing 1" Q8IWY4 22 43197283-43343388 "Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 35.8;retina: 48.1" "Cell type enriched" "Detected in many" 5 "Peritubular cells: 42.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "basophil: 2.4" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.4" "Group enriched" "Detected in some" 4 "HMC-1: 32.9;THP-1: 13.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA003190 Approved "Secreted to blood" NA NA 2170000 130000 "HPA003190: AB_1079882" "unprognostic (5.29e-2)" "unprognostic (7.15e-6)" "unprognostic (6.03e-3)" "unprognostic (8.33e-2)" "unprognostic (3.65e-1)" "unprognostic (4.55e-2)" "unprognostic (1.34e-1)" "unprognostic (5.76e-2)" "unprognostic (1.10e-1)" "unprognostic (1.99e-1)" "unprognostic (3.74e-2)" "unprognostic (1.22e-1)" "unprognostic (1.23e-2)" "unprognostic (1.02e-2)" "unprognostic (2.70e-1)" "unprognostic (2.30e-1)" "unprognostic (6.87e-3)" 3.3 5.3 0.4 1.1 2.0 0.1 3.5 0.3 2.3 1.3 5.5 0.9 1.3 5.9 1.3 0.7 14.8 1.2 0.8 1.0 0.5 0.7 3.4 4.6 7.5 0.1 3.4 1.9 35.8 0.4 0.3 3.8 3.5 1.9 6.4 2.0 48.1 5.3 0.5 8.0 0.6 7.6 1.0 3.5 6.9 7.3 8.5 0.1 0.0 3.1 0.5 0.1 4.2 6.3 0.3 0.3 2.4 0.3 0.5 0.3 0.1 0.0 0.0 1.4 5.1 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.0 0.0 0.4 0.0 0.0 0.4 0.1 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.7 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.2 0.8 0.0 0.1 0.0 0.2 0.0 13.0 0.0 0.2 0.1 0.4 0.0 1.4 2.5 0.0 0.3 0.0 0.1 2.4 0.2 0.3 0.2 0.3 0.3 0.3 0.3 0.2 0.1 0.3 0.3 0.3 1.0 0.5 0.3 0.3 0.2 0.1 0.4 2.0 0.3 2.3 0.5 0.7 3.4 1.9 1.9 0.1 8.9 1.7 0.0 0.0 0.2 0.0 1.1 0.0 1.4 1.2 0.0 0.0 0.1 1.7 0.0 2.3 0.6 0.0 0.0 0.0 8.9 0.9 0.0 1.1 1.1 0.7 0.0 0.0 0.6 0.0 2.6 7.2 0.0 0.0 0.0 0.0 5.2 0.1 0.0 42.8 0.1 0.2 0.0 0.0 3.0 1.5 0.1 0.3 0.0 0.0 0.0 SEMA4F "SEMAM, SEMAW" ENSG00000135622 "Ssemaphorin 4F" O95754 2 74654228-74683853 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" 4 "Cone photoreceptor cells: 11.8;Horizontal cells: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA064095, HPA065969" Approved Approved "Nucleoplasm,Plasma membrane,Centrosome" NA NA Nucleoplasm "Plasma membrane, Centrosome" "HPA064095: AB_2732710, HPA065969: AB_2685590" "unprognostic (9.69e-2)" "unprognostic (8.88e-3)" "unprognostic (1.58e-2)" "prognostic unfavorable (5.94e-5)" "prognostic unfavorable (6.96e-4)" "unprognostic (1.23e-2)" "unprognostic (1.61e-3)" "unprognostic (6.95e-2)" "unprognostic (9.01e-3)" "unprognostic (6.53e-2)" "unprognostic (2.21e-2)" "unprognostic (1.54e-1)" "prognostic unfavorable (9.74e-6)" "unprognostic (2.60e-2)" "unprognostic (8.08e-2)" "prognostic favorable (6.94e-4)" "unprognostic (4.69e-2)" 8.1 5.1 15.5 3.5 15.5 1.3 5.7 12.9 21.3 5.2 3.8 3.3 2.3 1.9 6.6 6.7 2.7 5.6 3.5 4.9 17.2 12.2 4.8 2.1 8.1 5.1 5.3 16.5 9.1 4.6 13.7 10.2 3.5 7.8 5.2 4.2 3.6 5.0 5.7 3.0 4.9 3.0 7.0 5.7 4.7 4.3 7.2 3.8 2.9 4.7 1.3 4.9 3.5 4.7 2.8 0.2 1.4 0.4 2.5 5.6 2.1 6.5 4.4 4.8 6.8 7.8 4.4 3.0 4.5 9.4 8.2 7.6 1.8 3.8 2.2 4.9 7.2 19.8 1.9 7.0 7.7 9.1 5.7 5.9 3.8 1.8 3.6 2.8 0.8 6.1 4.0 6.7 5.5 2.9 18.7 3.5 5.0 0.2 0.1 4.8 1.9 3.5 0.7 2.6 3.7 4.3 0.0 6.2 0.0 6.4 3.0 3.0 7.2 6.6 2.7 8.2 6.0 3.2 0.5 3.8 14.1 6.8 3.4 8.2 5.3 5.2 0.3 17.2 0.3 7.5 0.5 0.2 1.4 5.6 0.1 3.2 2.8 3.0 4.9 0.2 2.1 3.3 3.9 0.8 2.5 0.4 0.1 2.2 2.1 15.5 15.5 12.9 21.3 17.2 12.2 5.3 16.5 7.8 3.8 0.0 6.2 0.0 1.5 0.3 8.8 1.4 10.2 1.4 7.9 5.2 11.8 0.7 1.7 2.0 3.1 1.6 0.4 0.0 1.4 2.0 1.2 1.5 2.3 0.6 0.7 11.1 6.9 2.5 0.0 2.4 0.9 0.7 0.0 1.8 0.7 4.1 2.7 0.9 1.4 0.2 5.7 6.5 0.4 3.1 9.8 0.4 0.3 2.5 1.0 1.1 SIX6 "OPTX2, Six9" ENSG00000184302 "SIX homeobox 6" O95475 14 60508951-60512850 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 4 "pituitary gland: 43.3" "Cell type enhanced" "Detected in some" 33 "Cone photoreceptor cells: 27.5;Horizontal cells: 46.1;Muller glia cells: 158.1" "Cancer enriched" "Detected in single" 8 "glioma: 1.0" "Region enriched" "Detected in single" 8 "hypothalamus: 2.7" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "JURKAT: 9.3;MOLT-4: 29.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 12 "hypothalamus: 2.5" HPA001403 Approved Approved Nucleoplasm NA NA Nucleoplasm "HPA001403: AB_1079993" "unprognostic (2.76e-1)" "unprognostic (6.14e-2)" "unprognostic (8.18e-2)" "unprognostic (5.75e-2)" 0.1 0.0 0.3 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 43.3 0.0 0.0 0.4 0.0 10.6 0.3 0.0 2.2 0.0 0.0 0.0 0.0 0.1 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 29.4 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 3.8 0.8 0.0 0.0 0.0 0.0 27.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 46.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 158.1 0.0 0.0 0.0 0.0 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC13A4 "SUT-1, SUT1" ENSG00000164707 "Solute carrier family 13 member 4" Q9UKG4 7 135681237-135729258 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "brain: 85.4;placenta: 44.8;retina: 23.5" "Cell type enriched" "Detected in some" 7 "Syncytiotrophoblasts: 657.3" "Low cancer specificity" "Detected in single" "Region enriched" "Detected in many" 7 "pons and medulla: 85.4" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 6 "HDLM-2: 25.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA048582 Enhanced NA NA "HPA048582: AB_2680450" "unprognostic (2.40e-1)" "unprognostic (2.51e-1)" "unprognostic (9.70e-3)" "unprognostic (1.78e-1)" "unprognostic (7.69e-2)" "unprognostic (3.96e-6)" "unprognostic (3.33e-2)" "unprognostic (1.32e-1)" "unprognostic (8.56e-3)" "unprognostic (9.23e-2)" "unprognostic (2.89e-1)" "unprognostic (1.87e-1)" "unprognostic (2.30e-6)" "unprognostic (1.53e-1)" "unprognostic (3.07e-2)" "unprognostic (2.00e-1)" "unprognostic (6.73e-2)" 0.3 0.4 0.7 0.3 1.4 0.3 0.4 4.0 8.9 1.2 0.3 34.0 0.0 0.3 0.4 0.3 4.1 0.8 0.4 0.4 12.3 0.8 0.3 0.4 0.4 0.3 1.4 5.4 0.4 0.5 0.4 1.4 44.8 85.4 0.3 0.3 23.5 1.0 0.4 0.3 0.4 0.3 0.4 5.1 0.3 0.3 5.4 0.5 0.0 0.3 0.0 1.9 0.3 1.8 0.0 0.2 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.5 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.0 0.0 0.0 25.7 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.1 0.0 2.1 0.1 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 1.4 4.0 8.9 12.3 0.8 1.4 5.4 85.4 0.5 0.0 0.0 0.0 0.5 0.0 2.6 1.6 0.0 6.7 0.0 0.0 3.9 99.4 0.0 0.1 0.4 0.3 0.0 0.0 0.0 5.3 1.1 0.4 0.0 0.0 13.1 3.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 0.0 13.2 0.0 0.0 0.0 0.2 0.1 657.3 0.0 0.0 0.3 SLC16A8 "MCT3, REMP" ENSG00000100156 "Solute carrier family 16 member 8" O95907 22 38078134-38084093 "Plasma proteins, Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "retina: 70.9" "Cell type enhanced" "Detected in some" 9 "Leydig cells: 4.0;Melanocytes: 5.0;Spermatogonia: 4.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 6.1;RT4: 4.5;SiHa: 6.5;T-47d: 7.8;U-266/70: 11.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA075017 Enhanced Approved "Intermediate filaments,Focal adhesion sites" No NA "Focal adhesion sites" "Intermediate filaments" "HPA075017: AB_2732276" "unprognostic (1.22e-2)" "unprognostic (2.25e-2)" "unprognostic (5.07e-6)" "unprognostic (2.99e-2)" "unprognostic (1.37e-1)" "unprognostic (1.84e-2)" "unprognostic (2.99e-2)" "unprognostic (1.74e-1)" "unprognostic (1.24e-1)" "unprognostic (1.76e-1)" "unprognostic (1.63e-2)" "unprognostic (1.32e-2)" "unprognostic (2.34e-4)" "unprognostic (7.69e-2)" "unprognostic (1.15e-1)" "unprognostic (4.06e-1)" "unprognostic (9.71e-5)" 1.6 2.6 1.9 0.8 5.1 1.2 0.8 0.8 3.3 0.8 0.8 0.8 0.8 0.5 1.3 0.8 1.1 1.2 2.7 2.9 2.7 2.9 0.8 0.8 0.8 0.9 2.8 0.8 0.8 2.1 0.0 2.6 0.8 1.3 4.0 0.0 70.9 10.0 0.8 1.9 4.2 0.8 0.8 3.7 1.8 2.3 2.0 0.8 0.8 0.9 0.8 0.8 1.6 0.8 0.0 0.0 0.0 0.0 0.5 0.6 0.0 1.4 0.7 1.2 0.2 0.0 0.0 6.1 0.5 0.0 0.0 0.0 1.3 3.5 0.4 1.7 0.0 0.1 0.8 0.0 0.0 0.0 0.0 1.9 0.3 1.0 0.1 0.2 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.1 1.6 0.0 4.0 0.0 0.0 1.4 0.1 0.1 2.0 0.0 0.0 0.0 4.5 2.0 0.3 6.5 0.3 1.0 0.6 7.8 0.2 0.0 0.0 3.6 0.3 0.0 11.5 1.6 0.1 0.0 0.2 0.2 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 1.9 5.1 0.8 1.2 2.7 2.9 2.8 0.8 1.3 0.8 0.0 0.0 0.0 0.5 1.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.0 0.8 0.0 0.0 1.3 0.3 1.6 4.0 0.0 5.0 0.0 0.0 0.9 0.2 0.0 2.1 0.0 0.5 0.0 0.9 0.9 4.1 0.6 0.0 0.0 0.0 0.1 SLC1A7 EAAT5 ENSG00000162383 "Solute carrier family 1 member 7" O00341 1 53087179-53142632 "Predicted membrane proteins, Transporters" "Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 7 "retina: 70.1" "Group enriched" "Detected in some" 17 "Bipolar cells: 228.0;Cone photoreceptor cells: 66.8;Rod photoreceptor cells: 66.6" "Cancer enhanced" "Detected in many" "lung cancer: 3.4" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 12 "gdT-cell: 5.7;memory CD8 T-cell: 2.2;naive CD8 T-cell: 2.6" "Lineage enriched" "Detected in single" 58 "T-cells: 5.7" "Cell line enriched" "Detected in some" 9 "HHSteC: 24.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA049124 Enhanced NA NA "HPA049124: AB_2680643" "unprognostic (2.33e-1)" "unprognostic (1.31e-1)" "unprognostic (1.09e-1)" "unprognostic (9.48e-4)" "unprognostic (2.31e-1)" "unprognostic (8.73e-2)" "unprognostic (1.52e-2)" "unprognostic (6.26e-3)" "unprognostic (4.35e-1)" "unprognostic (1.45e-2)" "unprognostic (1.59e-1)" "unprognostic (7.65e-2)" "unprognostic (1.19e-3)" "unprognostic (2.58e-3)" "unprognostic (5.43e-2)" "unprognostic (8.12e-2)" "unprognostic (4.70e-3)" 2.0 0.2 1.1 0.6 0.6 0.0 1.2 0.6 0.7 0.9 1.0 0.7 0.6 4.1 1.3 1.2 2.1 2.2 9.6 2.9 1.7 1.1 0.7 2.8 0.9 0.6 1.2 0.6 3.8 0.6 0.0 0.6 0.6 1.1 0.9 0.0 70.1 0.6 0.6 2.1 1.2 5.3 0.6 1.3 0.6 1.1 0.9 0.6 0.6 0.6 0.6 0.6 2.5 0.9 0.0 0.0 0.0 0.0 0.0 5.7 0.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 24.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.7 0.0 0.0 0.0 0.1 2.2 0.0 0.0 0.2 2.6 0.0 0.0 0.0 0.0 0.1 0.8 1.1 0.6 0.6 0.7 1.7 1.1 1.2 0.6 1.1 0.6 0.0 0.6 0.0 0.0 0.0 228.0 0.4 0.0 0.0 0.0 0.0 66.8 0.1 0.0 0.0 0.0 0.0 7.0 0.0 1.3 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.6 0.0 0.0 1.1 0.0 0.0 0.0 0.7 5.2 0.0 2.9 1.1 0.2 66.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SLC24A1 "CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX" ENSG00000074621 "Solute carrier family 24 member 1" O60721 15 65611366-65660995 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision" "Congenital stationary night blindness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 7 "retina: 91.1" "Cell type enriched" "Detected in many" 11 "Rod photoreceptor cells: 301.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA039370 Enhanced Approved Microtubules NA NA Microtubules "HPA039370: AB_10960279" "unprognostic (9.47e-2)" "unprognostic (9.97e-2)" "unprognostic (1.66e-1)" "unprognostic (3.66e-3)" "unprognostic (6.39e-3)" "unprognostic (4.64e-1)" "unprognostic (8.82e-2)" "unprognostic (1.86e-1)" "unprognostic (4.69e-2)" "unprognostic (3.94e-1)" "unprognostic (2.01e-1)" "unprognostic (9.91e-2)" "prognostic favorable (2.33e-6)" "unprognostic (8.45e-2)" "unprognostic (9.22e-2)" "unprognostic (3.04e-2)" "unprognostic (1.96e-2)" 6.2 5.3 4.5 7.7 5.0 2.6 9.3 7.0 3.4 8.9 5.0 5.6 7.5 3.7 10.6 12.2 4.2 9.0 6.2 4.1 4.7 4.1 7.9 4.7 12.0 6.0 5.3 2.6 9.7 6.6 6.5 6.1 8.9 4.0 6.0 4.1 91.1 6.4 8.3 3.8 8.5 4.5 5.0 6.8 7.8 4.2 10.8 3.2 6.9 9.0 4.6 4.8 6.0 5.3 3.8 2.6 4.7 1.5 2.3 1.8 0.4 1.5 3.1 3.3 3.0 5.0 8.4 4.1 3.9 4.2 3.8 2.5 1.4 6.6 2.1 12.9 3.7 1.3 4.2 3.9 4.2 2.3 2.1 2.9 4.6 2.3 6.8 7.2 3.0 6.3 7.1 6.2 2.1 12.8 5.4 6.6 4.9 4.8 7.2 6.2 6.4 1.9 2.8 4.3 13.5 1.2 2.0 1.0 1.4 5.8 6.0 1.6 2.3 1.0 2.9 8.0 4.8 6.2 4.2 9.4 3.9 3.9 1.5 2.6 2.9 5.2 2.5 4.1 6.5 3.3 4.7 1.5 2.1 1.4 1.3 1.8 1.4 1.5 1.2 1.1 3.8 1.1 1.5 1.7 2.3 0.6 2.6 0.3 0.4 4.5 5.0 7.0 3.4 4.7 4.1 5.3 2.6 4.0 3.2 6.0 3.2 1.4 1.2 1.3 26.9 1.9 0.0 4.0 5.7 0.0 25.5 3.3 0.0 1.1 1.1 7.0 2.8 0.0 1.1 2.0 1.5 1.1 2.3 1.5 1.7 19.1 1.7 4.3 2.2 1.8 2.8 1.5 1.7 0.0 2.2 23.4 1.7 0.0 2.1 0.5 301.7 0.0 1.4 10.4 6.4 0.9 2.1 0.8 2.1 0.8 SLC32A1 "bA122O1.1, VGAT, VIAAT" ENSG00000101438 "Solute carrier family 32 member 1" Q9H598 20 38724462-38729372 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 38.3" "Cell type enriched" "Detected in some" 14 "Horizontal cells: 55.6" "Cancer enhanced" "Detected in single" "glioma: 1.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 20 "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 20 "dendritic cells: 1.9" "Group enriched" "Detected in some" 12 "MOLT-4: 5.5;SH-SY5Y: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB037156, HPA058859, HPA059985" Enhanced Supported NA NA "CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187" "unprognostic (1.13e-2)" "unprognostic (2.09e-1)" "unprognostic (1.17e-1)" "unprognostic (6.57e-2)" 1.0 1.1 4.6 1.0 38.3 1.5 1.0 4.9 25.8 1.0 1.0 0.8 0.0 1.0 1.0 1.0 1.0 1.1 1.0 1.0 3.9 9.7 1.0 1.0 1.0 1.0 4.4 6.8 1.0 1.1 1.0 4.1 1.0 10.4 1.0 1.0 0.7 1.0 1.0 1.0 1.0 1.1 1.0 4.4 1.0 1.0 1.6 7.9 0.0 1.0 0.0 1.0 1.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 4.6 38.3 4.9 11.9 3.9 9.7 4.4 6.8 10.4 7.9 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 55.6 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.9 0.4 0.0 0.0 0.0 0.0 0.0 SLC6A6 TAUT ENSG00000131389 "Solute carrier family 6 member 6" P31641 3 14402576-14489349 "Predicted membrane proteins, Transporters" "Neurotransmitter transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "retina: 76.4" "Group enriched" "Detected in many" 4 "Cone photoreceptor cells: 538.0;Rod photoreceptor cells: 502.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 33.2" "Lineage enriched" "Detected in many" 5 "granulocytes: 33.2" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 45.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA015028, HPA016488" Enhanced Approved "Cell Junctions,Cytosol" NA NA "Cell Junctions, Cytosol" "HPA015028: AB_1857200, HPA016488: AB_1857202" "unprognostic (8.25e-2)" "unprognostic (7.29e-3)" "unprognostic (2.63e-2)" "prognostic favorable (5.22e-5)" "prognostic unfavorable (5.75e-8)" "unprognostic (4.14e-2)" "prognostic unfavorable (8.78e-4)" "unprognostic (2.58e-1)" "unprognostic (2.56e-1)" "unprognostic (3.81e-1)" "unprognostic (6.96e-2)" "unprognostic (2.38e-1)" "unprognostic (2.78e-3)" "unprognostic (1.11e-1)" "unprognostic (1.01e-2)" "unprognostic (9.65e-2)" "unprognostic (1.90e-1)" 10.2 25.9 5.7 18.0 16.5 46.4 8.1 11.1 12.2 11.3 9.5 8.7 3.6 8.5 14.5 4.4 7.0 7.0 14.5 23.2 5.6 4.6 16.6 2.3 18.6 12.9 18.0 7.6 31.3 2.8 3.8 9.6 18.0 13.3 5.0 4.1 76.4 15.7 7.7 26.6 16.8 22.2 8.2 11.1 20.3 14.0 4.0 12.6 6.2 10.4 11.3 11.2 8.8 6.1 1.6 1.9 33.2 6.9 0.7 3.9 2.3 4.6 17.3 6.2 4.7 8.1 2.5 12.8 7.0 27.8 8.3 6.1 6.3 8.0 13.5 6.4 11.0 12.0 3.7 4.2 5.7 7.4 1.5 5.2 12.8 22.7 9.4 0.2 3.5 27.8 1.3 1.7 7.6 2.0 7.2 9.0 6.3 7.1 2.7 7.3 4.9 9.8 6.8 9.6 6.5 5.0 7.0 7.4 21.1 45.5 9.7 11.5 4.1 5.2 2.8 1.5 24.4 10.7 1.9 22.7 10.6 5.7 2.6 5.0 3.0 3.4 5.0 24.7 6.9 32.4 2.5 5.1 5.0 1.3 4.2 0.7 1.6 1.4 1.7 1.9 0.9 0.2 0.3 33.2 0.7 6.9 0.7 3.9 2.3 5.7 16.5 11.1 12.2 5.6 4.6 18.0 7.6 13.3 12.6 6.0 22.1 4.7 11.2 43.8 102.1 3.6 2.5 12.0 12.5 19.2 538.0 2.2 0.0 9.6 17.0 16.1 0.7 0.0 7.1 12.8 16.4 5.5 12.7 0.4 26.7 9.5 13.8 11.6 62.5 13.3 16.1 47.4 16.9 129.0 2.9 28.2 21.5 2.9 16.3 26.3 502.9 0.0 8.2 0.5 1.5 20.8 4.2 22.4 1.2 10.6 SPATA7 "HSD3, LCA3" ENSG00000042317 "Spermatogenesis associated 7" Q9P0W8 14 88384924-88470350 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Leber congenital amaurosis, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 55.6" "Group enriched" "Detected in many" 24 "Early spermatids: 817.6;Late spermatids: 902.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038082, HPA038083" Enhanced Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Nucleoplasm, Mitochondria, Cytosol" "HPA038082: AB_10671738, HPA038083: AB_10671519" "unprognostic (2.09e-2)" "unprognostic (6.72e-2)" "unprognostic (1.10e-1)" "unprognostic (6.50e-3)" "unprognostic (3.22e-2)" "unprognostic (6.75e-2)" "unprognostic (1.29e-3)" "unprognostic (4.70e-2)" "unprognostic (1.70e-1)" "unprognostic (5.45e-3)" "prognostic favorable (4.16e-5)" "unprognostic (2.88e-1)" "prognostic favorable (2.50e-5)" "unprognostic (8.41e-2)" "unprognostic (1.29e-2)" "unprognostic (6.09e-2)" "unprognostic (2.81e-2)" 6.3 7.2 7.8 2.8 10.3 2.2 7.1 18.0 12.5 6.1 4.5 6.5 4.5 2.9 7.7 8.5 3.7 9.6 6.5 5.3 8.1 7.4 10.5 5.9 5.0 3.0 6.4 9.7 13.6 6.9 9.2 15.0 3.6 13.3 5.8 4.1 5.5 4.6 5.9 4.7 6.6 2.8 6.4 5.8 3.7 4.3 55.6 5.9 3.3 13.5 3.9 2.0 5.7 4.4 3.7 4.4 1.7 3.0 0.9 5.6 2.2 2.1 3.3 4.9 6.8 8.1 15.4 5.0 3.7 8.4 4.7 3.1 0.9 4.1 1.5 2.3 5.0 3.5 2.1 2.3 3.5 4.4 2.5 1.6 0.1 1.6 1.1 12.1 3.4 0.3 7.3 5.9 1.9 3.6 15.4 8.6 4.2 1.1 2.4 4.3 2.5 1.5 3.1 0.6 2.6 4.2 3.5 5.1 0.8 7.5 1.3 2.9 4.5 4.7 6.4 3.8 5.1 5.5 3.7 4.4 2.9 3.8 4.8 2.0 2.4 1.2 0.5 5.8 1.0 2.4 0.0 2.2 0.6 4.8 3.0 5.6 3.7 4.0 2.2 4.4 0.9 2.2 4.2 1.7 0.9 1.8 4.3 1.4 2.2 7.8 10.3 18.0 12.5 8.1 7.4 6.4 9.7 13.3 5.9 11.9 5.3 0.8 8.2 2.2 10.8 10.9 5.1 36.1 10.3 3.5 19.6 2.1 8.3 7.6 817.6 5.2 1.1 0.0 6.3 3.2 6.4 3.4 1.1 3.4 5.0 14.3 15.6 6.2 8.6 902.3 19.0 3.3 8.5 4.6 4.4 10.6 5.8 4.8 15.9 19.9 19.4 6.5 5.0 18.2 13.5 1.8 0.9 3.8 4.6 2.7 SPTBN5 "BSPECV, HUBSPECV, HUSPECV" ENSG00000137877 "Spectrin beta, non-erythrocytic 5" Q9NRC6 15 41848144-41894077 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 10.0" "Group enriched" "Detected in some" 22 "Cone photoreceptor cells: 198.3;Rod photoreceptor cells: 225.5" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 8 "cerebellum: 10.0;midbrain: 6.8;pons and medulla: 3.7" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 4.6;SCLC-21H: 6.4;TIME: 16.5;WM-115: 5.2" "Not detected" "Not detected" HPA055283 Approved NA NA "HPA055283: " "unprognostic (5.46e-2)" "unprognostic (2.49e-1)" "unprognostic (3.28e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-2)" "unprognostic (5.84e-3)" "unprognostic (1.12e-1)" "unprognostic (6.84e-3)" "unprognostic (6.40e-3)" "unprognostic (2.25e-1)" "unprognostic (2.96e-2)" "unprognostic (6.92e-2)" "unprognostic (1.83e-2)" "unprognostic (3.98e-2)" "unprognostic (2.28e-1)" "unprognostic (1.37e-2)" "unprognostic (1.11e-2)" 1.4 0.3 0.7 1.4 0.7 0.7 1.2 10.0 0.8 0.7 0.7 0.7 0.7 0.6 0.7 1.8 2.0 0.2 1.9 4.6 0.7 0.3 1.2 1.9 1.2 1.2 6.8 0.7 1.2 2.6 1.8 2.3 0.7 3.7 1.8 0.2 7.4 6.8 0.7 1.4 1.8 0.7 0.7 1.0 0.7 1.2 1.9 0.7 0.7 2.6 0.7 0.7 4.4 0.7 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.6 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.7 0.0 1.0 0.0 1.9 0.5 0.0 0.3 0.0 1.0 0.1 0.0 1.7 0.0 0.0 0.0 1.7 0.0 0.1 0.1 0.1 0.0 4.6 0.0 0.0 0.1 0.3 0.0 0.0 0.1 0.5 0.2 0.5 0.0 0.3 0.0 0.4 1.7 6.4 0.1 0.2 0.5 0.1 0.5 1.0 0.0 16.5 0.0 1.7 0.4 2.0 1.9 2.7 0.0 0.0 0.1 5.2 0.0 0.0 0.0 0.8 0.0 0.5 0.0 0.0 0.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.7 10.0 0.8 0.7 0.3 6.8 0.7 3.7 0.7 0.0 3.7 0.0 0.8 0.7 7.6 3.4 0.0 1.4 2.3 0.0 198.3 0.0 0.0 0.4 1.0 1.1 0.0 0.0 0.2 0.2 0.0 0.3 1.1 0.4 1.5 3.2 0.0 0.6 0.0 0.4 0.0 0.8 1.7 1.0 0.3 9.5 0.9 0.9 0.0 0.3 225.5 0.0 0.2 0.3 0.4 1.1 0.0 0.0 0.2 0.9 TFAP2A "AP-2, AP2TF, TFAP2" ENSG00000137203 "Transcription factor AP-2 alpha" P05549 6 10393186-10419659 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 130.5;retina: 48.1" "Cell type enhanced" "Detected in many" 17 "Cytotrophoblasts: 245.7;Extravillous trophoblasts: 224.5;Syncytiotrophoblasts: 585.5" "Cancer enhanced" "Detected in many" "melanoma: 45.6" "Region enhanced" "Detected in single" "cerebellum: 2.2" "Cell type enriched" "Detected in single" 10 "myeloid DC: 1.0" "Lineage enriched" "Detected in single" 10 "dendritic cells: 1.0" "Cell line enhanced" "Detected in many" "AN3-CA: 28.0;HDLM-2: 31.3;hTCEpi: 30.2;SuSa: 31.6" "Region enhanced" "Detected in single" "cerebellum: 4.3" "Region enhanced" "Detected in single" "cerebellum: 8.6" "CAB000326, HPA056871" Enhanced Enhanced Nucleoplasm NA NA Nucleoplasm "CAB000326: AB_667767, HPA056871: AB_2683262" "unprognostic (5.97e-2)" "unprognostic (2.18e-1)" "unprognostic (1.31e-2)" "unprognostic (1.14e-1)" "unprognostic (3.87e-2)" "unprognostic (1.27e-1)" "unprognostic (7.62e-5)" "prognostic unfavorable (1.09e-4)" "unprognostic (1.45e-1)" "unprognostic (2.76e-2)" "unprognostic (3.33e-3)" "unprognostic (2.82e-1)" "unprognostic (1.40e-11)" "unprognostic (1.46e-2)" "unprognostic (2.14e-1)" "unprognostic (1.72e-4)" "unprognostic (2.25e-2)" 0.4 0.3 0.3 0.0 0.3 0.0 19.0 2.2 0.5 4.4 0.8 0.0 18.7 0.2 0.5 17.8 18.3 0.4 1.7 0.7 0.3 0.2 6.4 0.2 0.5 0.1 0.2 0.2 0.3 0.3 0.0 0.4 130.5 0.6 5.8 0.2 48.1 19.4 26.7 0.2 36.0 0.4 0.1 0.4 0.2 0.7 1.6 0.0 0.1 0.4 16.6 9.9 2.4 9.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 16.3 6.3 0.0 28.0 0.1 0.0 6.0 12.1 9.3 9.9 9.8 0.6 6.1 0.9 1.6 3.5 5.7 17.5 1.5 20.7 9.5 31.3 15.8 0.1 14.8 0.0 0.0 0.4 0.4 0.0 30.2 0.0 22.0 5.6 0.0 0.3 0.9 0.0 0.1 3.6 0.0 5.1 0.1 1.0 7.8 1.7 1.5 0.6 5.6 6.6 4.1 0.1 14.9 26.2 23.8 31.6 17.3 0.5 0.0 3.0 0.8 2.1 7.6 0.0 1.4 0.2 1.6 0.5 18.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 2.2 0.3 0.3 0.2 0.2 0.2 0.6 0.0 0.0 0.0 0.0 37.5 116.1 3.1 2.2 0.0 8.1 15.9 29.6 2.0 245.7 6.6 2.0 4.6 0.8 0.0 0.0 0.3 224.5 5.3 38.8 0.0 0.0 17.7 76.3 1.2 0.0 0.0 2.1 0.6 0.2 118.1 0.0 0.5 2.4 2.2 0.0 0.0 0.2 4.2 0.0 2.1 3.9 11.8 120.9 585.5 0.0 0.4 39.3 TFAP2B AP2-B ENSG00000008196 "Transcription factor AP-2 beta" Q92481 6 50818723-50847613 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 5 "epididymis: 65.5" "Cell type enriched" "Detected in some" 4 "Horizontal cells: 413.2" "Cancer enriched" "Detected in some" 8 "breast cancer: 12.1" "Group enriched" "Detected in some" 41 "cerebellum: 4.7;pons and medulla: 6.3" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 4 "AF22: 32.4;SH-SY5Y: 60.4" "Region enhanced" "Detected in some" "cerebellum: 11.2" "Low region specificity" "Detected in many" "HPA034683, HPA062942" Enhanced Approved Nucleoplasm NA NA Nucleoplasm "HPA034683: AB_10670966, HPA062942: AB_2684909" "unprognostic (2.02e-1)" "unprognostic (2.29e-2)" "unprognostic (4.27e-2)" "unprognostic (5.88e-4)" "unprognostic (9.76e-2)" "unprognostic (2.10e-1)" "unprognostic (1.00e-1)" "unprognostic (4.57e-1)" "unprognostic (6.58e-6)" "unprognostic (1.13e-2)" "unprognostic (1.88e-1)" "unprognostic (7.17e-3)" 0.2 3.0 0.0 0.0 0.0 0.0 9.4 4.7 0.0 0.2 0.2 0.0 8.8 0.0 0.0 65.5 5.8 0.0 0.0 0.1 0.0 0.1 6.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 6.3 0.1 0.0 12.2 7.0 0.6 0.0 6.3 0.0 0.0 1.1 0.0 0.0 1.5 0.0 0.0 0.0 0.3 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 32.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 0.0 0.0 60.4 0.0 0.2 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.1 0.1 0.0 6.3 0.0 0.0 0.0 0.0 0.0 10.4 6.9 0.6 0.0 0.0 0.0 48.8 7.9 10.5 46.4 0.0 11.5 0.3 0.0 0.0 0.0 3.7 0.3 0.0 0.0 0.0 1.0 413.2 0.0 0.0 0.0 0.5 0.0 0.0 101.3 0.0 0.0 2.3 0.0 0.0 0.4 0.7 9.7 0.0 0.0 0.5 0.0 3.8 4.1 0.0 0.0 0.0 TMEM221 ENSG00000188051 "Transmembrane protein 221" A6NGB7 19 17435509-17448567 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 11.4" "Group enriched" "Detected in some" 11 "Cone photoreceptor cells: 13.7;Muller glia cells: 51.3;Rod photoreceptor cells: 22.4" "Cancer enhanced" "Detected in some" "ovarian cancer: 3.3" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in some" "AN3-CA: 7.4;PC-3: 11.3;REH: 6.3" "HPA041580, HPA062945" Supported Approved "Nuclear membrane" NA NA "Nuclear membrane" "HPA041580: AB_10795700, HPA062945: " "unprognostic (3.60e-2)" "unprognostic (7.86e-2)" "unprognostic (4.51e-4)" "unprognostic (2.09e-2)" "unprognostic (2.61e-2)" "unprognostic (9.14e-3)" "unprognostic (3.19e-1)" "unprognostic (2.42e-1)" "unprognostic (1.72e-2)" "unprognostic (4.20e-2)" "unprognostic (1.98e-1)" "unprognostic (9.47e-4)" "unprognostic (2.37e-2)" "unprognostic (6.67e-2)" "unprognostic (2.76e-1)" "unprognostic (2.42e-2)" "unprognostic (1.23e-1)" 1.0 6.1 5.4 0.7 2.9 0.5 1.6 1.3 7.0 0.9 0.8 1.1 0.0 0.4 1.2 3.1 0.9 6.2 1.5 1.2 6.0 2.1 0.7 0.4 0.7 0.6 1.2 2.5 11.4 5.4 10.2 2.5 0.5 3.3 3.8 0.4 6.5 3.3 4.6 0.6 1.2 0.6 0.6 3.1 0.5 0.6 2.4 1.8 0.0 1.4 1.1 0.4 0.9 3.3 0.0 1.6 0.0 0.1 0.0 0.7 0.1 0.8 2.5 1.0 7.4 0.0 0.0 0.2 0.3 0.0 0.1 0.4 0.1 0.2 0.2 1.5 0.0 0.6 0.3 2.2 0.1 0.0 0.1 1.9 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.4 0.0 0.0 0.7 0.0 0.5 0.1 0.1 0.0 0.1 0.2 0.3 1.6 0.6 11.3 6.3 0.2 0.0 0.5 0.5 0.1 0.3 0.0 0.0 0.1 0.7 0.3 0.3 0.1 0.1 0.2 0.3 0.1 0.5 0.1 0.0 0.0 0.1 0.4 0.0 0.0 0.0 0.1 0.1 0.7 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 0.1 5.4 2.9 1.3 7.0 6.0 2.1 1.2 2.5 3.3 1.8 0.0 0.3 0.0 0.1 0.0 0.9 0.3 2.5 0.0 0.0 0.0 13.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 2.8 1.6 0.0 1.8 0.0 0.0 1.1 0.0 0.0 0.0 0.0 51.3 0.1 0.0 1.1 0.0 22.4 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.1 TRPM1 "CSNB1C, LTRPC1, MLSN1" ENSG00000134160 "Transient receptor potential cation channel subfamily M member 1" Q7Z4N2 15 31001061-31161273 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Sensory transduction, Transport, Vision" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital stationary night blindness, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "retina: 99.0" "Cell type enriched" "Detected in some" 5 "Bipolar cells: 705.2" "Cancer enriched" "Detected in single" 179 "melanoma: 14.6" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in single" "naive B-cell: 1.0" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in single" 113 "SK-MEL-30: 16.3" "Not detected" "Not detected" "Not detected" "Not detected" "HPA014779, HPA071139" Enhanced Uncertain "Golgi apparatus,Plasma membrane,Centriolar satellite" NA NA "Centriolar satellite" "Golgi apparatus, Plasma membrane" "HPA014779: AB_2669090, HPA071139: " "unprognostic (5.28e-2)" "unprognostic (1.35e-1)" "unprognostic (9.89e-2)" "unprognostic (3.07e-1)" "unprognostic (1.97e-1)" "unprognostic (1.70e-1)" "unprognostic (1.29e-3)" "unprognostic (2.83e-1)" "unprognostic (2.89e-2)" "unprognostic (1.67e-1)" "unprognostic (1.45e-2)" "unprognostic (2.58e-1)" "unprognostic (7.84e-2)" "unprognostic (6.20e-4)" "unprognostic (1.48e-1)" "unprognostic (2.63e-2)" 0.1 0.0 0.4 0.0 0.6 0.0 0.1 0.1 0.3 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.2 0.3 0.1 0.1 0.1 1.6 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 99.0 0.4 0.0 0.2 10.4 0.0 0.1 1.9 0.0 0.0 2.9 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.0 0.0 0.3 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.1 0.4 0.6 0.1 0.3 0.7 0.2 1.6 0.0 0.3 0.1 0.0 0.0 0.0 0.0 3.8 705.2 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 30.8 0.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.1 12.7 0.0 0.0 0.0 2.4 0.0 0.0 150.1 0.0 0.0 10.0 0.0 0.0 0.0 0.6 18.1 0.0 0.0 7.9 3.8 0.9 0.8 0.0 0.0 0.0 TYR "OCA1, OCA1A, OCAIA" ENSG00000077498 Tyrosinase P14679 11 89177452-89295759 "Disease related genes, Enzymes, FDA approved drug targets, Predicted membrane proteins" "Melanin biosynthesis" "Monooxygenase, Oxidoreductase, Tumor antigen" "Albinism, Deafness, Disease mutation, FDA approved drug targets, Waardenburg syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 70 "retina: 82.0;skin 1: 25.2" "Cell type enriched" "Detected in some" 8 "Melanocytes: 175.5" "Cancer enriched" "Detected in single" 1755 "melanoma: 351.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 864 "SK-MEL-30: 86.4" "Not detected" "Not detected" "Not detected" "Not detected" "CAB000079, HPA043241, HPA050889, HPA064583" Enhanced Enhanced Vesicles NA NA Vesicles "CAB000079: AB_564045, HPA043241: AB_2678383, HPA050889: AB_2681264, HPA064583: " "unprognostic (1.16e-1)" "unprognostic (1.01e-1)" "unprognostic (1.85e-3)" "unprognostic (9.75e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 82.0 0.7 0.0 0.0 25.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 86.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.3 0.0 175.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 1.8 0.0 0.0 0.0 0.0 UNC119 "HRG4, POC7, POC7A" ENSG00000109103 "Unc-119 lipid binding chaperone" Q13432 17 28546707-28552668 "Disease related genes, Predicted intracellular proteins" "Endocytosis, Protein transport, Sensory transduction, Transport, Vision" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "retina: 197.8" "Group enriched" "Detected in many" 6 "Bipolar cells: 683.7;Cone photoreceptor cells: 807.0;Rod photoreceptor cells: 1668.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041912 Enhanced NA NA "HPA041912: AB_10795267" "unprognostic (8.93e-2)" "unprognostic (3.34e-1)" "unprognostic (1.98e-1)" "unprognostic (1.14e-3)" "unprognostic (4.95e-3)" "unprognostic (2.10e-1)" "unprognostic (1.44e-2)" "unprognostic (6.64e-2)" "prognostic unfavorable (2.38e-4)" "unprognostic (2.76e-3)" "prognostic favorable (8.09e-5)" "unprognostic (2.65e-1)" "unprognostic (8.08e-3)" "unprognostic (5.51e-3)" "unprognostic (1.87e-1)" "prognostic unfavorable (9.82e-4)" "unprognostic (1.71e-3)" 10.0 12.3 15.0 15.1 16.1 34.8 10.3 16.3 21.6 10.1 8.2 6.8 9.1 8.1 9.3 12.9 11.5 9.5 10.2 9.8 15.4 19.8 14.3 20.7 9.0 18.1 13.3 10.1 10.6 13.5 10.5 12.5 8.3 13.3 12.1 7.6 197.8 17.3 15.0 4.4 15.3 10.2 9.5 6.5 23.7 7.7 22.9 6.4 11.4 12.1 5.7 19.7 11.4 10.3 9.1 22.4 32.3 47.9 4.3 4.9 7.4 12.2 15.5 15.6 21.6 16.4 16.1 7.7 10.2 14.0 18.5 17.5 21.5 4.1 10.1 11.1 15.5 12.7 20.4 13.1 15.1 9.9 18.7 24.5 7.0 7.5 6.5 11.3 10.3 22.0 14.7 20.9 13.3 6.7 17.5 14.8 11.0 7.1 8.4 11.3 19.3 10.1 10.4 15.1 10.4 11.3 16.3 25.5 4.4 14.0 13.7 6.1 21.4 14.6 23.9 15.2 18.9 18.8 17.8 11.1 10.7 20.4 17.2 9.8 9.6 9.9 2.2 17.6 16.7 9.7 5.2 11.5 28.2 2.2 27.9 2.3 6.8 4.3 3.5 20.0 9.1 4.9 3.4 32.3 4.3 47.9 22.4 3.7 7.4 15.0 16.1 16.3 21.6 15.4 19.8 13.3 10.1 13.3 6.4 0.0 4.8 13.7 16.5 11.8 683.7 10.9 12.7 2.7 2.3 12.2 807.0 21.7 28.2 17.0 2.0 14.3 16.5 0.0 16.2 7.5 14.3 18.3 12.7 10.4 31.4 138.2 24.3 10.4 32.2 4.0 13.6 47.2 18.6 55.1 13.5 174.9 15.8 13.9 20.1 16.1 1668.5 45.3 15.3 1.7 11.3 12.5 16.7 18.8 11.4 16.9 VAT1L KIAA1576 ENSG00000171724 "Vesicle amine transport 1 like" Q9HCJ6 16 77788530-77980107 "Plasma proteins, Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adrenal gland: 57.3;brain: 47.1;retina: 32.1" "Group enriched" "Detected in some" 15 "Horizontal cells: 281.3;Muller glia cells: 83.1" "Cancer enhanced" "Detected in many" "glioma: 7.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.1" "Lineage enhanced" "Detected in single" "dendritic cells: 1.1" "Cell line enhanced" "Detected in some" "AF22: 9.4;BJ hTERT+: 27.7;fHDF/TERT166: 15.1;NTERA-2: 32.6;U-87 MG: 34.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044061, CAB046032, HPA061138" Enhanced Approved Cytosol NA NA Cytosol "CAB046032: AB_11126308, HPA044061: AB_10959610, HPA061138: " "unprognostic (1.49e-2)" "unprognostic (8.74e-3)" "unprognostic (8.80e-3)" "unprognostic (3.39e-2)" "unprognostic (3.62e-2)" "unprognostic (1.70e-2)" "unprognostic (2.39e-3)" "unprognostic (1.37e-1)" "unprognostic (1.86e-1)" "unprognostic (7.65e-2)" "unprognostic (8.57e-3)" "unprognostic (2.46e-1)" "prognostic unfavorable (3.01e-6)" "unprognostic (2.50e-2)" "unprognostic (6.53e-2)" "unprognostic (1.19e-1)" "unprognostic (5.96e-2)" 1.1 57.3 7.9 3.0 41.3 1.2 1.0 28.4 20.1 1.3 3.4 5.7 0.0 2.4 1.8 6.3 2.0 1.4 3.8 12.7 3.8 47.1 5.3 1.4 0.9 1.0 8.4 12.7 0.9 2.1 0.6 1.5 2.0 27.2 0.8 5.2 32.1 0.9 1.0 0.6 0.6 3.1 2.6 15.4 0.7 1.7 2.1 5.8 0.0 2.0 0.0 2.4 1.4 0.4 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 3.2 0.0 0.0 1.1 27.7 0.3 0.3 0.0 0.0 0.0 0.0 15.1 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.3 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 32.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.2 1.5 0.0 0.4 0.0 6.0 0.0 7.3 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 34.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 41.3 28.4 9.1 3.8 47.1 8.4 12.7 27.2 5.8 0.0 0.0 0.0 0.0 0.0 7.2 8.7 5.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.2 281.3 2.9 0.0 0.0 2.3 0.0 0.0 0.0 1.0 0.0 83.1 0.1 0.0 0.0 0.0 11.8 0.0 0.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 VSX2 "CHX10, HOX10, RET1" ENSG00000119614 "Visual system homeobox 2" P58304 14 74239472-74262738 "Disease related genes, Predicted intracellular proteins, Transcription factors" "Sensory transduction, Transcription, Transcription regulation, Vision" "Activator, Developmental protein, DNA-binding, Repressor" "Cataract, Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "retina: 29.0" "Group enriched" "Detected in some" 10 "Bipolar cells: 128.4;Muller glia cells: 90.5" "Cancer enriched" "Detected in single" 34 "testis cancer: 2.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 1.3;HAP1: 1.0;SK-BR-3: 1.2;U-698: 1.4" "Not detected" "Not detected" "Region enriched" "Detected in single" 13 "pons and medulla: 2.3" HPA003436 Enhanced NA NA "HPA003436: AB_1078523" "unprognostic (2.87e-1)" "unprognostic (1.22e-1)" "unprognostic (2.79e-1)" "unprognostic (3.29e-1)" "unprognostic (3.21e-4)" "unprognostic (7.77e-2)" "unprognostic (8.39e-4)" "unprognostic (3.13e-1)" 0.3 0.1 0.3 0.4 1.0 0.2 0.1 0.3 0.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.4 0.0 0.0 0.1 1.7 0.5 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.1 0.1 29.0 0.0 0.0 0.1 0.0 0.0 0.0 1.4 0.0 0.0 1.6 0.0 0.2 0.2 0.0 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.2 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 1.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.0 0.3 0.2 0.5 0.4 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 128.4 0.3 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 90.5 0.0 0.0 0.0 0.0 10.6 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0